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The enzyme Topoisomerase II Beta (Top2B) has previously been shown to be a crucial 
component of neuronal differentiation and development in mammals. It is also 
expressed in adult neuronal tissue where it plays important roles in facilitating 
transcription of long genes and early response genes and may also be involved in DNA 
repair. To date, studies investigating age-related changes in Top2B expression in 
neuronal tissue are limited and the importance of Top2B in the maintenance of neuronal 
function and integrity during ageing has not yet been fully elucidated, thus this study 
aimed to further investigate Top2B during the ageing process. 
The development of an in vitro murine model of neuronal ageing was successfully 
achieved using the Cath.a-differentiated (CAD) cell line. A neuronal-like phenotype in 
CAD cells was achieved through serum starvation and cells were then chronologically 
aged. Levels of Top2B mRNA and protein were seen to decline significantly during 
ageing of the cells in RT-qPCR and western blotting experiments, respectively. 
Concomitant increases in protein levels of the tumour suppressor gene p21 were also 
observed as well as a significant accumulation of double strand breaks as shown by 
γH2AX assays. In addition, preliminary in vivo experiments also revealed age-related 
declines of Top2B in mouse hippocampus. The development of an equivalent human in 
vitro model using the human neuroblastoma cell line SH-SY5Y was unsuccessful.  
Further in vivo experiments using Drosophila brain tissue also revealed significant age-
related declines in Topoisomerase II (Top2) protein levels with ageing in both males 
and females, which was accompanied by a decline in locomotor function and increases 
in advanced glycation end-products (AGEs) in females. Interestingly, in Drosophila this 
was not accompanied by a reduction in Top2 mRNA levels.  
Reduction in the levels of mouse Top2B and Drosophila Top2 with age may have 
profound effects on transcription and the ability of cells to repair DNA damage and may 
result in increased vulnerability to oxidative stress, ultimately having detrimental effects 
on longevity and normal ageing. Thus, these models offer an opportunity to further 
elucidate the functional effect of this loss, its causes and potential pharmaceutical 
interventions to reverse these effects. Importantly, they also illustrate the need for such 
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1.  Introduction 
1.1 Effects of ageing  
Ageing is a gradual, continuous process that is characterised by an aggregation of   
biological changes that leads to functional decline in humans resulting ultimately in 
death (Liguori et al., 2018). Losses in regenerative potential, decreases in genomic 
stability and alterations to metabolism are all key molecular features of cellular ageing 
and can be driven by biological processes such as cellular senescence and oxidative 
stress-induced DNA damage (Kubben & Misteli, 2017). Ageing is not determined and 
caused by any single event, but rather a whole host of biological and environmental 
factors that influence and affect the rate at which biological ageing occurs (Partridge, 
2010). Age-related declines in function not only give rise to mental and physical 
impairments, such as problems with language comprehension, memory loss, reductions 
in grip strength and increases in hip fractures (Haigh, 1993; Harada et al., 2013; Kubben 
& Misteli, 2017) but also susceptibility to developing diseases, such as diabetes and 
cancer, as well as other conditions affecting cardiovascular and musculoskeletal health 
(McPhee et al., 2016; Houck et al., 2018).  
Neurodegeneration is a common problem associated with ageing (Kritsilis et al., 2018). 
The nervous system, consisting of the central nervous system (CNS) and the peripheral 
nervous system (PSN), is a group of complex and specialised cells that interact and 
coordinate bodily responses to sensory information through the transmission of 
electrochemical signals via neural pathways to create somatic and autonomic outputs 
(Llinas, 1988; Monje, 2018). Normally, neuronal cells transmit these electrochemical 
signals and relay information between afferent and efferent neurons, which allows the 
body to maintain homeostatic regulation of all systems (Ramocki & Zoghbi, 2008). 
Cellular metabolism and other fundamental processes experience reductions in 
efficiency with age and can lead to a number of neurodegenerative diseases, such as 
Alzheimer’s disease and Parkinson’s disease, which typically manifest in the elderly. 
Thus, ageing is a major risk factor for neurodegeneration (Kritsilis et al., 2018). 
Autopsy analysis of aged brains that have not been diagnosed with neurological 
conditions consistently show synaptic dystrophy, a loss of neurons and brain volume as 
well as the accumulation of Lewy bodies, amyloid plaques and TAR DNA-binding 
protein 43 (TDP-43) when compared to younger brains (Chen-Plotkin et al., 2010; 
Wyss-Coray, 2016). Alzheimer’s disease, which is characterised by progressive declines 
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in memory, language, problem solving and other cognitive functions (Venkataraman et 
al., 2013), and Parkinson’s disease, which is a progressive nervous system disorder that 
affects movement, show significant increases in a number of these proteins, which 
suggests an important overlap between ageing and neurodegeneration (Elobeid et al., 
2016). Numerous factors including genetic mutations, environmental toxins and 
components of the diet may bring about neuronal cell death in ageing and 
neurodegenerative diseases (Hutchins & Barger, 1998; Castelli et al., 2019). These 
potential triggers can cause initiating factors to promote alterations to cellular functions, 
including energy and calcium homeostasis changes, increased oxygen radical 
production and apoptotic cascade activation. These cellular alterations, occurring in 
conjunction to age-related increases of oxidative stress, dysregulation of energy and ion 
homeostasis and decreases in DNA stability, can challenge neuronal integrity and cause 
disruptions to synaptic function and promote cell death (Mattson & Magnus, 2006).  
 
1.2 Cellular senescence 
Cellular senescence is a homeostatic response that aims to prevent an accumulation of 
damaged cells and development of pro-carcinogenic mutations through a phenotype 
typically characterised by irreversible cell cycle arrest (Moreno-Blas et al., 2019). 
Unlike necrosis and apoptosis, senescent cells remain metabolically active and can be 
divided into acute and chronically senescent cells (Martínez-Cué & Rueda, 2020). 
Acute senescence occurs during biological processes in embryonic development and 
tissue repair, whereas chronic senescence is induced over prolonged periods of stress. 
Cellular senescence primarily has roles in anti-tumour responses but evidence has 
shown that the loss of function associated with ageing and age related diseases can 
partly be accredited to chronic cellular senescence (Martínez-Cué & Rueda, 2020). 
Different categories of chronic cellular senescence have been identified and are used to 
describe the way in which a cell becomes senescent. Primarily, senescence is caused 
through replicative senescence or stress-induced premature senescence (Jurk et al., 
2012). Replicative senescence occurs over prolonged periods of time during normal cell 
division. After each division telomeres become shorter. The shortening of telomeres 
reduces the protection available to the end of a chromosome and can leave them 
exposed to DNA damage, which in turn triggers a DNA damage response. If DNA 
repair pathways cannot repair the damage, chronic DNA damage response signalling 
can initiate other pathways, including cell death by apoptosis or induction of cell cycle 
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arrest via replicative senescence, both of which possess potential anti-cancer functions 
(Campisi, 1997; Herranz & Gil, 2018). Stress-induced premature senescence is 
described as the early onset of senescence in cells resulting from prolonged or repeated 
exposure to sub-cytotoxic concentrations of cellular stressors, such as oxidative stress 
(Kuilman et al., 2010). The increase of cells displaying this phenotype occurs during 
healthy ageing but also contributes to functional alterations associated with 
neurodegenerative diseases (Fielder et al., 2017).  
Cellular senescence is not just limited to a phenotype of cell cycle arrest but a range of 
changes in protein expression and secretion, which ultimately causes a cell to develop a 
senescence-associated secretory phenotype (SASP) (Coppé et al., 2010). Persistent 
DNA damage signalling causes the synthesis and release of inflammatory cytokines, 
chemokines, growth factors and secreted insoluble proteins/extracellular matrix 
components and are all characteristics of SASP (Chen et al., 2015). Both endogenous 
and exogenous stresses are regulated by complex signalling pathways. Persistent DNA 
damage response signalling proteins Ataxia Telangiectasia Mutated (ATM) and 
checkpoint kinase-2 (CHK2) have been shown to be essential for the secretion of 
senescence-associated cytokines, such as interleukin-6 (IL-6) and tumour necrosis 
factors (Raghuram & Mishra, 2014). IL-6 expression in senescent cells has been shown 
to directly affect neighbouring cells and subsequently cause progressive expression of 
the transcription factor nuclear factor kappa B (NF-κB). The expression of the 
proinflammatory NF-κB signalling system is thought to be the crucial pathway that 
induces SASP and inflammatory responses in cellular senescence (Salminen et al., 
2012). Mitochondrial dysfunction, which is predominantly caused by oxidative stress, is 
one of the leading triggers of senescence (Chapman et al., 2019). Dysfunction of 
mitochondria alters cell signalling and subsequently causes SASP (Vizioli et al., 2020). 
Molecules that are secreted by SASP have been seen to have both beneficial and 
deleterious roles to play throughout different life stages (Coppé et al., 2008). 
Senescence is thought to follow the antagonistic pleiotropic theory of ageing, which 
proposes that age-related declines in function are partly due to genetic programs that are 
pleiotropic. The theory suggests that genes that are beneficial to reproduction in early 
life are favoured by natural selection despite any negative effects that these genes might 
have in later life (Williams, 1957; Austad & Hoffman, 2018). Senescence-induced cell 
cycle arrest has beneficial properties as it can prevent neoplastic malignancies from 
developing. However, an accumulation of non-proliferating senescent cells can reduce 
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the ability of renewable tissues to repair or regenerate (Pérez-Garijo & Steller, 2014). 
Cytokine network components of SASP contribute to the maintenance of senescence 
cell-cycle arrest. It is also suggested that numerous components of SASP contribute to 
tissue repair and regeneration by signalling and initiating DNA damage responses 
(Kritsilis et al., 2018). However, as more senescent cells develop through life, persistent 
signalling of these molecules contributes to a chronic inflammatory status, which is a 
pervasive characteristic of ageing and a key driving force of age-related dysfunction 
(Coppé et al., 2008). DNA damage signalling is known to activate the tumour 
suppressor gene p53 (Ungewitter & Scrable, 2009). p53 activities can determine the fate 
of damaged cells, i.e. whether they enter apoptosis or senescence. p53 possesses 
regulatory effects on the SASP through transcriptional regulation of its target genes and 
has been shown to actively restrain it, thus preventing the development of a 
proinflammatory environment (Beauséjour et al., 2003). Age-related declines in p53 
expression causes a quick increase in cells developing SASP (Feng et al., 2007). The 
age-related accumulation of senescent cells with inflammatory characteristics have been 
seen to be a driving force of cancer with many proteases secreted by senescent cells 
overlapping with those found in malignant tumours (Coppé et al., 2010).  
No individual marker of senescence can be measured or monitored to confirm if a cell is 
senescent. However, a number of common features of senescent cells can be observed 
to suggest a senescent phenotype: Senescence-associated β-galactosidase is a lysosomal 
enzyme most commonly used as a senescence biomarker (Dimri et al., 1995). A 
common feature of senescent cells is a persistent DNA damage response, which can be 
detected through analysis of phosphorylated H2A histone family member X (γH2AX) 
foci (Redona et al., 2002), which become elevated in senescent cells at the sites of DNA 





 increase during senescence and are also used as biomarkers 
(Caliò et al., 2015). An accumulation of the nondegradable oxidation product lipofuscin 
can also be seen commonly in aged post-mitotic cells (Moreno-García et al., 2018).   
Although fully-differentiated neuronal cells are post-mitotic and do not display typical 
senescence-associated cell cycle arrest, they have been shown to express other key 
features of senescent cells and develop a senescence-like state (Fielder et al., 2017). The 
cell cycle arrest of proliferating cells, which is conventionally seen as the defining 
hallmark of mitotic cellular senescence, has been suggested to be just one of many 
phenotypic changes that occur due to the downstream effects of signalling pathways of 
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the DNA damage response. Therefore, senescence is not exclusive to proliferating cells 
and can be used to describe senescence-like states of post-mitotic cells such as neurons 
(Jurk et al., 2012). An increase in oxidative stress has been shown to be associated with 
increased activity of the tumour suppressor gene p21 and senescence-associated β-
galactosidase in the neurons of mice (Jurk et al., 2012). This is a phenotype that has 
been shown to become more prominent with ageing as the efficiency of DNA repair 
mechanisms, such as non-homologous end joining, declines with age, thus contributing 
to increased genomic instability and incidence of neurodegeneration (Vaidya et al., 
2014).  
1.2.1 Oxidative stress and DNA damage in neurons 
During normal ageing neuronal cells develop an accumulation of damaged proteins, 
whilst experiencing increased levels of oxidative stress. This can cause mutations in 
nucleic acids and disrupt normal energy homeostasis (Castelli et al., 2019). The effects 
of normal ageing are amplified in neurodegenerative diseases (Mattson & Magnus, 
2006). Numerous neurodegenerative diseases are linked to increases in oxidative stress 
and subsequent DNA damage including: Parkinson’s disease, Alzheimer’s disease, 
multiple sclerosis, motor neurone disease, Huntington’s disease, mild cognitive 
impairment and cerebral ischemia (Venkataraman et al., 2013). 
The balance between reactive oxygen species (ROS) and the antioxidant system is 
crucial for the maintenance of structural and functional qualities of neurons and 
subsequently the brain. The point at which cellular antioxidant defences are no longer 
able to keep ROS below the threshold for toxicity describes the state of ‘oxidative 
stress’ (Schulz et al., 2001). ROS are the main source of oxidative stress in living 
organisms and include oxygen-derived molecules such as hydrogen peroxide, 
superoxide and hydroxyl radicals that are highly reactive towards biomolecules (Aguiar 
et al., 2013). Glutathione is one of the most abundant small molecule antioxidant thiols 
and is heavily involved in the modulation of ROS and is a key component of the 
oxidative stress response. Age-related declines of intracellular glutathione 
concentrations have been demonstrated in murine brain models (Sasaki et al., 2001; 
Wang et al., 2003). In response to an increase of ROS, the transcription factor nuclear 
factor erythroid 2-related factor (Nrf2) becomes active. Activation of the Nrf2 pathway 
causes the expression of numerous endogenous antioxidants to increase, which helps to 
counteract ROS accumulation. The activation of Nrf2 has also been shown to decline in 
an age-related manner (Duan et al., 2009). Reductions in glutathione and reduced 
6 
 
activation of Nrf2 transcription factors contribute to the overall increase of oxidative 
stress throughout the ageing process.  
Excess levels of ROS contribute to adverse modifications of cellular components and 
can amplify the development of damage to DNA, lipids and proteins and can induce 
apoptosis and necrosis (Lundgren et al., 2018). The formation of DNA base lesions is 
one of the most deleterious consequences of oxidative stress. When bases become 
oxidised the base excision repair (BER) pathway typically recognises the damage and 
repairs it. However, when bases become simultaneously oxidised on opposing strands of 
DNA, attempted repair through BER can lead to double strand breaks in which sites on 
both strands of the DNA helix are broken on the sugar phosphate backbone (Srinivas et 
al., 2019). Closely spaced transversion mutations can lead to lesions such as this and 
can be severely genotoxic if left unrepaired. The low redox potential of guanine makes 
it the most vulnerable base to oxidative stress, with 7,8-dihydro-8-oxoguanine (8-oxoG) 
being the predominant product of guanine oxidation. As guanine is the most vulnerable 
base, 8-oxoG is subsequently the most common base lesion caused by ROS (Aguiar et 
al., 2013). 8-oxoG is considered one of the predominant endogenous mutagens that 
contribute greatly to spontaneous cell transformations if left unrepaired. During 
replication 8-oxoG frequently mispairs with adenine as it is functionally able to mimic 
thymine. Consequently, this can lead to an increase in the number of G:C to T:A 
transversion mutations, which are among the most common somatic mutations seen in 
human cancers (Nakabeppu, 2014).  
The lipid content of neurons is high and makes them particularly susceptible to lipid 
peroxidation, the process by which electrons are removed from lipids by ROS and, in 
turn, cause damage to the membrane structure of a cell. The predominant source of 
endogenous ROS originates from the oxidative metabolism of mitochondria as by-
products in the forms of superoxide anions and hydrogen peroxide, which are produced 
through the action of the electron transport chain (Votyakova & Reynolds, 2001).  
1.2.2 DNA repair in neurons 
The proper repair of DNA damage is vital for the preservation of genomic integrity. In 
neurons the majority of DNA damage is caused by oxidative stress. As previously 
stated, one of the DNA repair pathways responsible for repairing this damage and 
maintaining genomic integrity is the base excision repair pathway (BER) (Fleming et 
al., 2017). Bases that become oxidatively damaged, deaminated cytidines and adenines 
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and single strand breaks (SSBs) are primarily repaired through BER (Yang et al., 2019). 
In addition to this, there are two main repair pathways that repair DSBs, non-
homologous end joining (NHEJ) and homologous recombination (HR) (Brandsma & 
Gent, 2012). The error-prone NHEJ pathway is the predominant DSB repair pathway in 
neurons (Vyjayanti & Rao, 2006) with NHEJ activity seen in both developing and post-
mitotic neurons (Oka et al., 2000; Kanungo, 2012). It had been assumed that the NHEJ 
pathway was the only pathway utilised in post-mitotic neurons to repair DSBs 
associated with oxidative damage as HR typically requires a sister chromatid template, 
which is not present in non-replicating neuronal cells. However, recent studies have 
discovered RNA-templated HR repair mechanisms of DSBs in terminally differentiated 
post-mitotic neurons at active transcription sites. The HR repair protein RAD52 has 
been shown to be recruited to DSB sites and has demonstrated an HR repair mechanism 
in these cells (Welty et al., 2018). In addition to BER, NHEJ and HR, other repair 
pathways have shown to be of importance in response to DNA damage such as 
nucleotide excision repair (NER) and mismatch repair (MMR). NER is the main repair 
pathway used by mammals to remove bulky DNA lesions, which can be caused by 
numerous factors including ROS (Schärer, 2013). Lesions such as this can cause large 
disruptions to transcription and replication. Although mismatch repair recognises and 
repairs incorrectly paired nucleotides predominantly in replicating cells, studies in 
differentiated neuroblastoma SH-SY5Y cells suggest that neurons possess MMR 
activity and that it is triggered following oxidative stress (Fishel et al., 2007).  
With important roles in a number of cellular processes such as DNA replication, 
transcription, recombination, chromosome organization and segregation as well as being 
a pivotal enzyme during neuronal development, it has been suggested that the enzyme 
Topoisomerase II beta (Top2B) may be involved in DNA repair processes (Emmons et 
al., 2006; Gupta et al., 2012; Morotomi-Yano et al., 2018). Top2B is a member of a 
larger family of enzymes that possess the ability to regulate DNA topology in all cells 








1.3 Topoisomerase family 
1.3.1 Topoisomerase classification 
The topology of the double helix structure of DNA, i.e., the way in which it tightly 
twists and coils to remain compact, can cause numerous issues for biological processes 
such as transcription, replication, recombination and repair where strand separation and 
access to single strands of DNA is required. Discovered during the 1970s (Wang, 1971), 
DNA topoisomerases are a family of enzymes that control the topological state of DNA 
by catalysing transient SSBs or DSBs and allowing an intact single strand of DNA or a 
DNA duplex to pass through the break, respectively. The enzyme then reseals the break 
(Nitiss, 2009). 
Topoisomerases are divided into a number of classes depending on their structural and 
biological functions. Primarily topoisomerases are divided into type 1 and type 2 
variants. Topoisomerases that cleave and reseal only one single strand of DNA are 
classified as type 1 topoisomerases. Type 1 topoisomerases can be further classified into 
subfamilies, which include those that link to a 5’ phosphate in the cleaved DNA (Type 
IA) and those that link to a 3’ phosphate in the cleaved DNA (Type 1B) (Champoux, 
2001). Topoisomerases that cleave both strands of DNA to create a double strand DNA 
break prior to religation are described as being type 2 topoisomerases (Harkin et al., 
2015) with any further divisions of the subfamilies being due to structural differences 
(Table 1.1). Type 2 topoisomerases are classified as either Type IIA or Type IIB. They 
share homologous B subunits (N-terminal domains) but their A subunits (central 
domains) share neither sequence or structural homology, so are therefore classified 













Table 1.1 Classification of Type I and II topoisomerases (Champoux, 2001) 
Topoisomerase  Subfamily Type 
Eubacterial DNA topoisomerase I & III  IA 
Yeast DNA topoisomerase III  IA 
Mammalian DNA topoisomerase III α & β  IA 
Eubacterial and archaeal reverse DNA gyrase  IA 
Eukaryotic DNA topoisomerase I IB 
Poxvirus DNA topoisomerase IB 
Eubacterial DNA topoisomerase V IB 
Eubacterial DNA gyrase IIA 
Eubacterial DNA topoisomerase IV IIA 
Yeast/Drosophila DNA topoisomerase II IIA 
Mammalian DNA topoisomerase II alpha IIA 
Mammalian DNA topoisomerase II beta IIA 











1.3.2 Catalytic cycle of topoisomerase II 
The overall reaction strategy of eukaryotic type 2 topoisomerases is the generation of a 
transient double strand break in one DNA duplex and passing an unbroken DNA duplex 
through it, before resealing the break in order to relax torsional stress and resolve knots 









Figure 1.1 Diagrammatical representation of the actions of type 2 topoisomerases on DNA 
topology (Nitiss, 2009). 
 
The catalytic domains of topoisomerase II include an N-terminal domain, a central 
domain and a C-terminal domain (Figure 1.2) (Burden & Osheroff, 1998). The catalytic 
cycle of eukaryotic topoisomerase II is initiated by the binding of the enzyme to its 
DNA substrate. Initially, prior to nucleotide binding, the highly conserved N-terminal 
domain, which contains the ATPase domain, is in an open conformation. This allows 
one DNA duplex (termed the G-segment) to bind to the gated region of the central 
domain, which resides in the interior of the enzyme (Laponagov et al., 2013). The 
segment of DNA to be transported and passed through the G-segment, known as the T-
segment, then travels through the open region of the N-terminal. The binding of ATP 
molecules then causes a 90
°
 movement of the domains such that they dimerize and 
capture the T-segment in its interior, creating a closed clamp conformation (Schmidt et 














Figure 1.2 Structural domains of topoisomerase II.                                                
The three structural domains of topoisomerase II shown as the N-terminal domain, the central 
DNA binding domain, which is divided into the Toprim (topoisomerase-primase) domain (red), 
Winged Helix domain (WHD)/ catabolite activation protein (CAP) (orange) and the tower 
domain (green), and the C-terminal domain (C-gate coloured yellow) (Riccio et al., 2019). 
 
The ATPase region initiates significant conformational changes to the enzyme, which 
ultimately leads to the cleavage of the G-segment of DNA through the actions of the 
Toprim and WHD/CAP subdomains forming a G-gate (Aravind et al., 1998). These 
domains transiently cleave a pair of opposing phosphodiester bonds four base pairs 
apart in the G-segment of DNA, in the presence of Mg
2+
, which generates a staggered 
topoisomerase II-DNA cleavage complex (Wu et al., 2011). This is achieved by a 
transesterification reaction mediated by a conserved tyrosine residue in both subunits of 
the enzyme. As a result, the active site tyrosines (Residue 821) become transiently 
covalently linked to the 5’ ends phosphoryl groups via covalent phosphotyrosine bonds 
(Deweese & Osheroff, 2009). Simultaneously, events in the ATPase domain also 
prompt the opening of the G-gate through which the T-segment can be passed (Berger et 
al., 1996). Once the T-segment reaches the lower cavity of the enzyme next to the C-
gate, the G-gate closes and is resealed via a transesterification reaction between the 
hydroxyl groups of the G-segments 3’ ends and the phosphotyrosyl linkages (Berger et 
al., 1996). The T-segment is then released via the opening and closure of the C-gate at 










through the G-gate and concludes to allow the N-gate to reopen, allowing further 
catalytic cycles to take place (Figure 1.3) (Burden & Osheroff, 1998; Champoux, 2001). 
The mechanism of DNA cleavage utilised by topoisomerase II provides a number of 
advantages. The nature of the covalent complexes that are created between 
topoisomerase II and the G-segment are mostly freely reversible. This helps to protect 
the integrity of the cleaved DNA strands as no rearrangement or recombination of the 
DNA occurs during religation (Nitiss, 2009). This reversible covalent bond also allows 










Figure 1.3 Diagrammatical representation of the mechanism of topoisomerase II isoforms. 
Adapted from Laponogov et al. (2013).                                             
Topoisomerase II resembles the shape of an open clamp prior to interaction with DNA. The 
section of DNA to be cleaved (G-segment) binds to a gated region in the central domain of 
topoisomerase II known as the DNA gate (1). The T-segment approaches and moves through 
the gate region of the N-terminal and subsequent binding of ATP causes this gate to close 
behind the DNA segment (2) (Laponogov et al., 2013). The G-segment is then cleaved to form 
the G-gate by transesterification reactions, which results in the 5’ ends of the strands becoming 
linked to tyrosine residues through covalent phosphotyrosyl bonds. Hydrolysis of the first ATP 
to ADP + Pi allows the T-segment to be transported through the G-gate (3). The G-gate is then 
resealed and the T segment is released via the C-gate (4). The closing of the C-gate through 
hydrolysis of the second ATP and subsequent release of ADP + Pi resets the ATPase domains 
back to the open conformation (the N-terminal domain reopens) allowing further catalytic 





1.3.3 Structure of type II topoisomerases 
Eukaryotic type 2 topoisomerases function as homodimeric enzymes and when aligning 
amino acid sequences to that of the Type II topoisomerase found in bacteria, DNA 
gyrase (Figure 1.4), three distinct functional domains that are linked by flexible hinge 
regions are identifiable (Champoux, 2001). Eukaryotic topoisomerase II isoforms share 
up to 65% homology with DNA gyrase. DNA gyrase was the first type 2 topoisomerase 









Figure 1.4 Homology of amino acid sequences in type II topoisomerases. 
Type 2 topoisomerase amino acid sequence homology compared to bacterial DNA gyrase. N-
terminal domains of eukaryotic topoisomerase II (B’), E.coli topo IV (ParE) and E.coli DNA 
gyrase (GyrB) are shaded grey. Central domains A’, ParC and GyrA are shown with grey 
diagonal shading and C-terminal domains are coloured white (Champoux, 2001). 
 
The catalytic domains of topoisomerase II include an N-terminal domain, a central 
domain and a C-terminal domain (Figure 1.2) (Burden & Osheroff, 1998). The N-
terminal domain, which approximately spans the first 660 amino acids of type 2 
topoisomerases and is the most conserved domain within the family, is homologous to 
the B subunit of DNA gyrase and contains the active site for ATP binding (Corbett & 
Berger, 2004; Burden & Osheroff, 1998). This region can be divided into two 
subdomains, which include the GHKL (gyrase, HSP90, histidine kinase, MutL) ATP 
binding domain and a transducer domain, which forms a gated region known as the N-
Gate (Schmidt et al., 2012). The A subunit of DNA gyrase, which extends to 
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approximately amino acid 1200, is homologous to the central domain of topoisomerase 
II and is the domain responsible for DNA binding through an active site tyrosine residue 
(Laponogov et al., 2013). The central domain has a large central cavity and can be 
divided into three subdomains, which together form the DNA-gate region of the 
enzyme. These include the Winged Helix Domain (WHD) (sometimes referred to as 
catabolite activator protein [CAP] domains), which contains the conserved catalytic 
tyrosine, the Toprim (topoisomerase-primase) domain, which contains the acidic triad 
DXD motif involved in metal binding, and  the tower domain (Nitiss, 2009; Bedez et 
al., 2018). The Toprim domain contains a cluster of conserved acidic residues that are 
thought to form binding sites for Mg
2+
 ions, which are a crucial cofactor essential to 
complete catalytic function (Corbett & Berger, 2004). The C-terminal of topoisomerase 
II is the most variable domain and contains no regions of amino acid sequence 
homology with DNA gyrase (Sengupta et al., 2003). The C-terminal domain of 
topoisomerase II plays roles in the regulation of cellular functions including key nuclear 
localisation signalling and many post-translational modifications including 
phosphorylation, acetylation, sumoylation and ubiquitination (Adachi et al., 1997; 
Linka et al., 2007).  
1.3.4 Topoisomerase II isoforms 
First discovered in the 1970s (Wang, 1971; Gellert et al., 1976), DNA gyrase isolated 
from E.coli was the first type 2 topoisomerase to be identified. In mammals, research 
from Drake et al. (1987) showed that analysis of purified topoisomerase II from the 
P388 leukaemia cell line by SDS-PAGE gave two protein bands for topoisomerase II; 
one band at 170 KDa and one band at 180 KDa. Staphylococcus V8 protease cleavage 
patterns of the two proteins showed distinct differences between them (Drake et al., 
1987). They were individually purified and antibodies were raised against each of the 
two proteins. After western blot analysis the antibodies specifically recognised the 170 
KDa protein and the 180 KDa protein, respectively, further supporting the distinct 
identities of the two proteins (Austin et al., 2018). The 170 KDa isoform later became 
known as Topoisomerase II alpha (Top2A) and the 180 KDa isoform became known as 
Topoisomerase II beta (Top2B). Nucleotide sequence analysis of the two proteins 
mapped Top2A to chromosome 17 and Top2B to chromosome 3 (Tan et al., 1992). 
Although Top2A and Top2B share large portions of sequence homology, this study 
confirmed that Top2A and Top2B were different isoforms rather than Top2B being a 
spliced variant of Top2A. Although similar in structure, Top2A and Top2B demonstrate 
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clear differences genetically, biochemically and immunologically (Wendorff et al., 
2012).  
Non-vertebrate eukaryotes such as Drosophila and yeast possess just a single 164 KDa 
topoisomerase II enzyme, Top2 (Hohl et al., 2012). Both Drosophila Top2 and each of 
the human topoisomerase isoforms, Top2A and Top2B, can rescue the phenotype of 
yeast Top2 mutants, which highlights the strong functional conservation of type II 
topoisomerases between species (Wyckoff & Hsieh, 1988; Jensen et al., 1996).  
Although these type 2 topoisomerases are highly conserved, it has been suggested that 
only the chromosomes of Drosophila are morphologically comparable to chromosomes 
of vertebrates (Mengoli et al., 2014). In this organism, Top2 has been shown to be 
expressed in mitotically active cells but has also been found to be stably expressed 
bound to chromatin in non-dividing cells. Based on this expression, indications might 
be made for homologous roles between Drosophila Top2 and mammalian Top2A and 
Top2B (Lee & Berger, 2019). 
1.3.5 Homology of mammalian topoisomerase II isoforms 
Top2A and Top2B are paralogues and share large portions of homology (Figure 1.4). 
Both isoforms have an ATPase N-terminal domain, a central DNA binding domain and 
a C-terminal domain (Austin et al., 1993; Riccio et al., 2019). Analysis of the amino 
acid sequence shows Top2A and Top2B share 68% homology. However, the homology 
of individual domains shows significant differences (Wendorff et al., 2012). The most 
conserved domain, the N-terminal domain, shares 78% amino acid homology between 
the two isoforms, whereas the least conserved domain, the C-terminal domain, is only 
34% homologous between Top2A and Top2B (Austin et al., 2018). The difference in 
size and amino acid sequence of the C-terminal domain between the two isoforms 
suggests that Top2A and Top2B may have distinct roles in the cell (Linka et al., 2007). 
1.3.6 C-terminal divergence of mammalian topoisomerase II isoforms 
Both mammalian isoforms of topoisomerase II mechanistically function by passing 
strands of DNA through one another to relieve the torsional stress caused by DNA 
supercoiling. However, the divergence of amino acid sequence seen the in the C-
terminal domain between the two isoforms could explain their differential roles both in 
vivo and in vitro (Schoeffler & Berger, 2008). The C-terminal has been shown to be 
dispensable for the catalytic activity of both isoforms of the enzyme (Adachi et al., 
1997) but it is necessary for the nuclear localisation of each isoform (Linka et al., 
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2007). The production of C-terminally truncated recombinant chimeric type 2 
topoisomerases demonstrated the cell cycle-dependent roles for each of the two 
isoforms (Linka et al., 2007; Meczes et al., 2008). All chimeric proteins carrying a 
Top2A C-terminal domain were firmly associated with chromosomes during metaphase 
of mitosis and were able to support cell proliferation. However, chimeric proteins 
carrying a Top2B C-terminal domain were only able to support proliferation with 
minimal affect when expressed in high levels and they were not bound to chromosomes 
during metaphase in human cells (Linka et al., 2007). In addition to this, in vitro studies 
using C-terminally truncated recombinant chimeric proteins demonstrated that although 
the removal of the C-terminal domain does not have detrimental effects on the catalytic 
activity of either Top2A or Top2B, loss of the C-terminal did cause considerable 
increases in the binding of Top2B to DNA. Loss of the C-terminal in Top2A had no 
effect on the binding of Top2A to DNA but the chimeric protein of Top2A with β C-
terminal caused significant inhibition of the enzymes catalytic function, whereas the 
chimeric Top2B protein with α C-terminal caused a slight increase in the catalytic 
activity of Top2B (Meczes et al., 2008). These studies suggest that the specific cell 
cycle-dependent characteristics displayed by Top2A and Top2B are determined by the 
diverse amino acid sequence of their C-terminal domain (Madabhushi, 2018).  
1.3.7 Subcellular location of Topoisomerase II  
Type 2 topoisomerases are predominantly nuclear enzymes with the C-terminal 
domains of both Top2A and Top2B containing nuclear localisation signals. However, 
the specific interphase nuclear location of Top2B has been reported differently in a 
number of different studies. A study by Meyer et al. (1997) suggested that Top2B was 
completely excluded from the nucleoli, whereas research by Zini et al. (1992) suggested 
that Top2B was nucleolar. In addition to this, Top2B has also been reported to be 
expressed in both the nucleolus and the nucleoplasm, whilst being frequently associated 
with heterochromatin (Petrov et al., 1993). A study by Chaly & Brown (1996) reported 
that the interphase distribution of Top2B was quite variable and that both methodology 
and antibodies used can affect the results. They show that Top2B is predominantly 
nucleoplasmic but small amounts are also seen to be associated with intranucleolar 
chromatin. In addition to this, Cowell et al. (2011) demonstrated that Top2B is 
concentrated in heterochromatic regions in the nucleus of mouse C127I cells and that 
inhibition of the enzyme histone deacetylase by trichostatin A resulted in Top2B being 
redistributed to euchromatic regions with a more pan-nuclear distribution. Interestingly, 
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work by Onoda et al. (2014) demonstrated that the subcellular location of Top2B 
correlates to it endogenous activities. Activity attenuation experiments in conjunction 
with nuclear localisation data suggested that Top2B shuttles between the nucleoplasm 
and the nucleolus. Their data suggests that Top2B is active in the nucleoplasm and 
becomes quiescent in the nucleolus. In addition to the nuclear functions of Top2B, mass 
spectroscopy has identified the presence of a truncated form of Top2B in mitochondria, 
which has shown to be important for mitochondrial DNA maintenance (Low et al., 
2003; Zhang et al., 2014). The apparent diversity in subcellular locations of Top2B may 
be attributed to a number of factors. As stated by Chaly & Brown (1996), differences in 
methodology within their own experiment caused variability of results, which could go 
some way to explaining the discrepancies seen between different studies. The variability 
of species, cell cultures, methodological techniques and antibodies used may all have 
contributed to differences seen in Top2B subcellular distribution.    
 
1.4 Top2A 
1.4.1 Role of Top2A in replication 
The unwinding of DNA and the subsequent copying of each strand of DNA that occurs 
during semi-conservative replication can lead to topological issues in the absence of 
topoisomerase (Nitiss, 2009). Unwinding of the parental DNA duplex and subsequent 
movement of the replication machinery along the double helix causes superhelical strain 
to build up around the elongating replication fork resulting in the formation of positive 
supercoils ahead of the replication fork and precatenanes behind it (Figure 1.5) 


















Figure 1.5 Diagrammatical representation of topological changes caused by advancing 
replication machinery. 
The enzyme helicase unwinds and opens up the DNA double helix to create two Y-shaped 
structures at the origin of replication and are called replication forks. As replication machinery 
advances, the replication forks are extended bi-directionally creating positive supercoils [(+)Sc] 
ahead of the replication machinery. Compensatory replication fork rotation creates precatenanes 
behind the replication fork from the newly synthesised DNA (Bermejo et al., 2007). 
 
The term ‘supercoil’ is often used in the context of DNA topology. It is a fundamental 
property of DNA and describes the overwound (positive supercoil) or underwound 
(negative supercoil) state of DNA (Gilbert & Allan, 2014). The overwinding of DNA 
ahead of the replication fork and subsequent accumulation of positive supercoils results 
in a compensatory underwinding of DNA behind the replication machinery through 
rotation of the replication fork. Underwinding of DNA behind the replication machinery 
causes daughter duplexes to become intertwined, thus forming structures known as 
precatenanes (Postow et al., 2001). Supercoils and precatenanes pose significant 
obstacles to the progression of replication. Supercoiling makes the separation of a DNA 
duplex into its individual strands difficult and an accumulation of supercoils can prevent 
the replication machinery from progressing (Heintzman et al., 2019). If precatenanes are 
left unresolved they can form catenated duplex daughter chromosomes, which can result 
in topological issues in replication termination if left unresolved. The relaxation of 
supercoils through the actions of topoisomerase is essential for the progression of the 
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replication machinery and the removal of precatenated/catenated DNA is essential to 
allow chromosomes to separate during mitosis (Gonzalez et al., 2011).  
The modulation and resolution of these topological issues are accredited to 
topoisomerases. Both type 1 and type 2 topoisomerases have been shown to remove and 
relax positive supercoiling. However, only type 2 topoisomerases can remove 
precatenanes efficiently, hence most models have postulated that type 1 topoisomerases 
act ahead of the replication fork and type 2 topoisomerases act behind it (Postow et al., 
2001). In addition to this, analysis of the two mammalian isoforms of type 2 
topoisomerases has shown that Top2A preferentially removes positive supercoils from 
DNA. Human Top2A has been seen to remove positive supercoils >10-fold faster than 
negatively supercoiled DNA whereas Top2B, which is not required for replication, does 
not show any preference, which suggests that Top2A may also work in front of the 
replication fork, which goes against previous suggestions (McClendon et al., 2005). 
Previous studies have shown that the simultaneous knockdown of mammalian Top2A 
and Top2B does not affect transcription initiation or elongation. However, cells with 
depleted type 2 topoisomerases displayed increases in cell cycle and mitosis duration 
with disruptions causing dysfunction to chromosome condensation and sister chromatid 
segregation. This eventually led to cell death or permanent cell cycle arrest, which 
suggests the actions of type 2 topoisomerases are required for functional DNA 
replication (Gonzalez et al., 2011). Similarly, the inactivation of Top2 in budding yeast 
cells has been seen to prevent decatenation during S-phase of the cell cycle, which in 
turn caused extensive chromosome missegregation resulting ultimately in dysfunctional 
cytokinesis and cell death (Baxter & Diffley, 2008).  
1.4.2 Role of Top2A in chromosome segregation  
A specific and unique role for type 2 topoisomerases was proposed for the segregation 
of daughter chromatids after DNA replication. More specifically, it is the actions of 
Top2A that are essential for this process (Pommier et al., 2016). Top2A protein levels 
show significant variability depending on the stage of the cell cycle in proliferating 
cells, which is in contrast to Top2B and type 1 topoisomerases that do not show any 
significant fluctuations in expression throughout the cell cycle (Cortés et al., 2003). 
mRNA levels of Top2A have been seen to peak during late S and G2/M phases of the 
cell cycle with levels increasing 2-3 fold (Bower et al., 2010). These increases seen 
during G2/M phases and subsequent decreases as cells become differentiated support 
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the suggestion that Top2A is primarily required during the final stages of DNA 
replication in order to aid chromosome untangling and segregation (Woessner et al., 
1991; Chen et al., 2015). The importance of Top2A in chromosome segregation has 
been highlighted in previous studies in which topoisomerase II poisons and catalytic 
inhibitors of the enzyme have been used. Top2A malfunction/inhibition prevents 
daughter chromosome separation towards the cell poles during anaphase and results in 
the production of polyploid cells (Cortés et al., 2003). This has been supported by 
another study carried out in the human cell line HTETOP, which demonstrated 
phenotypic cell cycle arrest and cell death with a significant number of cells developing 
combinations of enlarged, distorted and polyploid nuclei in response to the absence of 
Top2A (Carpenter & Porter, 2004). In addition to this, Akimitsu et al. (2003) 
demonstrated incomplete nuclear division followed by enforced cytokinesis in Top2A 
knockout mouse models with embryos terminating at the 4 to 8 cell stage with 
chromosome defects. Reports in Drosophila, amphibians and mammals all show this 
conserved role for type 2 topoisomerases (Shamu & Murray, 1992; Christensen et al., 
2002; Mengoli et al., 2014). Although these cells are able to continue through the cell 
cycle up to a point, eventually they die, which is one of the primary reasons 
topoisomerase II poisons that target Top2A are utilised to treat a wide range of cancers 
(Jain et al., 2013; Chen, et al., 2015).  
1.4.3 Role of Top2A in transcription 
As well as having roles in chromosome segregation and untangling chromosomes 
during mitosis, Top2A has also been found to be required in the RNA polymerase II-
dependent transcription of chromatin bound DNA. Mondal et al. (2003) showed that 
elongation of RNA polymerase II during transcription on chromatin templates causes 
increasing tension in DNA due to the accumulation of positive supercoils in front of 
RNA polymerase, which inhibits further elongation and subsequently transcription of 
RNA transcripts over 200 nucleotides in the absence of topoisomerase. In addition to 
this, Top2A has shown to be a component of an initiation-competent RNA polymerase 
Iβ complex and directly interacts with RNA polymerase I-associated transcription factor 
RRN3 through its specific C-terminal, which in turn interacts with the promotor-bound 
SL1 transcription factor in U2OS and HTETOP cell lines. Absence of Top2A has been 
seen to influence assembly and stability of this pre-initiation complex, thus highlighting 





Discovered in 1987, Top2B has been reported to play key roles in transcriptional 
regulation and genome organisation with particular activity seen during neuronal 
development and in post-mitotic cells (Drake et al., 1987). Although Top2B is 
expressed throughout the cell cycle in all mammalian cells, it is significantly 
upregulated when cells enter a state of terminal differentiation (Tsutsui et al., 1993; 
Tiwari et al., 2012; Harkin et al., 2015; Austin et al., 2018).  
1.5.1 Role of Top2B in transcription 
The actions of RNA polymerase during transcription introduces axial rotation in DNA, 
which results in positively supercoiled DNA forming in front of the enzyme and 
negatively supercoiled DNA behind the enzyme (Figure 1.6), thus increasing torsional 
stress, whilst also displacing nucleosomes in the process (Björkegren & Baranello, 
2018). The increase of positive supercoils and subsequent torsional stress can inhibit 
RNA polymerase activities and disrupt transcription. The roles of topoisomerase in 
relieving torsional stress are essential to maintaining DNA templates in a 
transcriptionally competent state (Gilbert & Allan, 2014).  
The initiation of transcription is highly influenced by the presence of supercoiled DNA. 
The controlled action of topoisomerases and their ability to make alterations to DNA 
topology facilitates protein interactions with DNA and allows key biological processes 
to take place (Durand-Dubief et al., 2011). It has been suggested that topoisomerase I 
activity is mainly responsible for the resolution of supercoiling that has been generated 
by transcription but topoisomerase II activity is required for the most highly expressed 





















Figure 1.6 Diagrammatical representation of supercoil formation during transcription 
through the actions of RNA polymerase. 
As RNA polymerase tracks along DNA it is unable to turn around the helical shape of DNA. 
Instead, segments of DNA turn around its helical axis to allow the transcription machinery to 
proceed. However, the process of DNA unwinding and the tracking of RNA polymerase 
subsequently introduces torsional stress in the DNA that results in the formation of supercoils. 
As RNA tacks along a segment of DNA, positive supercoils are formed ahead of the enzyme 
and negative supercoils form behind it (Ma & Wang, 2016). The actions of topoisomerase 
relieve the torsional stress caused by supercoiling (Liu & Wang, 1987).  
 
A role for Top2B in transcriptional regulation has also been observed through the 
formation of stimulus-induced DSBs. Nucleosome-specific recruitment of Top2B has 
been seen to activate transcription by generating a break in double-stranded DNA, 
allowing subsequent relaxation of chromatin, and driving gene expression. Top2B-
mediated cleavage of DSBs has been seen to be essential for the expression of oestrogen 
receptor-α (ERα) target genes. Through the use of chromatin immunoprecipitation 
(ChIP), analysis of the oestrogen-responsive promoter gene pS2 has been examined in 
17β-estradiol (E2)–treated Michigan Cancer Foundation (MCF)–7 cells with rapid 
increases in Top2B recruitment seen after E2 treatment, resulting in the formation of 
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transient DSBs within the promoter (Ju et al., 2006). Subsequent increases in the 
recruitment of DNA DSB repair machinery, including DNA-dependent protein kinase 
(DNA-PK), Ku86, Ku70 and Poly [ADP-ribose] polymerase 1 (PARP-1) was also seen. 
Type 2 topoisomerases typically create transient DSBs and reseal them immediately 
after resolving torsional stress, without needing DNA repair factors (Morimoto et al., 
2019), but it is hypothesised that these proteins are in the locality to repair 
any  incorrectly repaired Top2B mediated DBSs (Haffner et al., 2011). This particular 
role during promoter gene activation implies a mode of type 2 topoisomerase activity in 
addition to removing supercoils. After E2 treatment histone H1 was replaced by high 
mobility group B 1/2 (HMGB1/2) on the nucleosome containing the oestrogen receptor 
binding site and is thought to be part of the ERα-mediated transcriptional activation of 
the pS2 gene. The inhibition of either Top2B or PARP-1 prevented the exchange of 
histone H1 for HMGB1/2, which resulted in the suppression of the pS2 gene suggesting 
mechanistic cooperation between Top2B and components of the DNA damage response 
machinery during regulation of gene transcription. Although numerous important repair 
proteins are recruited to the site of the DSB, they do not appear to be required to repair 
the Top2B induced DSB. Instead, it appears that Top2B is recruited to the promoter as 
part of a larger complex, which also includes proteins from DNA repair pathways 
(Nitiss, 2009). In addition to its roles regarding ERα-dependent promoters, Top2B has 
also been reported to have analogous roles in retinoic acid receptor, androgen receptor, 
thyroid receptor, and activating protein 1 (AP-1)–dependent transcriptional activation, 
which all utilise Top2B-mediated DNA DSB activities and subsequent activation of 
PARP-1 and histone H1-HMGB1/2 exchange (Ju et al., 2006). In addition to this, 
Top2B is thought to play an important role in the development of adaptive responses 
and the formation of long-lasting memories by facilitating the transcription of genes that 
allow alteration in the morphology and connectivity of neural circuits in the brain. The 
initiation of new gene transcription programmes is crucial for this and occurs in two 
phases, early and late. It is thought that Top2B-induced DSBs in promoter regions of 
the neuronal early response genes Fos, Npas4 and Egr1 is needed to induce their 
expression as knockdown of Top2B attenuates both DSB formation and early response 
gene expression (Madabhushi et al., 2015). The activities of Top2B have not only been 
seen to upregulate genes but may also be responsible for repression of gene expression 
and silencing. Studies by Huang et al. (2011) demonstrated that inhibition of Top2B can 
cause unsilencing of the paternal allele of ubiquitin protein ligase E3A (Ube3a) in 
Ube3a-Yellow Fluorescent Protein knock-in mouse models suggesting that 
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topoisomerase inhibitors can potentially rescue cellular, molecular and behavioural 
deficits that are observed with a loss of Ube3a. In addition to this, expression of Ube3a 
was also seen to be upregulated in Top2B knockout mice providing further support that 
Ube3a expression is regulated by topoisomerases (Huang et al., 2011). Studies by 
McNamara et al. (2008) suggested that Top2B negatively modulates expression of 
retinoic acid receptor α (RARα). Knockdown of Top2B in NB4 cells was seen to 
upregulate retinoic acid gene expression, whilst overexpression of Top2B caused a 
reduction in retinoic acid-induced expression of target genes and differentiation. 
Therefore, it may be postulated that the down-regulation of Top2B may lead to 
unsilencing and activation of numerous genes.  
Top2B activity has been seen to facilitate the formation of a favourable chromatin 
environment that allows transcription initiation. Top2B co-purifies with ATP-dependent 
chromatin assembly factor (ACF), which is a chromatin remodeler that regulates 
nucleosome spacing, whereas Top2A does not (Madabhushi, 2018). In addition to this, 
CCCTC-binding factor (CTCF), a transcription factor that also acts as a transcriptional 
activator, is a key player in the regulation of chromatin structure and gene regulation 
and has been shown to be enriched at Top2B binding sites (Barutcu et al., 2017). CTCF 
forms chromatin loops and can attract numerous transcription factors to chromatin, 
including transcriptional activators, repressors, cohesin and RNA polymerase II (Racko 
et al., 2018). A study demonstrated that approximately half of all CTCF/cohesin-bound 
regions in primary mouse liver cells were also occupied by Top2B, using chromatin 
immunoprecipitation analysis followed by DNA sequencing, and suggested that activity 
of Top2B could regulate supercoiling at CTCF binding sites (Uusküla-Reimand et al., 
2016). Further studies also demonstrated that Top2B is co-localised at sites that are 
occupied by CTCF and cohesin but also suggested that Top2B exerts its actions 
primarily at the anchors of chromatin loops (Canela et al., 2017). Together, these 
studies suggested that chromatin architecture and organisation could have major 
implications in DNA topology and could be a source of topological stress. The 
resolution of topological stress that is caused during chromatin looping is thought to be 
carried out by Top2B and therefore considered an important component in the 






1.5.2 Top2B in neuronal development 
At early embryonic stages Top2A is prominent in areas concomitant with proliferating 
neurons i.e., within the ventricular zones and in the external granular layer of the 
cerebellum (Harkin et al., 2016). In contrast, Top2B is observed to be distributed 
throughout the brain both in mice, rats and in the human foetus (Harkin et al., 2016).  In 
addition, post-mitotic granule cells in the external granular layer of the cerebellum in 
rats have displayed a transition in expression of Top2 isoforms from Top2A to Top2B 
during development (Tiwari et al., 2012). 
Thus, it is clear that Top2B is important in neuronal development, illustrated by the 
genetic deletion of Top2B in mice, which has been seen to cause neuronal defects 
during development (Lyu & Wang, 2003). Mice lacking Top2B display defective 
embryonic brain development and die shortly after birth due to respiratory failure. 
Perinatal death phenotypes have also been observed in Top2B null mutant mouse 
models (Yang et al., 2000), with analysis of mutant embryos revealing an inability of 
motor neurons to innervate muscles of the diaphragm, which further supports the 
important role that Top2B plays in neuronal development. In addition to this, defects in 
corticogenesis, including abnormal lamination patterns in the developing cerebral 
cortex, have also been observed in brain-specific Top2B knockout mice models (Lyu & 
Wang, 2003). Further work by Lyu et al. (2006) carried out transcriptional profiling 
analysis of gene profiles in the brains of wild-type mouse embryos in comparison to 
Top2B null mouse embryos at three developmental stages. Genes responsible for 
encoding cell growth functions and early differentiation markers were not affected by 
the absence of Top2B and Top2B was shown to only be required for the expression of a 
small subset of Top2B-sensitive genes during embryonic development of the brain. 
However, 30% of the subset of developmentally regulated genes were affected as a 
result of Top2B being knocked out, suggesting that Top2B may regulate the expression 
of developmentally regulated genes at later stages of differentiation.  
Work by Tiwari et al. (2012) demonstrated that during neural maturation Top2B binds 
preferentially to regions containing H3K4 methylation, a feature of euchromatin, and 
that Top2B is particularly enriched at promoters at times when neurons exit the cell 
cycle. Also in their study they found that knockdown of Top2B caused an upregulation 
in a small set of Top2B bound genes. They hypothesised that these genes are actively 
repressed and that the mode of repression is dependent on the structure of the chromatin 
(as it is the case for gene activation above) and that Top2B is required for this 
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maintenance. One such repressed gene is Ngfr p75, which increases when Top2B is 
knocked down. Ngfr p75 is a member of the tumour necrosis factor receptor superfamily 
and during neuronal development Ngfr p75 plays an important role in central and 
peripheral nervous system cell death and becomes down-regulated in adults (Chan & 
Tahan, 2010). Expression of Ngfr p75 has been shown to only increase in adults in a 
response to injury with higher levels seen in neurodegeneration-related cell death 
(Miller & Kaplan, 2001). In the absence of Top2B, Ngfr p75 becomes upregulated, 
which does not hinder cellular processes during the early stages of neuronal 
differentiation but causes phenotypic premature cell death in post-mitotic neurons. 
Top2B knockout neurons displayed a delay in death of cells that had depleted Ngfr p75. 
In addition to this, Ngfr p75 knockout neurons also displayed significant reductions in 
cell death when compared to wild-type neurons after Top2B had been chemically 
inhibited by ICRF-193. This study suggests a role for Top2B in the regulation of target 
genes that are responsible for controlling programmed cell death during neuronal 
differentiation.  
Further supporting the roles of Top2B in the regulation of developmentally regulated 
gene expression, research by King et al. (2013) also suggests important developmental 
roles for Top2B in establishing correct neural circuitry for proper brain function. 
Mutations in topoisomerases have been seen in neurodevelopmental disorders such as 
autism spectrum disorder (ASD) (Neale et al., 2012). The gene ubiquitin protein ligase 
E3A (Ube3a) plays a critical role in the normal development and function of the 
nervous system and has been associated with neurodevelopmental disorders. 
Topoisomerases have been implicated in Ube3a expression. Ube3a is a long gene and 
Top2B has been shown to be crucial in facilitating the expression of long genes, 
including numerous long ASD candidate genes that are thought to contribute to ASD 
pathology (Lam et al., 2017). Inhibition of Top2B has been shown to cause reductions 
in expression of long genes, suggesting that higher order structure constrains short and 
long genes differentially. This indicates a mechanistic link between transcriptional 
elongation and expression of numerous long genes with findings suggesting chemical 
and genetic mutations that cause topoisomerase impairment may have the potential to 
contribute to length-dependent impairments of gene transcription in neurons during 
development, thus contributing to neurodevelopmental disorders such as ASD (King et 




1.5.3 Expression levels and patterns of Top2B during development 
Northern blot analysis of Top2A and Top2B using specific probes has shown 
differential expression patterns of RNA transcripts in the two isoforms in various 
murine tissues from embryonic, new-born and adult tissue samples. During early 
embryogenesis both isoforms are expressed highly with post-natal increases of Top2B 
expression seen in the brain. More than a 6-fold increase in Top2B expression was seen 
in new-borns compared to embryos, adding to the increasing evidence that Top2B is 
important for neuronal development. Differential expression of Top2A and Top2B has 
also been reported in rats, human foetal tissues and the developing human telencephalon 
(Tsutsui et al., 1993; Zandvliet et al., 1996; Harkin et al., 2015). Previous studies by 
Tsutsui et al. (1993) have shown that Top2A is highly expressed in the embryonic brain 
and in the cerebellum of two day old rats followed by a sudden decrease in expression 
and undetectable levels at four weeks old. The cells within the cerebellum expressing 
Top2A were strictly confined to the proliferative outer mitotic region of the external 
granular layer. This differs to Top2B, which is expressed throughout embryonic and 
post-natal stages and is not limited to the outer mitotic region of the external granular 
layer of the cerebellum but is expressed throughout the entire cortical region (Tsutsui et 
al., 1993; Watanabe et al., 1994). Further studies by Kondapi et al. (2004) have also 
reported high levels of Top2B in the cerebellum of young rats (<10 days), but in 
addition to this claimed Top2B was only found in cerebellar regions. Their studies 
indicated that levels of Top2B in the cerebral cortex and mid-brain were negligible with 
analysis of hippocampal regions similarly showing negative results. High levels of 
Top2B were seen in the cerebellar region during the early post-natal period suggesting 
roles in development. This contradicts findings by Maeda et al. (2000), which suggest 
that not only is Top2B expressed in the hippocampus, but is expressed differently across 
the CA1, CA2 and CA3 regions of the hippocampus. Positive expression of Top2B was 
observed in both immunohistochemistry and immunoblotting experiments in 
hippocampal tissue in early post-natal rats. In addition to this Top2B expression was 
also seen in the neocortex (a component of the cerebral cortex) and in tissue of the 
olfactory bulb. The conflicting results from these studies suggest that regional 
differences of Top2B expression in the brain are yet to be fully elucidated. 
1.5.4 Regulation of Top2B expression 
Guo et al. (2014) suggested a role for the transcription factor specificity protein 1 (Sp1) 
in the regulation of Top2B expression during neuronal differentiation. Sp1 was one of 
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the first transcription factors to be identified and previous research suggests that Sp1 
plays key roles in gene expression, particularly in embryonic development and early 
foetal development of neural tissue (Saffer et al., 1991; Marin et al., 1997). However, 
activity of Sp1 has been seen in a number of cellular processes including cell 
differentiation, cell growth, chromatin remodelling, immune responses, responses to 
DNA damage and apoptosis by binding to the GC and GT box sequences of gene 
promoters (Gory et al., 1997). Results showed an increase in Top2B expression at both 
the mRNA and protein level during retinoic acid-induced neuronal differentiation of the 
neuroblastoma cell line SH-SY5Y over a five day period (Guo et al., 2014). These 
results were similarly reported in mouse embryonic stem cells that were also 
undergoing differentiation (Tiwari et al., 2012). Alongside increases in Top2B 
expression, Sp1 levels of expression were also seen to increase over five days of cellular 
differentiation at the mRNA and protein level. Previous studies have provided 
functional analysis of the gene structure of Top2B through isolation, cloning and 
sequencing of the 1.3 kb 5’-flanking region of the gene to help understand Top2B 
promoter activity. A region within the Top2B promoter sequence between -533 and -
481 has been shown to be responsible for approximately 80% of the promoters’ activity 
(Lok et al., 2002). Analysis within this region identified two inverted CCAAT boxes 
that bind the transcription factor nuclear factor-Y (NF-Y), and a GC box in close 
proximity to the inverted CCAAT box that binds Sp1. Mutation of these binding sites 
causes significant reductions in Top2B promoter activity, which suggests a synergy 
between the two binding sites and indicates key roles for these sites in Top2B 
transcription and subsequent expression regulation (Lok et al., 2002). In addition to this, 
interference of Sp1 binding to GC-rich DNA sequences through treatment with the 
compound mithramycin A (MIT) resulted in a decrease in expression of Top2B at both 
the mRNA and protein level, further suggesting that Sp1 might regulate Top2B 
expression by binding to its GC box in the promoter region (Guo et al., 2014). 
Other regulators of Top2B expression include nuclear receptor related 1 protein 
(NURR1). NURR1 is a transcription factor and binds to specific DNA binding sites in 
the promoters of regulated target genes as a monomer, homodimer or heterodimer 
(Decressac et al., 2013). Studies suggest that NURR1 influences the development and 
differentiation of mesencephalic dopaminergic neurons through axon genesis regulation 
(Heng et al., 2012). It is also seen to have essential roles in maintenance of function in 
dopaminergic neurons and provide neuroprotection as well as being identified as having 
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a distinctive role in Parkinson’s disease pathology (Eells et al., 2002). Previous studies 
show that Top2B plays significant roles in axon genesis and neurite outgrowth (Nur-E-
Kamal et al., 2007). ChIP assays have identified a region on the Top2B promoter that 
NURR1 directly binds to suggesting its importance in Top2B expression and axon 
genesis in dopaminergic neurons. Double immunofluorescent staining of coronal brain 
sections of mice showed co-expression of NURR1 and Top2B in the nuclei of ventral 
mesencephalon neurons and cells of the hippocampus and cerebral cortex. In addition to 
this, Top2B expression was seen to significantly reduce in NURR1 knockout mouse 
brain sections, whilst Top2B null mice showed significant loss of dopaminergic neurons 
in the substantia nigra and lack of neurites along the nigrostriatal pathway. Inhibition of 
Top2B caused dopaminergic neurons to exhibit shortened neurites in ventral 
mesencephalon neurons isolated from 13.5-day-old mouse pups. However, over-
expression of Top2B in SH-SY5Y cells rescued NURR1 deficiency-induced neurite 
impairments. In addition to this, using a Top2B silenced neurally-differentiated human 
mesenchymal (hMSC) cell line and cerebellar granule neurons (CGNs) it was shown 
that Top2B is necessary for effective NURR1 expression and normal axonal length in 
differentiated cells (Terzioglu-Usak et al., 2017). As two functional NURR1 binding 
sites in the proximal Top2B promoter have been identified, it has been proposed that 
NURR1 may influence axon genesis in dopaminergic neurons by recruiting Top2B, 
hence suggesting that NURR1 can directly regulate Top2B expression and interactions 
between NURR1 and Top2B both in vitro and in vivo are important for the regulation of 
mesencephalic dopaminergic neuronal development, differentiation and maintenance 
(Heng et al., 2012).  
1.5.5 Top2B in neuronal ageing 
The activities of Top2B appears to peak during neuronal differentiation and 
development in a number of neuronal cells, including purkinje and cerebellar granule 
cells, before decreasing, as demonstrated in work by Tsutsui et al. (2000). After 
neuronal differentiation Top2B expression decreased by approximately half of the 
maximum peak but it continued to be expressed at this level into adulthood, which 
suggests other roles for Top2B outside of neuronal differentiation. The expression of 
Top2B can be observed in most adult tissues (Capranico et al., 1992).  
The importance of Top2B in differentiation and development of neuronal cells has been 
well published but age-related changes in Top2B expression is yet to be fully 
elucidated. Age-dependent decreases of Top2B activity in the brains of rats and in cell 
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cultures have been reported in a very limited number of studies. Decreases of Top2B 
expression have been seen in the cerebellum of rats (Kondapi et al., 2004), with cell 
cultures of cerebellar granule neurons similarly showing a decrease with age (Bhanu et 
al., 2010). Kondapi et al. (2004) attempted to determine the regional distribution of 
Top2B and identify any age-dependent changes in Top2B expression. They suggested 
that Top2B is only expressed in cerebellar tissue and that expression is high in young 
rats, moderate in adults and low in old rat cerebellar regions. As described previously, 
data from Maeda et al. (2000) contradicts findings by Kondapi et al. (2004) as they 
indicate Top2B is present in rat hippocampal tissue. However, this data does not analyse 
Top2B expression throughout the ageing process and looks at developmental levels of 
expression in post-natal rats compared to adults. Further studies incorporating aged rats 
would be required to elucidate Top2B expression in hippocampal tissue throughout the 
ageing process. As the numbers of studies in this area are so limited, it isn’t possible to 
confirm the roles, regulation and expression of Top2B throughout the ageing process. 
Top2B associates with chromatin and has been shown to be fundamentally important 
for chromatin architecture (Uusküla-Reimand et al., 2016). During the ageing process 
epigenetic changes, including histone modifications and specific changes in DNA 
methylation occur (Armstrong et al., 2019). These age-related changes in DNA 
methylation and histone modifications can alter and disrupt chromatin architecture, 
which in turn is associated with the neuropathology and progression of numerous 
neurodegenerative diseases (Berson et al., 2018). In the early stages of 
neurodegenerative diseases epigenetic modifications, such as those previously 
described, can affect specific gene expression and correlates with the presence of 
misfolded proteins in specific regions of the brain (Martínez-Cué & Rueda, 2020). 
Altered proteostasis is a common feature of senescent cells with increases in unfolded 
protein response (UPR) frequently seen and, as stated previously, numbers of senescent 
cells increase with age. In neurodegenerative diseases, such as Alzheimer’s disease, 
dysregulation of histone modifications and DNA methylation have been seen to be 
prominent features (Prasad & Jho, 2019). As Top2B plays an important role in 
maintaining neuronal function and is associated with maintaining chromatin 
architecture, it is possible that age related declines that have been previously reported in 
Top2B expression (Kondapi et al., 2004; Bhanu et al., 2010) may influence the 
progression of neurodegenerative diseases. In addition to this, the histone code 
hypothesis describes the idea that gene regulation depends partly on histone 
31 
 
modifications. Post-translational modifications to histones act like a molecular code and 
can be recognised by non-histone proteins to modulate specific chromatin functions 
(Rando, 2012). Altered/aberrant histone modification and DNA methylation themselves 
may be responsible for changes in Top2B expression.  
1.5.6 Top2B and repair 
Top2B has been reported by a number of studies to be involved in DNA repair. Gupta et 
al. (2012) suggested an indirect but significant role of Top2B in regulating BER 
capacity in neurons and suggested it is an important component in the promotion of 
DNA break repair through the BER pathway in cerebellar granule neurons. DNA 
damage induced by ROS in these cell types can cause abasic sites, which are commonly 
repaired by BER (Maynard et al., 2009). In addition to ROS induced damage, abasic 
sites are also formed at the initial stage of BER as a processed intermediate. Abasic sites 
are highly mutagenic, so efficient repair of these sites is critical. Interestingly, the 
presence of abasic sites, such as methoxyamine-bound abasic sites, within the vicinity 
of Top2B cleavage sites have been seen to act as endogenous topoisomerase II poisons 
and significantly stimulate Top2B-mediated cleavage. Gupta et al. (2012) reported that 
the activities of Top2B at abasic sites suggested a possible overlap of Top2B in BER 
processing regions, thus implicating Top2B activity in the regulation of BER pathway 
intermediates. In addition to abasic sites, crosslinks have been shown to interfere with 
cellular metabolism, causing DNA replication and transcription dysfunction, leading to 
cell death (Hashimoto et al., 2016). Work by Emmons et al. (2006) suggested that 
levels of Top2B are a determinant of melphalan-induced crosslinks. In the study 
Emmons et al. (2006) demonstrated that knocking down Top2B inhibited the repair of 
melphalan-induced crosslinks in K562 cells, which indicated that Top2B participates in 
the repair of alkylating agent-induced DNA damage. Furthermore, Top2B was seen to 
dynamically respond to DNA damage and rapid recruitment of Top2B to DSB sites has 
been demonstrated. Inhibition of Top2B reduced the enzymes mobility and prevented 
recruitment to DSB sites. In addition to this, Top2B knockout cells displayed increased 
sensitivity to the DNA damaging agent bleomycin and subsequently caused decreases in 
HR-mediated DSB repair, thus implicating the role of Top2B in DSB repair pathways 
(Morotomi-Yano et al., 2018). Indeed, if Top2B does decline with age as suggested by 
Kondapi et al. (2004) and Bhanu et al. (2010), this may have subsequent consequences 
for DNA repair pathways such as BER and HR and could lead to an accumulation of 




Top2B has been shown to be a critical component of neuronal differentiation and 
development with the expression of developmentally regulated genes relying on its 
activities (Guo et al., 2014; Tiwari et al., 2012). Active regulatory regions of the 
genome that are responsible for transcriptional modulation of target genes essential to 
neuronal differentiation are occupied by Top2B (Tiwari et al., 2012). However, the 
roles and regulation of Top2B in neurons throughout the ageing process are yet to be 
elucidated with a very limited number of studies in this area of research.  
The main focus of this project was to investigate the expression of Top2B in aged 
neurons through the development of suitable models. 
Different models of ageing, including cell culture and animal models were utilised to 
accomplish this aim. Research focussed on the development of a reliable model of 
ageing in a differentiated neuronal cell culture and in chronologically aged Drosophila.  
Levels of Top2B protein and mRNA were investigated in differentiated neuronal cell 
cultures and Drosophila brain tissue over time. The ageing process was carried out 
through chronological ageing of differentiated neuronal cell lines and chronological 
ageing of wild-type Drosophila.  
The DNA damage response of neuronal cell lines was investigated during chronological 
ageing by analysing γH2AX foci and carrying out Comet assays.   
Immunohistochemical techniques were used to attempt to investigate Top2B expression 









2. Materials and methods 
2.1 Materials 
The following section lists all the materials used for experiments in this thesis.  
2.1.1 Antibodies 
Table 2.1 Antibodies for western blotting 
Name Host Supplier and product number Dilution 
Anti-Top2A Mouse Santa Cruz Biotechnology: sc-166934 1/500 
Anti-Top2A Mouse BD biosciences: 611326 1/500 
Anti-Tob2B Mouse  BD Bioscience: 611493 1/500 
Anti-Top2B Rabbit Novus Biologicals: NBP1-89527 1/500 
Anti-Top2B Mouse Santa Cruz Biotechnology: sc-365071 1/250 
Anti-Top2 Mouse Santa Cruz Biotechnology: sc-65742 1/200 
Anti-Top2 Mouse Santa Cruz Biotechnology: sc-65743 1/200 
Anti-β-Actin Mouse Santa Cruz Biotechnology: sc-47778 1/500 
Anti-β-Actin Mouse Thermo Fisher: AM4302 1/1000 
Anti-α-Tubulin Mouse Santa Cruz Biotechnology: sc-8035 1/200 
Anti-α-Tubulin Mouse Cell signaling: 3873s 1/100 
Anti-p21 Mouse Santa Cruz Biotechnology: sc-6246 1/250 
Anti-p21 Mouse Novus Biologicals: NBP2-29463 1/500 
Anti-GAPDH Mouse Santa Cruz Biotechnology: sc-47724 1/200 
Anti-β-Tubulin Mouse Santa Cruz Biotechnology: sc-365791 1/200 
Anti-Actin 
 






Rabbit Dako: P0260 1/1000 
Donkey anti-
rabbit IgG HRP  










Table 2.3 Primers for RT-qPCR 
Primer Supplier Sequence 
Drosophila  
Top2 








Eurofins Forward: AAGAATCGTCGTCGTGGTAAGA 
Reverse: CTGCGCGTACTCCTGTTGG 
Name Host Supplier and product number Dilution 
Anti-Top2B Rabbit Novus Biologicals: NBP1-89527 1/500 
Anti-Top2 Mouse Santa Cruz Biotechnology: sc-
65742 
1/200 
Rabbit IgG isotype 
control 
Rabbit Novus Biologicals: AB-105-C 1/500 
Alexa Fluor 488 
anti-H2A.X 
Mouse Biolegend: 613406 1/100 
Goat anti-rabbit 
IgG FITC 
Goat Novus Biologicals: NBP2-30342 1/100 
Alexa Fluor 488 
Goat anti-rabbit 
IgG 
Goat Jackson Immuno Research: 111-
545-003 
1/200 
Alexa Fluor 488 
Goat anti-mouse 
IgG 
Goat Thermo Fisher: A32723 1/100 
Goat anti-mouse 
IgG FITC 

















Table 2.4 Reagents  
Name Supplier and product code 
PrecisionPLUS qPCR master mix with SYBR green Primer Design: PPLUS-SY 
Precision Plus Protein Dual Colour Standards Bio-rad: 1610374 
PCR water: Ultra-pure 18.2MΩ DNase/RNase-free 
H2O 
Bioline: BIO-37080 
Bradford reagent Sigma-Aldrich: B6916 
Agarose, low melting point, analytical Promega: V2111 
Tris Base Thermo Fisher: BP152 
p-Coumaric acid Sigma-Aldrich: C9008 
Luminol Sigma-Aldrich: A8511   
Phenylmethanesulfonyl fluoride solution (PMSF) Sigma-Aldrich: 93482 
Acetic Acid  Thermo-Fisher: 10171460 
Hydrogen peroxide solution 30 % (w/w) in H2O Sigma-Aldrich: H1009 
Deoxyribonuclease I from bovine pancreas (DNase) Sigma-Aldrich: D4263-5VL 
Acrylamide/Bisacrylamide 30% solution Sigma-Aldrich: A3699 
Triton X-100 Sigma-Aldrich: T8787 
Sodium chloride Sigma-Aldrich: S7653 
Glycerol Melford: G22020 
Glycine Sigma-Aldrich: G8898 
Agarose Melford: A20090 
N,N,N',N'-Tetramethylethylenediamine (TEMED) Melford: T18000 
Paraformaldehyde Sigma-Aldrich: P6148 
Fluoroshield with DAPI Sigma-Aldrich: F6057 
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Ethylenediaminetetra-acetic acid (EDTA), disodium 
salt dehydrate  
Melford: E57020 
Sodium Dodecyl Sulphate (SDS) Melford: B2008 
Potassium ferricyanide (III) Sigma-Aldrich: 702587 
Potassium ferrocyanide Sigma-Aldrich: P3289 
β-Mercaptoethanol Sigma-Aldrich: M-6250 
Bovine serum albumin Sigma-Aldrich: A2153-50G 
Bromophenol blue Sigma-Aldrich: 11439 
Methanol Thermo Fisher: M/4000/PC17 
Ethanol Thermo Fisher: M/4450/15 
Ammonium persulfate (APS) Thermo Fisher: 17874 
Citric acid Sigma-Aldrich: 251275 
Brilliant Blue R Sigma-Aldrich: B7920 
Sodium phosphate dibasic Sigma-Aldrich: S7907 
Sodium hydroxide Thermo Fisher: 10502731 
Magnesium chloride Sigma-Aldrich: M8266 
X-Gal Thermo Fisher: R0404 
 
2.1.4 Cell culture reagents 
Table 2.5 Reagents used in cell culture 
Name Supplier and product code 
DMEM GlutaMAX Gibco: 21885-025 
DMEM/F12 GlutaMAX Gibco: 2113894 
Foetal Bovine Serum (FBS) Gibco: 10500-064 




Trypsin-EDTA (0.5%) Gibco: 15400054 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich: D8418 





2.1.5 Special consumables 
Table 2.6 Special consumables 
Name Supplier and product code 
T25 culture flask Greiner Bio-One: 690175 
T75 culture flask Greiner Bio-One: 658175 
6 well plate Greiner Bio-One: 657160 
12 well plate Greiner Bio-One: 665180 
24 well plate Greiner Bio-One: 662160 
96 well plate Greiner Bio-One: 655180 
5 ml graduated pipette Greiner Bio-One: 606180 
10 ml graduated pipette Greiner Bio-One: 607180 
25 ml graduated pipette Greiner Bio-One: 760180 
Colourcoat adhesion positively charged 
microscope slides 
Cellpath: MDB-0106 
Histobond+ slides Marienfeld Superior: 0810721 
Thin blot paper filter paper Bio-Rad: 1620118 
0.45 µm Nitrocellulose blotting 
membrane 
Amersham protran: 10600002 
10 µl Manual Filter Tips Featuring 
Chem-Resin 
Biotix: M-0009-9FC 
20 µl Manual Filter Tips Featuring 
Chem-Resin 
Biotix: M-0021-9FC 
1250 µl Manual Filter Tips Featuring 
Chem-Resin 
Biotix: M-1251-9FC 
Cryospray Cellpath: KNA-0173-00A 
Eppendorf DNA/RNA LoBIND S/L 








2.1.6 Commercially available kits and products 
Table 2.7 Commercially available kits and products 
Name Supplier and product code 
Avidin/Biotin blocking kit Vector: SP-2001 
Peroxidase substrate kit DAB Vector: SK-4100 
Vectastain ABC kit peroxidase IgG Vector: PK-4001 
Mini protean 3 system glass plates Bio-Rad: 1653312 





 Total RNA mini kit Bio-Rad: 7326820 
qPCRBIO cDNA synthesis kit PCR Biosystems: PB30.11-10 




2.1.7 Buffers and solutions 
All buffers and solutions were made up in H2O unless stated otherwise. 
Table 2.8 Buffers and solutions 
Name Composition 
10x Phosphate buffered saline (PBS) 1.37 M NaCl, 27 mM KCl, 0.1 M 
Na2HPO4, 18 mM NaH2PO4. 
4x SDS-PAGE Loading buffer 20% (v/v) glycerol, 4% (w/v) SDS, 25% 
(v/v) stacking gel buffer, 10% (v/v) 
βmercaptoethanol, 5% (v/v) H2O, trace 
bromophenol blue. 
10x SDS-PAGE running buffer 250 mM Tris, 1.92 M Glycine, 1% (w/v) 
SDS. 
SDS-PAGE stacking gel buffer 0.25 M Tris-HCl pH 6.8. 
SDS-PAGE stacking gel solution 6 ml stacking gel buffer, 3.7 ml H2O, 2 
ml 30% acrylamide, 120 µl 10% SDS, 
120 µl 10% APS, 60 µl TEMED. 
SDS-PAGE separating buffer 0.75 M Tris-HCl pH 8.8. 
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7.5 % SDS-PAGE separating gel solution 7.5 ml separating buffer, 3.75 ml 30% 
acrylamide, 3.45 ml H2O, 150 µl 10% 
SDS, 100 µl 10% APS, 50 µl TEMED.  
1x Wet western transfer buffer 25 mM Tris-HCl pH 8.3, 192 mM 
glycine, 20% (v/v) Methanol, 0.1% (w/v) 
SDS. 
Enhanced chemiluminescence (ECL) 
solution  
45 µl coumaric acid (1.5% w/v in 
DMSO), 100 µl luminol (4.4% w/v in 
DMSO) in 10 ml 100 mM Tris-HCL pH 
8.5 combined with 6 µl H2O2 in 10 ml 
100 mM Tris-HCl pH 8.5. 
5x Tris Buffered Saline (TBS) 100 mM Tris-HCl pH 7.5, 2.5 M NaCl. 
TBST  1x TBS, 0.05% (v/v) Tween20. 
Deoxyribonuclease I, standardised vial 
containing 2,000 Kunitz units of DNase I 
(Sigma-Aldrich) 
500 µl 0.15 M NaCl, 500 µl glycerol 
(store at -20°C). 
Buffer I 111 mM Tris-HCl pH 7.4, 0.56% (w/v) 
SDS, 22.2 mM MgCl2. 
Whole Cell Extraction Buffer 50% (v/v) DNase I, 45.2% (v/v) Buffer I, 
50 µg/ml RNase, 2 µg/ml pepstatin, 2 
µg/ml leupeptin, 1 mM dithiothreitol 
(DTT), 1 mM benzamidine, 1 mM 
phenylmethylsulfonyl fluoride (PMSF). 
Mild stripping buffer 200 mM glycine, 0.1% SDS (w/v), 1% 
Tween20, adjusted to pH 2.2. 
Drosophila lysis buffer (1) 1% (v/v) Triton X-100, 2 µg/ml 
pepstatin, 2 µg/ml leupeptin, 1 mM DTT, 
1 mM benzamidine, 1 mM PMSF, made 
up in 10 ml PBS. 
Drosophila lysis buffer (2) 50 mM Tris-HCl pH 7.5,  1.5 mM MgCl, 
125 mM NaCl, 0.5% (v/v) Triton X-100, 
5% (v/v) glycerol, 2 µg/ml pepstatin, 2 
µg/ml leupeptin, 1 mM DTT, 1 mM 
benzamidine, 1 mM PMSF. 
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10x Tris/acetic acid/ EDTA buffer (TAE)  0.4 M Tris-HCl, 1.142% (v/v) glacial 
acetic acid, 10 mM EDTA pH 8.0. 
Coomassie Blue Stain 45% (v/v) Methanol, 45 % (v/v) H2O, 
10% (v/v) glacial acetic acid, 0.004% 
(w/v) Brilliant Blue R. 
Coomassie Blue de-stain 45% (v/v) Methanol, 45% (v/v) H2O, 
10% (v/v) glacial acetic acid.  
Tris/EDTA buffer (TE) 10 mM Tris-HCl pH 8.0, 1 mM EDTA 
pH 8.0. 
Comet lysis buffer 2.5 M NaCl, 0.1 M EDTA, 10 mM Tris-
HCl, adjust to pH 10.0. 1ml Triton X-100 
added immediately before use. 
Comet electrophoresis buffer 0.3 M NaOH, 1 mM EDTA. 
Comet neutralising buffer 0.4 M Tris-HCl pH 7.5. 
Senescence-associated β-galactosidase 
staining solution 
1 mg/ml X-Gal, 40 mM citric acid, 40 
mM sodium phosphate dibasic, 5 mM 
potassium ferrocyanide pH 6.0, 5 mM 
potassium ferricyanide pH 6.0, 150 mM 
NaCl, 2 mM MgCl2.  
PTN buffer 0.1M Sodium Phosphate pH 7.2, 0.1% 
Triton-X-100 
KCM+T 120 mM KCl, 20 mM NaCl, 10 mM Tris-
HCL pH 8.0, 1 mM EDTA, 0.1% Triton 
X-100. 
 
2.1.8 Cell lines 
Table 2.9 Cell lines  
Name Obtained from 
SH-SY5Y. Human neuroblastoma. Newcastle University 
CAD (cath. a-differentiated). Murine 






2.2.1 Drosophila work 
2.2.1.1 Preparing food vials 
2 g of Plain White Medium (Drosophila quick mix 173202 Blades biological Ltd) was 
added to a Drosophila vial (Regina industries drosophila vials P1014). 8 ml of H2O 
(food vials can be prepared using laboratory tap water) was pipetted into the vial. The 
vial was gently tapped on the lab bench to prevent air pockets from forming in the food 
mix and was then left for 30-60 seconds to set before placing a stopper in the vial.   
2.2.1.2 Transferring Drosophila to new vials 
Drosophila (Dahomey strain) that needed to be transferred to new vials containing fresh 
food were selected. Drosophila were tapped to the bottom of their current vial, the 
stopper was removed quickly and both index and middle fingers were placed over the 
open vial to prevent Drosophila escaping. Drosophila were tapped to the bottom of the 
vial once again and a new vial containing fresh food was inverted and quickly placed on 
top of the opening of the vial containing Drosophila. The vials were held together and 
inverted so that the new vial was now on the bottom. The vials were tapped on the lab 
bench to transfer Drosophila from the old vial into the new vial containing fresh food 
and then a stopper was quickly placed in the vial. 
2.2.1.3 Environmental conditions  
Drosophila were housed in a Percival AR36L3 Environmental Chamber on a 12 hour 
light/dark cycle at 24°C with 60% relative humidity.  
2.2.1.4 Anaesthetising Drosophila 
It was necessary to anaesthetise Drosophila to aid physical manipulation of individual 
flies. In order to do this two methods were used. Drosophila were anaesthetised using 
either CO2 or ice.  
2.2.1.4.1 Carbon Dioxide anaesthetisation 
A vial containing Drosophila was selected and tapped to move flies towards the 
stopper. This was done to prevent flies from getting stuck in the food once they were 
anaesthetised. A blunt fill needle, which was attached to a CO2 cylinder via a flexible 
plastic tube (Figure 2.1A), was inserted between the rim of the vial and the stopper. CO2 
was then released into the vial for 5-10 seconds to anaesthetise the flies. Once fully 
anaesthetised, flies were tipped out of the vial onto a CO2 pad (Figure 2.1B) and could 
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subsequently be processed. Drosophila were kept under CO2 anaesthesia for no longer 








Figure 2.1 CO2 apparatus used for Drosophila anaesthetisation. 
(A) A blunt fill needle was attached to a CO2 cylinder via a flexible plastic tube. (B) CO2 pad 
composed of a semi-permeable plastic that allowed Drosophila to be physically manipulated 
while anaesthetised.  
 
2.2.1.4.2 Ice anaesthetisation 
Alternatively, flies were anaesthetised by cooling. Drosophila were transferred to an 
empty vial containing no food and a stopper was added. The vial was then placed in 
crushed ice and after approximately 1 minute Drosophila became incapacitated. Once 
incapacitated, Drosophila were processed. 
2.2.1.5 Sexing Drosophila 
Where experiments were carried out on male and female Drosophila separately, male 
and female flies were identified and reared in separate vials.  
Vials of flies were selected and anaesthetised using CO2 as described previously 
(2.2.1.4.1). Flies were viewed under a stereomicroscope (GXM-XTL3101) and then 
picked up using fine forceps and sorted into male and female groups. Drosophila have a 
number of observable features that make this possible. Males are typically smaller than 
females and possess a more rounded abdomen. The colouration of Drosophila also 
distinguishes them. On the dorsal side of the abdomen females display a dark narrow 




their rearmost abdominal sections. Males also have dark, rounded genitalia that are 












Figure 2.2 Differences in male and female Drosophila anatomy. 
(A) Adult male fly displaying uniformly dark patterning of lower abdomen. (B) Adult female 
fly displaying dark narrow banding pattern on lower abdomen. (C) Comparison of male (Right) 
and female (Left) Drosophila.  
 
2.2.1.6 Ageing Drosophila 
Mixed populations of Drosophila were kept in vials for 1-3 days to allow flies to mate 
and eggs to be laid. Flies were then removed after this period and vials were placed 
back in the incubator. Drosophila eclose between 12-14 days. New progeny were 
collected within 24 hours of eclosion and placed in a new vial containing fresh food. 
After 24 hours flies were sorted into male and female groups as stated in 2.2.1.5 and 
placed into new vials. Flies were transferred into new food vials (2.2.1.2) every week to 
avoid food from becoming dehydrated but to also help prevent food from becoming 
contaminated and affecting the population within a vial. Female Drosophila store sperm 
after mating and continue to lay eggs long after physical separation from male flies. It is 
therefore important to transfer female flies to new vials regularly to prevent new 





aged in this manner until they were required for experimentation. The age of the flies 
was recorded in days and was accurate within 24 hours (day of initial collection after 
eclosion was recorded as day 1).    
2.2.1.7 Drosophila head dissection 
A vial of flies were selected and anaesthetised on ice (2.2.1.4.2). An area of crushed ice 
within the ice box was flattened down for a petri dish to be placed. The petri dish was 
left for 1 minute on the ice to cool down before anaesthetised flies were tipped into it. 
One hand was used to hold an individual fly steady by closing fine forceps around the 
fly’s thorax while the other hand was used to remove the head by cutting at the neck 
using a scalpel. Heads were transferred to a microfuge tube containing 1 ml phosphate 
buffered saline (PBS) with protease inhibitors (2 µg/ml pepstatin, 2 µg/ml leupeptin, 1 
mM DTT, 1 mM benzamidine, 1 mM PMSF) and then either used immediately for 
experimentation or stored in a -80°C freezer for later use. Heads were stored at -80℃ 
for no longer than 1 month to preserve protein integrity.  
2.2.1.8 Drosophila brain dissection 
A vial of flies were selected and anaesthetised on ice (2.2.1.4.2). Flies were then 
transferred and submerged in a dish containing 70% ethanol (v/v) for approximately 30 
seconds. This dewaxes the cuticle of the flies and prevents air bubbles from adhering to 
them once they have been immersed in PBS dissecting solution. After ethanol 
submersion, flies were dabbed onto a paper towel to remove excess ethanol before being 
placed in a petri dish containing ice chilled 1x PBS under a stereomicroscope (GXM-
XTL3101). Using a set of fine forceps in each hand a fly was selected and held at the 
thorax using one hand, whilst the other hand removed the head from the body by 
grasping the neck and pulling the head away from the body. All dissection work was 
performed while keeping the fly fully submerged in PBS. Once the head had been 
removed the rest of the body was discarded. To maintain brain integrity it was important 
to not release the head and allow it to float to the surface of the petri dish. This can 
make grasping the head difficult without damaging the brain. After this, the second set 
of forceps was used to grasp the base of the proboscis and remove it. The head was then 
pinned to the bottom of the petri dish using the forceps, being careful not to damage the 
brain. When the proboscis is removed, a small hole is visible. Using this hole the medial 
edge of one of the eyes was grasped and gently pulled laterally until the eye was 
removed. Care was taken to avoid damaging the optic lobe. This was then repeated for 
the remaining eye. After this step it was relatively simple to remove the brain from the 
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remaining structures of the head by gently grasping and peeling back the frons to 
expose the brain. Any remaining pieces of the retina were removed from the optic lobes 
once the brain had been removed. Removing any visible trachea was also important 
during dissection as these structures can fill with air and cause the brain to float, which 
can impair any subsequent immunostaining procedures. Once fully dissected, brains 
were transferred to a microfuge tube containing PBS with protease inhibitors (2 µg/ml 
pepstatin, 2 µg/ml leupeptin, 1 mM DTT, 1 mM benzamidine, 1 mM PMSF) using a 
P20 pipette. PBS was drawn up and down the pipette tip to coat the surface of the tip 
prior to transferring the brain. This prevents the brain from sticking to the inner surface 
of the pipette tip. Brains were either used immediately for subsequent 
immunohistochemical experiments or pooled together and frozen down at -80°C in PBS 
with protease inhibitors to be used at a later date for protein extractions. Brains were 
stored at -80°C for no longer than 1 month to preserve protein integrity.  
2.2.1.9 Protein extraction from Drosophila 
Whole flies, heads or brains were placed into a 1.5 ml microfuge tube. In microfuge 
tubes of Drosophila heads and brains that had previously been pooled and frozen at -
80°C, the tubes were thawed and as much of the PBS with protease inhibitors was 
removed prior to protein extraction. 
Either Drosophila lysis buffer 1 or 2 was added to a microfuge tube containing whole 
flies, heads or brains. The volume of lysis buffer added to the microfuge tube varied 
depending on the number of whole flies, heads or brains. Enough volume was added so 
that flies could be crushed easily. After the addition of lysis buffer, Drosophila tissue 
was crushed and homogenised using a pellet pestle (Sigma Z359947) for approximately 
10 seconds. To aid lysis, samples were freeze/thawed in liquid nitrogen. Samples were 
added to liquid nitrogen for 30 seconds before being removed and crushed once again 
using a pellet pestle. Samples were freeze/thawed 3 times before being centrifuged at 
16000 g for 5 minutes at room temperature. After centrifugation, the supernatant was 
transferred to a new microfuge tube and either used immediately for downstream 






2.2.1.10 Immunofluorescent staining of Drosophila brains 
Drosophila brains were immunofluorescently stained using two methods; 
1. Drosophila brains were dissected (2.2.1.8) and pooled in groups of 5-10 in 1.5 
ml microfuge tubes. Isolated brains were fixed in 4% paraformaldehyde/PBS for 
30 minutes at room temperature. Samples were quickly washed 3 times in wash 
solution (PBS, 0.1% Triton X-100, 0.1% Tween 20) and then blocked for 1 hour 
at room temperature in blocking solution (0.1 M Tris·Cl pH 7.5, 0.15 M NaCl, 
0.1% Triton X-100, 10% heat-inactivated FBS). Blocking solution was removed 
and brains were incubated in primary antibody diluted in blocking solution at 
4°C overnight. Brains were quickly washed again 3 times in wash solution and 
incubated in fluorescent secondary antibody for 1 hour at room temperature. 
Microfuge tubes containing brains were wrapped in tin foil to protect the 
samples from light and prevent photo-bleaching. Brains were again washed 3 
times before being mounted on microscope slides with DAPI-containing 
mounting medium (Vectashield). Brains were transferred from microfuge tube 
to a microscope slide using a P200 pipette. Once on the microscope slide, a 
paper towel was used to carefully dab away excess wash solution from around 
the brains. Using a set of fine forceps the brains were moved and positioned in a 
grid pattern. A drop of DAPI-containing mounting media was then added to the 
centre of the microscope slide before a cover slip was gently lowered and placed 
over the brains. The edge of the cover slip was then sealed with clear fingernail 
polish and the brains were viewed using fluorescence microscopy.  
2. Drosophila brains were dissected (2.2.1.8) and pooled in groups of 5-10 in 1.5 
ml microfuge tubes. Isolated brains were fixed in 4% paraformaldehyde/PTN for 
30 minutes at room temperature with gentle rocking. Samples were quickly 
washed 2 times in PTN buffer and then washed 3 times for 20 minutes in PTN 
buffer with gentle rocking. After the final wash, brains were blocked for 30 
minutes in blocking solution (0.1M Sodium Phosphate, pH 7.2, 0.1% Triton-X-
100, 5% Normal Goat Serum) at room temperature with gentle rocking. 
Blocking solution was removed and brains were incubated in primary antibody 
diluted in blocking solution at 4°C with gentle rocking for 72 hours. Brains were 
quickly washed again 2 times in wash solution and then washed 3 times for 20 
minutes at room temperature with gentle rocking. The wash solution was 
removed and the brains were incubated in fluorescent secondary antibody for 3 
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hours at room temperature with gentle rocking. After the addition of the 
fluorescent secondary antibody, microfuge tubes containing brains were 
wrapped in tin foil to protect the samples from light and prevent photo-
bleaching. After incubation with the secondary antibody the brains were quickly 
washed 2 times in wash solution and then washed 3 times for 20 minutes at 
room temperature with gentle rocking. After the final wash, brains were 
mounted on microscope slides as described in the first method. 
 
2.2.1.11 Fluorescence microscopy  
Whole Drosophila brains were imaged using a Leica DM500 fluorescence microscope. 
Images were captured under A filter cube (320 nm-380 nm excitation filter and 425 nm 
emission filter) and I3 filter cube (450 nm-490 nm excitation and 515 nm emission 
filter) settings to show respective antibody staining. Both individual and overlay images 
were acquired.  
2.2.1.12 Measuring Drosophila longevity 
To measure Drosophila longevity flies were added to food vials within 24 hours of 
eclosion, 20 flies per vial. Male, female and mixed populations of flies were added to 
vials respectively. Every 3 days the vials were monitored and the number of flies that 
had died was recorded. Vials were analysed like this until all flies had died. Flies were 
transferred to new food vials twice every week. Survivorship was calculated by dividing 
the number of living flies at each time point by the total number of flies used in the 
experiment. 
2.2.1.13 Measuring Advanced Glycation End-Products (AGEs) 
Male and female flies were aged up to 5, 30 and 50 days old, respectively. 20 flies from 
each group were anaesthetised on ice and then transferred to 1.5 ml microfuge tubes. 1 
ml of PBS containing 5 mg/ml trypsin and 10 mM EDTA was added to each microfuge 
tube and flies were quickly crushed using a pellet pestle until homogenised. The 
microfuge tubes of fly homogenate were wrapped in tin foil and incubated at 37°C for 
24 hours. After 24 hours homogenates were centrifuged at 11000 g for 5 minutes. The 
supernatant was removed and transferred to a new microfuge tube before being 
centrifuged at 11000 g for a further 5 minutes to remove as much chitin and debris as 
possible. The supernatant was transferred to a new 1.5 ml microfuge tube and then 
diluted to an absorbance between 0.02-0.05 at 365 nm (Cecil CE 1011 
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spectrophotometer). This dilution step is important to ensure that the sample stays 
within the linear range of fluorescence, which helps to prevent any quantification 
problems that may occur due to the inner-filter effect. Diluted homogenate was 
aliquoted into a 96-well plate (200 µl per well) and fluorescence was measured at 
excitation and emission wavelengths of 365 nm and 440 nm respectively using a Tecan 
Spark 10M multimode microplate reader.   
2.2.1.14 Drosophila climbing assays 
Locomotor function of Drosophila was analysed using climbing assays. Flies were 
grouped into males and females aged 5, 30 and 50 days old, respectively. 20 flies from 
each group were anesthetised on ice and then transferred to a 250 ml graduated cylinder. 
The opening of the cylinder was sealed with parafilm and the flies were then left for half 
an hour to wake up and acclimatise. Target lines were marked on the cylinder 10 cm 
and 17 cm from the bottom. Flies were tapped to the bottom of the cylinder and then a 
timer was started. The number of flies that crossed each target line was recorded every 
10 seconds for 2 minutes.  
2.2.2 Mammalian cell culture 
2.2.2.1 General culturing procedure  
All cells were incubated and grown at 37°C with 95 % (v/v) air, 5 % (v/v) CO2 and 
>93% relative humidity (Thermo Scientific Heracell VIOS 160i). All cell culture 
procedures were performed in a Class II cell culture hood under sterile conditions.  
Before and after each use of the culture hood 70% (v/v) ethanol was used to sterilise all 
interior surfaces. All equipment entering the hood was also sterilised with 70% (v/v) 
ethanol.  
2.2.2.2 Reviving cryopreserved cells 
Frozen stocks of cell lines stored in cryovials at -150°C were revived by thawing 
rapidly in a 37°C water bath. The thawed cells were added to 5 ml of pre-warmed 
culture media and mixed. Cells were then centrifuged (Thermo Scientific, Heraeus 
Megafuge 16) at 1500 rpm for 3 minutes to pellet the cells. The supernatant was then 
removed and the cell pellet was resuspended in 12 ml of fresh culture media and then 





2.2.2.3 Subculturing cells 
For the SH-SY5Y cell line, the method of subculturing cells was as follows; 
Once a flask of cells had reached 80-90% confluency, the media was removed from the 
culture flask and discarded. Cells were then washed with PBS. Enough PBS was added 
to cover the surface of the tissue culture flask before gently rocking the flask. The PBS 
was removed before the addition of trypsin-EDTA to the flask. Again, enough trypsin-
EDTA was added to ensure that the cells were covered. The flask was then placed in the 
37°C incubator. The time taken to optimally trypsinise each cell line was determined 
empirically as both the cell line and confluency of the flask can implicate the time taken 
for adherent cell lines to detach from the bottom of a cell culture flask. Flasks were 
initially checked after 2 minutes of incubation to see if cells had detached and then 
every 30 seconds after that. The side of the flasks were hit with the palm of the hand to 
encourage detachment from the surface of the flask. When the majority of cells had 
detached, the flask was returned to the cell culture hood and fresh media was added to 
halt trypsinisation. When using T25 culture flasks, 5 ml of fresh media was added and 
when using T75 culture flasks, 10 ml of fresh media was added. The resuspended cells 
were pipetted into a falcon tube and centrifuged at 1500 rpm for 3 minutes. The 
supernatant was removed and cells were resuspended in fresh media and diluted 1 in 5 
before being added to new cell culture flasks and returned to the 37°C incubator. 
A trypsinisation step was not necessary for the CAD cell line as they were weakly 
adherent to the surface of the cell culture flask. Instead, they detached simply by 
removing media from the flask and forcefully pipetting fresh media onto the surface of 
the culture flask. Media was pipetted up and down to ensure the majority of cells were 
detached. Resuspended cells were diluted 1 in 5 and then added to new cell culture 
flasks.  
2.2.2.4 Cryopreservation 
A T75 flask of cells was grown until it had reached ≥80% confluency. Cells were then 
detached from the surface of the culture flask using the previously described 
subculturing method (2.2.2.3) and centrifuged to create a cell pellet. The supernatant 
was discarded and a freezing medium was prepared containing 90% (v/v) fresh cell 
culture media and 10% (v/v) DMSO. 4 ml of freezing medium was added to cells 
harvested from a T75 culture flask and resuspended to yield a concentration of ~ 1 x 106 
cells/ml. The cell suspension was aliquoted into cryogenic storage vials, adding 1 ml to 
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each. The cryovials were then placed in a Mr Frosty freezing container (Thermo Fisher 
Scientific, catalogue 5100-0001). These containers slow down the freezing process to -
1°C/min when placed in a -80°C freezer. The Mr Frosty freezing container was placed 
in a -80°C freezer for 24 hours. After 24 hours the cryovials were removed from the -
80°C freezer and transferred to a -150°C freezer for long term storage.  
2.2.2.5 Culturing SH-SH5Y 
SH-SY5Y cells were cultured in complete DMEM that contained media supplemented 
with 10% (v/v) FBS, 45 U/ml of penicillin and 45 U/ml of streptomycin. SH-SY5Y 
cells were subcultured twice per week.  
2.2.2.6 Culturing CAD cells 
CAD cells were cultured in complete DMEM/F12 that contained media supplemented 
with 10% (v/v) FBS, 45 U/ml of penicillin and 45 U/ml of streptomycin. CAD cells 
were subcultured twice per week. 
2.2.2.7 Differentiating cells 
2.2.2.7.1 Differentiating SH-SY5Y cells 
SH-SY5Y cells were differentiated through exposure to all-trans retinoic acid (RA). 
Two different techniques were used to induce differentiation; 
1. Culture flasks were seeded at 1 x 105 cells/ml in complete DMEM and incubated 
for 24 hours. Media was removed and replaced with fresh complete DMEM 
containing 0.5 µM or 1 µM RA and incubated for 72 hours.  
2. Culture flasks were seeded at 1 x 105 cells/ml in complete DMEM and incubated 
for 24 hours. Media was removed and replaced with fresh complete DMEM 
containing 10 µM RA and incubated for 24 hours. Media was removed and 
replaced with fresh complete DMEM containing 10 µM RA and incubated for 
further 48 hours. 
 
2.2.2.7.2 Differentiating CAD cells 
CAD cells were seeded at 2.5 x 10
4
 cells/ml in a T25 or T75 culture flask in complete 
DMEM/F12 and incubated for 24 hours. After 24 hours media was removed and 




2.2.2.8 Cell counting 
Prior to seeding culture flasks or well-plates, cells were counted using the Trypan blue 
exclusion method. Cells were harvested and centrifuged at 1500 rpm for 3 minutes to 
create a cell pellet. The pellet was then resuspended in 1 ml of media. 8 µl of cell 
culture was mixed in a 1:1 ratio with 8 µl of 0.4% Trypan blue and incubated for 1 
minute at room temperature. Both chambers of a glass haemocytometer were then filled 
with the cell culture/trypan blue solution. The haemocytometer was viewed under an 
inverted light microscope and the cells within one set of 16 squares were counted 
utilising the north-west rule. Only unstained cells were counted. The cells within the 
three remaining sets of 16 squares were then counted.  
The following calculation was then used; 
(Number of unstained cells x 2)   x 10000 = Number of cells/ml of cell culture.  
                      4 
 
2.2.2.9 Whole cell extraction 
A culture flask of cells was selected and the media was removed and discarded. Cells 
were harvested and centrifuged at 1500 rpm for 3 minutes to create a cell pellet. The 
supernatant was removed and the cells were resuspended in 1 ml phosphate buffered 
saline (PBS) with protease inhibitors (2 µg/ml pepstatin, 2 µg/ml leupeptin, 1 mM DTT, 
1 mM benzamidine, 1 mM PMSF) and transferred to a microfuge tube. Cells were 
centrifuged once more and the supernatant was removed. Harvested cells were then 
resuspended in whole cell extraction buffer. After resuspension the microfuge tube was 
placed on ice for 1 hour, after which, the lysate was used immediately for 
experimentation or frozen down at -80°C to be used at a later date. 
2.2.2.10 Protein quantification  
Protein from lysates was quantified using the Bradford assay. A standard curve of 
proteins with a known concentration was created alongside sample analysis. Bradford 
reagent was aliquoted into a falcon tube and allowed to reach room temperature. Bovine 
serum albumin (BSA) protein standards were created, ranging from 0-1.4 mg/ml 
dissolved in H2O. 5 µl of protein standard or protein sample was pipetted into an 
individual well of a 96-well plate alongside a blank composed of water for the protein 
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standard and extraction buffer for the protein sample. 250 µl of Bradford reagent was 
added to each well and mixed well by pipetting up and down. The 96-well plate was 
then incubated at room temperature for 10 minutes. After the incubation period, the 
absorbance of the samples was then read on a plate reader at 595 nm. A standard curve 
was created by plotting the net absorbance against the protein concentration of each 
standard used. The protein concentration of the unknown sample was then determined 
by comparing the net absorbance against the standard curve. 
2.2.2.11 WST-1 assay 
Cells were seeded in a 96-well plate in culture media at a density of 1 x 10
5 
cells/ml 
with 100 µl added to each well. The cells were then incubated for 48 hours at 37°C, 5% 
CO2. 10 µl of Cell Proliferation Reagent WST-1 (Roche- 05015944001) was then added 
to each well and incubated for 2 hours. The absorbance of the samples was then 
measured at 450 nm on a plate reader. The absorbance of the sample wells were 
measured against background control wells containing only culture media.  
2.2.2.12 Oxidative stress induced senescence of SH-SY5Y cells 
SH-SY5Y cells were subjected to hydrogen peroxide (H2O2) oxidative stress in order to 
induce senescence. Both differentiated and undifferentiated cells were exposed to a 
range of H2O2 concentrations from 10 µM to 2 mM (in complete media) to empirically 
determine the optimum concentration to induce senescence. Undifferentiated cells were 
seeded for 48 hours prior to H2O2 exposure and differentiated cells were exposed to 
H2O2 after following the differentiation protocol. Cells were incubated from 1-24 hours 
at varying H2O2 concentrations to determine optimum incubation times to cause cell 
cycle arrest and induce senescence. After each dose, media was replaced with fresh 
complete media. Cells were also subjected to a different number of doses ranging from 
a single dose up to a dose every day for 5 days.   
2.2.2.13 SA-β-galactosidase staining assay 
Cells were stained for β-galactosidase using two methods.  
1. Cells were stained using Sigma Senescence Cells Histochemical Staining Kit 
(CS0030). Cells were grown in 6-well plates prior to staining. Media was 
removed and cells were briefly washed twice with 1 ml of PBS per well. PBS 
was removed carefully to ensure that the cells did not become detached. 1.5 ml 
of fixation buffer (F1797) was added to each well for 6-7 minutes at room 
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temperature. Cells were briefly washed 3 times with PBS. 1 ml of staining 
mixture was added to each well (1ml staining solution [S5818], 125 µl Reagent 
B [R5272], 125 µl Reagent C [R5147], 250 µl X-gal solution [X3753], 8.5 ml 
ultrapure H2O) and incubated overnight at 37°C without CO2. The 6-well plate 
was wrapped in parafilm to prevent wells from drying out. Cells were viewed 
under a bright field microscope and the total number of blue-stained cells was 
counted against total cells and the percentage of senescent (blue-stained) cells 
was calculated.  
2. The second method used a similar protocol to the one previously described but 
differed in the following ways; 
Kit reagents were replaced with lab-made reagents; 
-Cells were fixed in 2% paraformaldehyde in PBS. 
-Staining mixture consisted of 8.5 ml SA-β-galactosidase solution (150 mM NaCl, 
2 mM MgCl2, 40 mM citric acid, 12 mM Na2HPO4 in H2O at pH 6), 1, 2, 3 or 4 mg/ml 
X-Gal and 1 ml of solution consisting of 50 mM potassium ferrocyanide and 50 mM 
potassium ferricyanide.   
 
2.2.2.14 γH2AX assay  
Differentiated CAD cells were aged to specific time points in T25 flasks prior to 
γH2AX assay. A sterilised 24 x 24 mm coverslip was placed in each of the wells of a 6-
well plate. Differentiated CAD cells were then seeded into the 6-well plate at a density 
of 5 x 10
4
 cells/ml (2 ml per well) and incubated at 37°C, 5% CO2 for 24 hours. Media 
was removed and discarded and wells were gently washed with 0.5 ml cold PBS. PBS 
was removed and cells were fixed in 0.5 ml methanol at -20°C for 5 minutes. Methanol 
was discarded and cells were rehydrated in 3 changes of PBS (10 minutes per wash at 
room temperature). The final PBS wash was discarded and 0.5 ml of KCM+T buffer 
was added to each well for 15 minutes to permeabilise the cells. KCM+T buffer was 
removed and 1 ml of blocking buffer (KCM+T, 2% BSA, 10% skimmed milk powder) 
was added to each well for 1 hour 30 minutes at room temperature or overnight at 4°C. 
Blocking buffer was removed and cells were incubated in 0.5 ml anti-γH2AX antibody 
(1:100 dilution in blocking buffer) overnight at 4°C, ensuring the 6-well flask was 
wrapped in tin foil to protect the light-sensitive antibody. Cells were gently washed 3 
times for 10 minutes in KCM+T buffer in reduced light conditions. A drop of 
Vectashield mounting media containing DAPI was placed onto a microscope slide. A 
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coverslip from one of the wells of the 6-well plate was placed face down onto the 
microscope slide. Coverslips were fixed in place with nail varnish and slides were 
stored in the dark at 4°C until required for analysis. 
2.2.2.14.1 Imaging and analysis 
Slides were viewed under a Leica DM500 fluorescence microscope and images were 
captured under A filter cube (320 nm-380 nm excitation filter and 425 nm emission 
filter) and I3 filter cube (450 nm-490 nm excitation and 515 nm emission filter) to 
collect images displaying both γH2AX foci and DAPI staining. Images were imported 
to the image processing program ImageJ. Images displaying γH2AX foci were stacked 
with the corresponding DAPI image and were converted to greyscale. Using the 
multipoint tool, γH2AX foci were counted in each individual cell. Cells were analysed 
based on number of γH2AX foci visible.    
2.2.2.15 Comet assay  
Differentiated CAD cells were aged to specific time points in T25 flasks prior to 
carrying out Comet assays. Microscope slides were dipped into coplin jars containing 
1% standard agarose to pre-coat the slide. Excess agarose was drained off and the back 
of each slide was wiped clean before being dried in a warming oven.   
4 x 10
4
 cells were harvested and centrifuged (1500 rpm for 3 minutes) to create a pellet. 
The supernatant was removed and cells were washed in PBS before being centrifuged 
once more. The supernatant was removed and 140 µl of 1% low melting point agarose 
in PBS was quickly added to the cells at 37°C and pipetted up and down to thoroughly 
disperse cells. Two drops of cells were placed onto a pre-coated microscope slide and 
18 x 18 mm coverslips were placed over each drop. The slide was refrigerated at 4°C 
for 5 minutes to set the agarose. 100 ml of pre-chilled Comet lysis solution was added to 
a coplin jar with 1 ml of Triton X-100. Coverslips were removed from the microscope 
slide, which was then placed into the lysis solution and incubated at 4°C for 1 hour. The 
slide was removed from the lysis solution and rinsed twice in dH2O. Slides were placed 
in a Comet assay electrophoresis tank (CSL-COM20 5055323200281) at 4°C and the 
tank was gently filled with pre-chilled Comet electrophoresis buffer until the slides 
became submerged. Slides were incubated in this alkaline buffer for 40 minutes to allow 
DNA to unwind and denature, after which, the tank was run at a constant voltage setting 
of 21 V for 40 minutes. Slides were removed from the tank and were washed 3 times for 
5 minutes in Comet neutralising buffer at 4°C before being left to air dry at room 
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temperature. Slides were stained with 20 µl of DAPI (1 µg/ml) and were covered with 
an 18 x 18 mm coverslip before viewing under a microscope. 
2.2.2.15.1 Imaging and analysis. 
Slides were viewed under a Leica DM500 fluorescence microscope and images were 
captured under A filter cube (320 nm-380 nm excitation filter and 425 nm emission 
filter) settings. Images were collected and processed in two ways;  
- Cells were analysed manually and were sorted into one of five classes ranging from 0-
4 depending on tail intensity as described by Collins et al. (1995). Cells with no DNA 
damage were given a score of 0 and cells that were highly damaged were given a score 
of 4. 
- Images were uploaded and analysed using the automated plugin OpenComet on the 
image processing program ImageJ. DNA damage was analysed through comparison of 
tail DNA percentages.    
2.2.3 Western blotting  
2.2.3.1 Sample preparation 
Following protein quantification samples were diluted in H2O for each western blot 
experiment to ensure all samples had an equal protein concentration prior to loading on 
an SDS-PAGE gel. Once diluted, 12.5 µl of 4x SDS loading buffer was added to 37.5 µl 
of protein sample and pipetted up and down to mix thoroughly. Samples were then 
heated at 68°C for 5 minutes before being centrifuged at 12000 g for ~10 seconds to 
ensure that the entire sample had collected at the bottom of the microfuge tube.     
2.2.3.2 SDS-PAGE 
SDS-PAGE gels were cast using spacer plates with 1.5 mm integrated spacers (Mini-
PROTEAN
® 
1653312). Spacer plates and short plates were placed together and clamped 
into a casting frame and then placed into a casting stand (Mini-PROTEAN Tetra Cell 
1658007). Separation gel solution was carefully pipetted into the casting plates, 
avoiding bubbles. H2O was then pipetted on top of the separation gel to help remove 
any remaining bubbles and to create a level surface. Once set (15-20 minutes), the H2O 
was poured off the separating gel and any residual liquid was dabbed away with a paper 
towel. The stacking gel was then pipetted directly on top of the separating gel and a 10-
well comb was slotted into position. Once set (10-15 minutes), the newly cast gel was 
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placed into an electrophoresis unit (Bio-Rad). The buffer atriums of the unit were filled 
with 1x SDS-PAGE running buffer and the 10-well comb was removed from the SDS 
gel. The wells in the SDS gel were flushed with running buffer using a 50 µl Hamilton 
syringe to remove any residual acrylamide from the well. Using the Hamilton syringe 
50 µl of prepared protein sample was loaded into each well alongside 4 µl of pre-stained 
molecular weight markers (Bio-rad: 1610374). Gels were run at 100 V for 90-120 
minutes until the bromophenol blue dye from the loading buffer had run out from the 
bottom of the gel.  
2.2.3.3 Electrophoretic transfer of proteins 
The transfer of proteins from an SDS-PAGE gel to nitrocellulose blotting membrane 
was carried out using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad 170-
3930). Prior to usage, the fibre pads of the assembly were soaked in 1x wet western 
transfer buffer for ~10 minutes along with two pieces of filter paper (Bio- Rad 1620118) 
and one piece of nitrocellulose blotting membrane (Amersham Protran 0.45 µm 
10600002) that had been cut to the size of the SDS gel. Once an SDS gel had been run it 
was carefully removed from the two glass plates. The pre-soaked nitrocellulose blotting 
membrane was placed over the gel, ensuring no air pockets were present between the 
surface of the gel and the membrane. This was then placed between the two pre-soaked 
pieces of filter paper, which in turn was placed in between the two pre-soaked fibre 
pads. This ‘sandwich’ was placed in a gel holder cassette and slotted into the electrode 
module within the buffer tank. An ice pack was placed in the buffer tank, which was 
fully filled with refrigerator-cooled wet western transfer buffer. A current and voltage of 
500 mA/100 V was applied to the electrophoretic transfer cell for 1 hour. The assembly 
was taken apart and the nitrocellulose membrane was carefully removed. 
2.2.3.4 Immunoassay probing of nitrocellulose membrane 
Nitrocellulose membranes were blocked in TBST with 3% (w/v) skimmed milk powder 
overnight at 4°C or 60 minutes at room temperature. The blocking solution was poured 
off the membrane, which was then washed three times in TBST for 10 minutes per wash 
at room temperature with gentle rocking. Primary antibodies were added to TBST with 
3% (w/v) skimmed milk powder at optimal concentrations that were empirically 
determined. Nitrocellulose membranes were incubated in primary antibody solution for 
2 hours at room temperature with gentle rocking. Primary antibody solution was poured 
off and the membrane was then washed 3 times in TBST for 5-10 minutes per wash at 
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room temperature with gentle rocking. Secondary antibodies were added to TBST with 
3% (w/v) skimmed milk powder. Membranes were incubated in secondary antibody 
solution for 2 hours at room temperature with gentle rocking. The secondary antibody 
solution was poured off and the membrane was washed a further 3 times in TBST for 5-
10 minutes. 
2.2.3.5 Protein detection 
Proteins on nitrocellulose membranes were detected using enhanced chemiluminescence 
(ECL). Membranes were submerged in ECL reagent for 1 minute and then exposed and 
imaged using a G-box chemiluminescent detection system (Synegene G-box chemi 
XX6).  Analysis of blot densitometry was carried out using GeneTools (Syngene).  
2.2.4 RNA work 
2.2.4.1 RNA extraction 
RNA was isolated using Aurum
TM
 Total RNA Mini Kit using the spin protocol. This kit 
was used to extract RNA from both Drosophila tissue and mammalian cell cultures. 
Samples of Drosophila tissue and mammalian cell culture were processed using the 
manufacturer’s instructions apart from the sample preparation for Drosophila tissue. 
2.2.4.1.1 Drosophila sample preparation 
Drosophila tissue was placed in an RNase/DNase-free 1.5 ml microfuge tube. 
Quantities of whole flies, heads and brains required for optimal RNA isolation was 
determined empirically. The microfuge tube was placed in liquid nitrogen for ~30 
seconds until the entire contents had frozen. The microfuge tube was removed from the 
liquid nitrogen and the Drosophila tissue was crushed using a pellet pestle (Sigma 
Z359947). This process was repeated a further two times to help breakdown the tissue. 
After the final freezing/crushing step the tissue was left to thaw. 350 µl of lysis solution 
was added to the microfuge tube and pipetted up and down to aid in sample disruption. 
The microfuge tube was then centrifuged at 12000 g for 3 minutes and the supernatant 
was transferred to a 2 ml capped microfuge tube. 350 µl of 60% ethanol was added to 






2.2.4.2 RNA quantification 
The quality and quantity of isolated RNA samples was analysed on a NanoDrop ND-
1000 spectrophotometer.  
2.2.4.3 cDNA synthesis 
Isolated RNA samples were reverse transcribed using PCR Biosystems qPCRBIO 
cDNA synthesis kit (PB30.11). 4 µl of 5x cDNA Synthesis Mix, 1 µl of 20x RTase and 
0.4 µg of total RNA was added to an RNase/DNase-free microfuge tube. PCR grade 
dH2O (Bioline  BIO-37080) was added to the microfuge tube to bring the total volume 
up to 20 µl and pipetted up and down to ensure all components were fully mixed. The 
microfuge tube was incubated at 42°C for 30 minutes followed by 10 minutes 
incubation at 85°C to denature the RTase. After cDNA synthesis, samples were either 
used immediately in downstream qPCR applications or stored at -20°C for later use.   
2.2.5 RT-qPCR 
All RT-qPCR experiments were carried out using a BIO RAD C1000 Thermal cycler 
(CFX96 Real-Time system). Each PCR reaction was pipetted into a well of a white PCR 
96-well plate and comprised of 10 µl Precision PLUS qPCR Master Mix (Primer design 
PPLUS-SY), 0.6 µl forward primer (300 nM working concentration), 0.6 µl reverse 
primer (300 nM working concentration), 2 µl cDNA and 6.8 µl PCR grade H2O. PCR 
reactions were run alongside a no-template control (NTC). The amplification protocol 
included a 2 minute enzyme activation (hot-start) at 95°C followed by 40 cycles at 95°C 
for 10 seconds and a 60 second data collection step at 60°C. Melt curve data were 
recorded and analysed to confirm the presence of a single PCR product after each run. 
Ct values were recorded and fold-change was calculated to determine relative gene 
expression (Pfaffl., 2001).  
2.2.6 Mouse work 
2.2.6.1 Animal collection and tissue preparation 
Animal licensing was held by Dr R. N. Ranson (UK Home Office personal licence). 
C57BL/6 male mice samples were transported to Northumbria University for 
immunofluorescence labelling and microscopy analysis. See Appendix E for letter 




2.2.6.2 Tissue preparation and brain sectioning 
Sections of mouse brain tissue were cut using a cryostat (Bright Instrument OTF/AS 
Cryostat) or a vibrating blade microtome (Leica VT1000S vibratome). Cryostat 
sectioning was utilised when cutting thin 12 µm sections, whereas vibratome sectioning 
was utilised when cutting thicker 30 µm sections. 
2.2.6.2.1 Cryostat sectioning 
Prior to cryostat sectioning, brain tissue was placed in a solution of PBS with 30% 
sucrose for 1 week at 4°C to cryopreserve tissue samples. 12 µm sections of mouse 
brain tissue were cut using a Bright Instrument OTF/AS Cryostat. Sections were cut 
sequentially and placed on Histobond+ slides (0810721), left to dry and then stored at 
4°C in a cardboard microscope slide storage box to be used when needed.  
2.2.6.2.2 Vibrating blade microtome sectioning 
30 µm sections of mouse brain tissue were cut using a Leica VT1000S vibratome and 
were placed sequentially into wells of a 24-well plate containing PBS. Sections were 
processed immediately when using this method of sectioning.  
2.2.6.3 Immunohistochemistry of brain tissue 
A Histobond+ slide of cryostat-cut mouse brain sections was selected and a thin 
hydrophobic barrier was drawn around the brain sections using a PAP (peroxidase-
antiperoxidase) pen. The sections were washed 3 times (5 minutes per wash) with 250 
µl PBS per slide. Slides were covered during 5 minute washes to ensure sections did not 
become dehydrated. The final wash was drained off and primary blocking solution 
(10% normal donkey serum [NDS] in PBS) was added to the slide for 1 hour 30 
minutes (250 µl per slide). The blocking solution was drained off and the edge of the 
slide was dabbed dry with a paper towel. The primary antibody (primary antibody, 
diluted in PBS with 1% NDS) was added to the sections at specified concentrations. 1% 
NDS in PBS was added to control slides and an isotype control (isotype control, diluted 
in PBS with 1% NDS) was added to another slide of sections. The slides were incubated 
overnight at 4°C in an incubation tray covered in tin foil. Cotton wool moistened with 
PBS was added to the inside edge of the tray to maintain a humid environment to 
prevent sections from drying out. The primary antibody was drained off and sections 
were washed 3 times for 5 minutes in PBS. The final wash was drained off and 
secondary antibody (made up in PBS) was added for 2 hours, after which the sections 
60 
 
were washed 3 times for 5 minutes in PBS. Autofluorescence blocking solution (2 mM 
copper sulphate, 50 mM ammonium acetate in dH2O) was added to the sections for 10 
minutes before being washed 4 times for 5 minutes in PBS. The final PBS wash was 
drained off the slide and the edges were dabbed dry with a paper towel. A drop of 
Vectashield containing DAPI was added onto each section and a coverslip was placed 
over the sections. The edges of the coverslip were sealed with nail varnish and the slides 
were viewed under a Leica DM500 fluorescence microscope.  
2.2.6.4 Peroxidase staining of brain tissue 
2.2.6.4.1 Peroxidase staining of cryostat sections 
All peroxidase staining used a Vectastain ABC peroxidase rabbit IgG PK-4001 kit. A 
Histobond+ slide of cryostat-cut mouse brain sections was selected and a hydrophobic 
barrier was drawn around the brain sections using a PAP pen. Sections were briefly 
washed in dH2O. A blocking solution of 0.3% H2O2 in methanol was added to the 
sections for 15 minutes to block endogenous peroxidases. Sections were washed 3 times 
for 5 minutes in PBS. Normal Goat serum (NGS) (3 drops pk-4001 in 10 ml of PBS) 
was added to sections for 1 hour 30 minutes at room temperature. Sections were then 
washed for 5 minutes in PBS. Avidin and biotin were blocked using Vector 
Avidin/Biotin Blocking Kit SP-2001. Sections were treated for 15 minutes with Avidin 
blocking solution and then washed for 5 minutes in PBS followed by a 15 minute 
treatment with Biotin blocking solution and another 5 minute wash in PBS. Primary 
antibody (Primary antibody, diluted in PBS with 1% NGS) was added to the sections 
and was incubated overnight at 4°C. Sections were washed 3 times for 5 minutes in 
PBS. Secondary antibody (Secondary antibody from Vectastain ABC kit) was added to 
the sections for 3 hours at room temperature. Sections were washed 3 times for 5 
minutes in PBS. The ABC complex from the kit was added to the sections for 1 hour. 
Sections were washed 3 times for 5 minutes in PBS. The sections were treated with a 
diaminobenzidine (DAB) peroxidase substrate kit (Vector peroxidase substrate kit DAB 
SK-4100) following manufacturer instructions. The sections were quickly washed in 
dH2O and then air dried for 48 hours. Sections were counterstained in 1% neutral red 
solution for 10 minutes and then washed briefly in dH2O. Sections were dehydrated in 
an alcohol series (70% ethanol 5 minutes, 95% ethanol 5 minutes, 2 times 100% ethanol 
5 minutes, 2 times histoclear 10-15 minutes) and then mounted in DPX. Slides were 




2.2.6.4.2 Peroxidase staining of vibratome sections 
Sections from paraformaldehyde-fixed mouse brains were cut using a Leica VT1000S 
vibratome and were placed sequentially into wells of a 24-well plate containing PBS. 
Vectastain ABC peroxidase rabbit IgG PK-4001 kit and methodology from 2.2.6.4.1 
was utilised apart from the following; 
-Staining of sections was carried out in a 24-well plate until counterstaining step. 
-Prior to counter staining, sections were mounted onto glass microscope slides and air 
dried for 48 hours. Counterstaining and all steps afterwards were carried out as 
described in 2.2.6.4.1.  
2.2.7 Statistical analysis 
Data in this study are presented as mean results and standard errors of the mean. 
ANOVA, f-tests and Student’s t-tests (two-tailed) were carried out using Microsoft 
Excel to determine p value significance. Other methods used in this study include; log-
rank tests (example calculation Appendix Figure A.1), calculating primer efficiencies 
(example calculation Appendix Figure A.3), calculating coefficient of variance 
(example calculation Appendix Figure A.6) and analysing qPCR data with one or two 














3. Development of an ageing Drosophila model to investigate changes in 
Top2 expression 
3.1 Introduction 
Investigations into the levels of topoisomerase II in multicellular organisms throughout 
the ageing process is incredibly limited, with age-dependent decreases of Top2B 
activity in rat brains and cultures of cerebellar granule neurons reported in a limited 
number of studies (Kondapi et al., 2004; Bhanu et al., 2010). The focus of this chapter 
was to develop a model of ageing in Drosophila and to investigate protein and mRNA 
levels of Top2 throughout the ageing process. Unlike mammals, Drosophila 
melanogaster possess a single isoform of topoisomerase II (Top2) but have 
chromosomes that are morphologically comparable to those of vertebrates (Mengoli et 
al., 2014). 
Drosophila melanogaster are one of the longest serving models of ageing with some of 
the first ageing experiments using Drosophila taking place over 100 hundred years ago 
(Hyde, 1913). The simplest model of ageing is an old organism and Drosophila 
possesses numerous attributes that make it an effective model of ageing. Many tissues 
in Drosophila are equivalent to those found in mammals and 77% of human genes 
associated with ageing-related diseases have equivalent counterparts found in tissues of 
Drosophila (Piper & Partridge, 2018). In addition to possessing a high proportion of 
gene homology to humans, the relatively short life span and high reproductive ability of 
Drosophila allows a continuous supply of tissue samples to be obtained to produce 
increased experimental output in comparison to other animal models of ageing. Adult 
female Drosophila lay up to 100 eggs every 24 hours and an adult fly emerges between 
9-10 days after fertilisation (Fernández-Moreno et al., 2007). The life span of 
Drosophila typically ranges from 60 to 80 days depending on culturing conditions 
(Jennings, 2011). This short life span of Drosophila allows aged samples to be obtained 
at a much quicker rate and lower cost compared to other animal models (Piper & 
Partridge, 2018). 
Although adult Drosophila only possess 100,000-150,000 neurons in their brain (Huang 
et al., 2019) compared to ∼86 billion neurons found in the human brain (Herculano-
Houzel, 2009), Drosophila are often utilised in neuroscience studies as they possess a 
number of neuronal structures that are equivalent to brain structures found in humans. 
For example, the mushroom bodies of Drosophila, that consist of ∼2,500 neurons, are 
63 
 
responsible for associative learning and memory of olfactory stimuli (Akalal et al., 
2006) and represent the equivalent brain structure to the hippocampus, which is a brain 
region that has major roles in learning and memory formation in humans (Figure 3.1) 
(Barnstedt et al., 2016). These brain structures make Drosophila suitable for studying 
neurodegenerative diseases such as Alzheimer’s disease, which is associated with 
declines in memory formation and reductions in cognitive ability with particular 
vulnerability seen in the hippocampus at early stages of the disease (Mu & Gage, 2011). 
Ageing phenotypes seen in humans have similarly been observed in Drosophila with 
previous studies showing intermediate and long term memory impairments with 
increasing age (Tonoki & Davis, 2015). In addition to this, Drosophila also display 
reductions in locomotor ability with increasing age and have been frequently used, 
alongside Drosophila possessing mutant genes, to study Parkinson’s disease. The 
degeneration of dopaminergic neurons is thought to play a key role in the development 
of Parkinson’s disease (Mamelak, 2018) and Drosophila have been shown to possess 
distinct dopaminergic neurons that innervate different areas of the Drosophila brain 
(Mao & Davis, 2009) making it a versatile model when studying ageing and age-related 











Figure 3.1 Diagrammatical representation of the Drosophila brain. 
Anterior view of the whole Drosophila brain with mushroom body structures coloured green 
(Zheng et al., 2018). 
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As previously stated, Drosophila possess a single isoform of topoisomerase II but it has 
been shown to play very similar roles as mammalian isoforms to control the topological 
state of DNA by catalysing transient DSBs and allowing an intact DNA duplex to pass 
through the break (Hohl et al., 2012; Mengoli et al., 2014). In mammals Top2A and 
Top2B have been shown to demonstrate clear and distinct roles between the two 
isoforms (Nitiss, 2009). Unlike Top2A, the expression of Drosophila Top2 has not been 
observed to be cell-cycle dependent (Whalen et al., 1991). Whalen reported fluctuations 
of Top2 mRNA and protein throughout embryogenesis and development, whilst 
establishing the presence of Top2 in non-proliferating cells by carrying out 
immunocytochemical analysis of adult head cryosections that found Top2 to be present 
in all identifiable nuclei. Thus, suggesting that Drosophila Top2 may not be a useful 
marker for the proliferative state. As the presence of Top2 is not dependent on 
proliferation, it may suggest that the single Top2 isoform performs the roles of both 
Top2A and Top2B (Lee & Berger, 2019). It is thought that the single Top2 isoform in 
Drosophila is able to perform several functions through post-translational modifications 
such as phosphorylation (Chen et al., 2016). Phosphorylation has been shown to 
modulate interactions between Top2 and its nucleic acid substrates in Drosophila 
(Ackerman et al., 1985). An observed effect of Top2 modification by casein kinase II-
induced phosphorylation is the considerable stimulation of its decatenation activity. As 
Top2 is seen to be active in mitotic cells, the cell cycle control of chromosome 
condensation may require phosphorylation of Top2, especially since the enzyme is seen 
to be more highly phosphorylated in metaphase than in G1 (Gasser et al., 1992). In vitro 
studies on Drosophila Top2 have demonstrated an enhanced ATP turnover through 
casein kinase II phosphorylation (Nakazawa et al., 2019). In addition, phosphorylation 
of Drosophila Top2 in vitro has been reported to enhance enzyme activity (Li et al., 
2008). However, eliminating phosphorylation of human Top2A by casein kinase II has 
been seen to have no effect on catalytic activity of the enzyme (Escargueil et al., 2000). 
Top2 phosphorylation events are generally more frequent during S phase through 
mitosis. However, the highly divergent C-terminals of topoisomerase II enzymes are the 
site for many phosphorylation events. Due to this divergence it is likely there are 
species-specific and site-specific effects of phosphorylation on enzyme activity (Lee & 
Berger, 2019). The C-terminal of Top2 has also been shown to be subjected to other 
post-translational modifications, including sumoylation. The small ubiquitin-related 
modifier (SUMO) pathway has emerged as an important determinant of Top2 function 
with its actions shown to be important for allowing Top2 to accumulate at mitotic 
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centromeres. It is suggested that sumoylation promotes the final step in decatenation, 
allowing chromatids to disjoin efficiently (Lee & Bachant, 2009). 
During Drosophila embryogenesis Top2 protein and mRNA levels have not been shown 
to be strictly correlated (Whalen et al., 1991). Gemkow et al. (2001) reported a strong 
correlation between Top2 mRNA transcription levels and mitotically active cells. 
However, an absence of Top2 mRNA in cells arrested for DNA replication was 
reported, whilst non-proliferating endoreplicating tissues were shown to express Top2 at 
a much lower level. Interestingly, it was also reported that Top2 protein levels persist in 
non-dividing cells, suggesting Top2 protein and mRNA levels are not directly 
comparable. In addition to this, Top2 protein has been detected throughout embryonic 
development in all regions and tissues with stable levels of chromatin-bound Top2 
protein seen from the beginning of cycle 15 to the end of embryogenesis in non-
replicating cells (Gemokow et al., 2001).  
Although Drosophila has been extensively used in ageing and neuroscience studies, the 
expression of Top2 throughout the adult lifespan of Drosophila has not been studied to 
the best of our knowledge. This chapter focussed on developing a Drosophila model to 
investigate the changes in Top2 protein and mRNA levels and Drosophila activity 
through the ageing process. 
 
3.2 Developing a Drosophila model of ageing 
3.2.1 Longevity of Drosophila 
To investigate Top2 expression throughout the adult lifespan of Drosophila, an 
appropriate model of ageing was required. The literature suggests that Drosophila have 
a mean lifespan between 2-3 months (Linford et al., 2013; Sun et al., 2013; Piper & 
Partridge, 2018). However, in order to select appropriate age groups for this study, 
longevity studies were carried out to determine survivorship of both male and female 
Drosophila, as well as mixed populations, under laboratory conditions. Survivorship 
curves are utilised most commonly to present longevity data and display the probability 
that an individual will survive to a given age (Linford et al., 2013). Results of male, 















Figure 3.2 Longevity of male, female and mixed populations of Drosophila.   
Survivorship of Drosophila maintained on Plain (white) Drosophila Medium (DTS 077) at 
24°C was calculated for male, female and mixed populations of Drosophila. Male and female 
Drosophila were collected within 24 hours of eclosion and placed into vials (20 male/female 
flies per vial or 10 of each sex for mixed populations) with a total of 5 vials used for each group. 
All longevity assays were carried out in triplicate and are presented as the mean survivorship ± 
standard error. Survivorship was calculated as described in methods (2.2.1.12) and log-rank 
tests were carried out (see Appendix Figure A.1). 
 
Although ageing in Drosophila has been extensively studied, there are relatively few 
studies investigating sex differences in ageing. The most extensive study focusing on 
sex differences in longevity demonstrated that longevity can be complex and is highly 
dependent on genotype, mating status and female fecundity (Malick & Kidwell, 1966). 
However, survivorship curves from Figure 3.2 show that under the environmental 
conditions described in 2.2.1.3, females can be seen to have a greater probability of 
surviving to an older age than male and mixed flies. Log-rank tests were carried out on 
the data set to compare the entire survival experience between groups and demonstrated 
significant differences between all three populations of Drosophila. Female Drosophila 
displayed the highest overall survivorship with differences between females-males and 
females-mixed seen to be statistically significant (p<0.001). Males displayed the second 
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highest overall survivorship and were also significantly different to the mixed 
population of flies (p<0.001), which displayed the lowest overall survivorship. Mixed 
populations were used initially in experiments (Figure 3.2) but extensive literature 
searches demonstrate numerous differences between males and females throughout the 
lifecycle (Hansen et al., 2012; Austad & Fischer, 2016; Regan et al., 2016). To further 
investigate these differences between males and females and to elucidate any sex-
related differences in Top2 expression with ageing, individual analysis of male and 
female Drosophila was carried out in subsequent experiments. Rather than carrying out 
further experiments on just young versus old Drosophila, it was decided that young, 
middle-aged and old Drosophila age groups would be selected based on longevity 
experiments to determine age-related changes in Top2 expression throughout the ageing 
process. To determine the age that would be selected for the oldest age group in 
subsequent experiments, the point at which survivorship had reduced by half 
(survivorship value of 0.5) was used. Males reached a survivorship value of 0.5 at ~50 
days and females reached a survivorship value of 0.5 at ~63 days. Large numbers of 
flies were required for subsequent experiments and the ability to collect such numbers 
decreased rapidly after the age of 50 days due to fly deaths, hence it was decided that 
flies aged 50 days old would be selected to represent an aged fly for this Drosophila 
model of ageing. Flies aged 5 days old were selected to represent a ‘young’ group and 
flies at 30 days old were selected to represent a ‘middle-aged’ group. Drosophila can be 
aged chronologically very easily but further experiments were required alongside 
longevity assays to support the selected age groups as a model of ageing.  
3.2.2 Locomotor activity of ageing Drosophila 
In addition to longevity assays, another important lifespan-related assay is the 
assessment of locomotor activity. The relationship between ageing and locomotor 
activity is well established with gradual declines in locomotor activity seen in ageing 
across many species including humans and Drosophila (Sun et al., 2013; Kulmala et al., 
2014). The negative geotaxis assay is a commonly used test to assess the locomotor 
activity of Drosophila. The negative geotaxis assay, otherwise known as the climbing 
assay, measures locomotor activity by utilising the innate escape response of 
Drosophila. When tapped to the bottom of a container Drosophila instinctively begin to 
ascend the walls. Their ability to do this has been seen to decline with age (Iliadi & 
Boulianne, 2010). Drosophila are typically added to a vial and tapped to the bottom and 
the ability of the flies to climb to a target height within a given time is then measured. 
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Traditional climbing assays typically measure the number of flies to climb up to a target 
height between 2-5 cm over a 10-20 second period (Orso et al., 2005; Chakraborty et 
al., 2011). However, Madabattula et al. (2015) suggested that these parameters make 
the traditional assay insensitive to mild locomotor defects and therefore suggested 
carrying out the assay over a longer period of time and measuring the climbing ability 
of the flies up to a greater target height. As locomotor declines are gradual in ageing, the 
decision was made to make alterations to the traditional climbing assay as described by 
Madabattula et al. (2015).    
Climbing assays were carried out using the age groups that were selected based on 
longevity assays. Experiments were carried out on both male and female Drosophila, 
respectively, at the previously determined ages (5, 30 and 50 days old) and results are 
shown in Figure 3.3. Comparisons between male and female locomotor ability at each 




































Figure 3.3 Climbing assays of male and female Drosophila at 5, 30 and 50 days old. 
20 flies from each group were transferred to a 250 ml graduated cylinder (section 2.2.1.14). 
Flies were tapped to the bottom of the cylinder before starting a timer. The number of flies that 
crossed a 17 cm target line was recorded every 10 seconds for 2 minutes. Climbing assays were 
carried out in triplicate and data is shown as the mean of three biological replicates ± standard 
error with results for male Drosophila shown in (A) and results for female Drosophila shown in 
(B). Performance was analysed at 120 seconds and p values were calculated. *=P<0.05 





























Figure 3.4 Comparison of locomotor activity between male and female Drosophila at 5, 30 
and 50 days old. 
Data from figure 3.3 displayed to show direct comparisons between male and female 






Results from Figure 3.3 show significant declines in locomotor function with increasing 
age for both male and female Drosophila. These findings are in agreement with 
Gargano et al. (2005) who also reported declines in locomotor function with increasing 
age in both male and female Drosophila. Differences between 5 day old and 30 day old 
male and female flies over the course of the 2 minute assay were not statistically 
significant. However, a large decline in locomotor function can be seen in both males 
and females between 30 days and 50 days with data displaying statistical significance. 
At 50 days old, male and female locomotor ability is significantly reduced when 
analysing endpoint data after 120 seconds of testing compared to 5 day old (Male p= 
0.012 and female p=0.008) and 30 day old flies (Male p=0.005 and female p=0.030). 
Endpoint analysis shows no statistical significance between male and female locomotor 
ability (Figure 3.4). In addition to endpoint analysis of data at 120 seconds, the time at 
which 50% of the flies had reached the target line was also analysed and compared. 
Similarly, results from this analysis showed significant differences between 50 day old 
Drosophila and the two other age groups for both males and females. The time at which 
50% of males had reached the target line, 50 day old flies were significantly slower than 
both 5 day old flies and 30 day old flies, taking 57.4 seconds (p=5.45x10
-5
) and 45.8 
seconds (p=0.014) longer on average to reach the target line, respectively. Differences 
between 5 and 30 day old males were not significant. Similarly, female 50 day old flies 
were significantly slower than both 5 day old flies and 30 day old flies, taking 30.9 
seconds (p=0.005) and 25.9 seconds (p=0.006) longer on average for 50% of the flies to 
reach the target line, respectively. Differences between 5 and 30 day old females were 
not significant. Although endpoint analysis between males and females shows no 
significant results between sexes at 120 seconds in each age group, after analysing the 
times at which 50% of the flies had reached the target line, 50 day old males are seen to 
be slower than 50 day old females. 50 day old males were 22.8 seconds slower than 
females on average (p=0.023). However, no other differences were seen between males 
and females in any other age group. Results show that although males and females 
demonstrate clear differences in survivorship it doesn’t necessarily equate to differences 
in locomotor ability. A decline in locomotor function is a consequence of ageing and 
has previously been shown in Drosophila (Gargano et al., 2005). Results from Figure 
3.3 also demonstrate a progressive decline in locomotor function with increasing age, 
thus suggesting age-associated changes can be observed in Drosophila using the age 
groups selected. To further support and verify that these selected age groups represent a 
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useful model of ageing, advanced glycation end-products (AGEs), which are a known 
biomarker of ageing, were analysed in each age group for both males and females.  
3.2.3 Advanced Glycation End-products as a biomarker of ageing in Drosophila 
AGEs are formed in a reaction between reducing sugars and amine residues on proteins, 
lipoproteins or nucleic acids and have been shown to increase and accumulate as a result 
of ageing and are therefore widely used as a biomarker of ageing. They are the product 
of multiple pathways including the Maillard reaction, Amadori rearrangements and 
Schiff base formation. Some AGEs display characteristic fluorescence, which can be 
measured at excitation wavelengths of 365 nm and emission wavelengths of 440 nm. 
Increases in fluorescent AGEs with progressing age have been measured in a number of 
organisms including Drosophila (Oudes et al., 1998; Jacobson et al., 2010). Jacobson et 
al. (2010) suggests accumulation of fluorescent AGEs correlates with higher mortality 
rates in flies maintained at higher temperatures (27°C) compared to those maintained at 
lower temperatures (18°C). Flies that were switched to either the higher or lower 
temperature acquired a rate of AGE accumulation characteristic of flies kept 
permanently at that temperature but carried a permanent level of accumulated damage 
consistent with their maintenance at the previous temperature. It was therefore 
suggested that non-reversible increases in mortality rate are mirrored by non-reversible 
increases in fluorescent AGE accumulation and supports the use of fluorescent AGEs as 
a biological marker of ageing in Drosophila.  
To determine whether AGEs increase in the Drosophila model, male and female flies 
were collected at 5, 30 and 50 days old and processed as described previously (section 
2.2.1.13). Results are shown in figure 3.5. 




















Figure 3.5 AGE products of male and female Drosophila aged 5, 30 and 50 days old. 
20 male and female Drosophila aged 5, 30 and 50 days old were selected and trypsinised for 24 
hours at 37°C as described in 2.2.1.13. Homogenates were then processed and aliquoted into 96-
well plates. Fluorescence was measured at excitation and emission wavelengths of 365 nm and 
440 nm, respectively. Results shown are the mean of four independent experiments ± standard 
error. **= p<0.01, ***= p<0.001 (Student’s t-test, two-tailed). 
 
Results from Figure 3.5 show an increase of AGEs in females from 5 days old up to 50 
days old. However, AGEs do not change with age in male Drosophila. Differences in 
AGEs seen in females between 5-30 days old and 5-50 days old are statistically 
significant (p= 0.0038 and p= 0.0011) but AGEs do not change significantly between 
30-50 days. An overall increase in AGE products between young and old Drosophila 
has been reported in previous studies (Oudes et al., 1998; Jacobson et al., 2010). Results 
for female Drosophila in Figure 3.5 are in agreement with this trend but results for 
males are not. However, previous studies have not looked at differences in AGE 
products between male and female Drosophila. Interestingly, differences in AGEs 
between males and females are statistically significant at every age group. Relative 
fluorescence of 5 day old males is >5 fold more than levels seen in 5 day old females 





and >3 fold (p=0.0008) more than their female counterparts, respectively.    
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After carrying out longevity assays (Figure 3.2), climbing assays (Figure 3.3 and Figure 
3.4) and analysing AGE products (Figure 3.5) in male and female Drosophila, a model 
of ageing has been established. This resulted in the selection of male and female 
Drosophila at 5, 30 and 50 days old to be used in subsequent experiments to investigate 
Top2 expression. 
 
3.3 Quantification of Top2 protein in Drosophila brains 
3.3.1 Optimising protein extraction and western blotting methods 
Western blotting experiments were utilised to generate semi-quantitative data of protein 
levels of Top2 in male and female Drosophila aged 5, 30 and 50 days old. In order to 
carry out such experiments, protein extraction techniques needed to be optimised. To 
analyse Top2 expression in ageing neurons a tissue source that was predominantly 
composed of neurons was required. For this reason, experiments were ultimately carried 
out on dissected brain tissue. However, for the purposes of optimising protein extraction 
techniques, either whole flies or heads were utilised as dissecting Drosophila brains is 
time consuming.  
Preliminary experiments attempting to extract protein from Drosophila tissue initially 
utilised Drosophila lysis (1) buffer as described in materials section (Table 2.8). Whole 
flies or heads were harvested and immediately added to a microfuge tube before adding 
lysis buffer. The tissue was then homogenised, centrifuged and the supernatant was 
collected prior to quantifying total protein using a Bradford assay. A standard curve was 
generated using bovine serum albumin (BSA) and Drosophila extracts were quantified. 




















Figure 3.6 Example standard curve of BSA. 
A 1.5 mg/ml stock solution of BSA was diluted to create stock solutions ranging from 0-1.4 
mg/ml. Standards were added to a 96-well plate and unknown protein samples were diluted 1:5 
in PBS and added in triplicate to the plate. Lysis buffer, by itself, was also diluted 1:5 and added 
to the 96-well plate in triplicate to act as a buffer control. Bradford reagent was added to each 
well and the plate was incubated at room temperature for 5 minutes before measuring 
absorbance at 595 nm on a plate reader. Mean absorbance of BSA standards was plotted against 
concentration to create a standard curve and unknown samples were quantified using y=mx+c. 
Final concentration of the unknown protein sample was calculated by multiplying the result by 
the dilution factor. 
 
Once quantified, protein samples were processed by western blot analysis and probed 
for Top2. Initially, protein extracts from 20 heads, 40 heads and 20 whole flies were 
analysed with protein loads of 47 µg, 70 µg and 124 µg, respectively. However, this 
failed to yield positive results (data not shown). Subsequent experiments focussed on 
optimising protein extraction and western blot methods. Although total protein 
quantification was suggesting substantial amounts of protein after each modification to 
the extraction methods, subsequent western blots failed to provide positive results. 
Ultimately, a new antibody (anti-Top2 sc-65742) was obtained and a new lysis buffer 
was used (Drosophila lysis buffer [2] Table 2.8), as described by Tian et al. (2013) and 
extraction methods were adapted before positive results were obtained. A range of head 
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numbers and whole flies were used to determine optimum protein loading conditions 








Figure 3.7 Optimisation of Drosophila protein extraction and western blot analysis of 
Top2. 
Drosophila were selected (Mixed ages), processed and protein was extracted as described in 
2.2.1.9 from 20 (47 µg total protein load), 30 (74 µg total protein load), 40 (70 µg total protein 
load), 50 (72 µg total protein load) heads and 15 whole flies (114 µg total protein load). Protein 
samples were loaded onto a 7.5% SDS gel and western blotting was performed.  
 
After carrying out numerous experiments it was discovered empirically that the careful 
processing of Drosophila tissue and removal of chitin was as equally important as 
protein load in order to obtain successful blots. Chitin, the major constituent of a fly’s 
exoskeleton, can interfere with protein quantification and subsequent gel electrophoresis 
if it is not adequately removed. After optimising extraction and western blotting 
techniques on whole Drosophila and heads, further experiments were carried out to 
empirically determine the number of brains that would be required to give enough 
protein to provide positive results. Preliminary western blot results of Drosophila brains 
used protein extracts from 20, 40, 50 and 60 dissected brains and can be seen in 
Appendix Figure A.2. Initial blots yielded poor results and Top2 signal was weak for all 
brain extracts tested. Further western blots were carried out using extracts from 100 
dissected brains alongside whole heads and can be seen in Figure 3.8. 
 
 










Figure 3.8 Optimisation of protein extraction and western blotting using Drosophila 
brains. 
Drosophila were selected (Mixed ages), brains were dissected and protein was extracted as 
described in 2.2.1.9 from 100 brains (114 µg total protein load). A protein extract from 15 heads 
(135 µg total protein load) was run alongside the brain extract for comparison. Protein samples 
were loaded onto a 7.5% SDS gel and western blotting was performed.  
 
Results from Figure 3.8 demonstrate that protein extracts from 100 brains is sufficient 
to achieve positive western blot results. Protein extracts from fewer than 100 brains 
yielded poor results, hence subsequent experiments were carried out using extracts 
obtained from 100 dissected brains.  
Levels of Top2 protein were semi-quantified in samples from the brains of male and 




























Figure 3.9 Semi-quantification of Top2 in male and female Drosophila aged 5, 30 and 50 
days old. 
Protein extracts were obtained from the brains of male and female Drosophila aged 5, 30 and 50 
days old. Each extract consisted of 100 dissected brains. Total protein was quantified as 
described in section 2.2.2.10 and equal protein loads (91 µg total protein) were added to wells of 
a 7.5% SDS gel. SDS-PAGE was carried out and protein was transferred to nitrocellulose paper 
by wet western transfer. Nitrocellulose blots were probed with a Top2 (A: top blot) antibody 
and an Actin (JLA20) load control (A: bottom blot) antibody. Analysis of blot densitometry was 
carried out using GeneTools (Syngene). Top2 expression is presented as a percentage of that 
seen in 5 day old flies (B). Results shown are the mean of four independent experiments ± 











Declines in Top2 protein levels can be observed for both male and female Drosophila 
with increasing age in Figure 3.9. In male Drosophila a significant average 66.5% 
decrease in Top2 protein can be seen between 5 day old flies and 30 day old flies 
(p=0.0035). Similarly, a significant average decrease of 44.6% in Top2 protein can be 
seen between 5 day old and 30 day old females (p=0.0284). Significant differences 
between 5 and 50 day old flies can also be seen for both male and female Drosophila 
with average 60.3% (p=0.0216) and 47.9% (p=0.0023) declines in Top2 protein seen, 
respectively. However, differences in Top2 expression seen between 30 and 50 day old 
males and females are not significant. These findings are novel in Drosophila to the best 
of our knowledge but are consistent with age-related declines that have been seen in 
mouse brain tissue (Kondapi et al., 2004). Male and female Drosophila display very 
similar Top2 decreases in percentage protein expression between age groups and show 
no significant differences between them. Further analysis comparing the raw data also 
showed no significant differences between males and females at each age group (data 
not shown). Although differences between males and females in longevity and 
biomarkers of ageing can be seen, this does not appear to correlate with differences in 
Top2 protein expression.  
 
3.4 Quantification of Top2 mRNA in Drosophila brains 
3.4.1 Selection of RT-qPCR reference genes 
Real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) is a 
widely used technique that allows rapid quantification of relative gene expression and is 
considered one of the prominent techniques in mRNA quantification. Numerous factors 
that can affect the reproducibility of a qPCR experiment such as variations in RNA 
extraction and reverse transcription efficiency as well as pipetting errors can have 
detrimental effects to the validity of results (Taylor et al., 2010). Therefore, the 
normalisation of data by incorporating internal reference genes into experimental 
procedure is an important step in minimising the influence of these factors. Internal 
reference genes are typically chosen from a set of housekeeping genes and are measured 
alongside target genes. These genes are abundantly and stably expressed across various 
experimental conditions and allow normalisation of data to be calculated. Previously, 
the most commonly selected reference genes for normalisation of Drosophila qPCR 
experiments were adopted from other species without verification. However, Ling & 
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Salvaterra (2011) measured expression stability for 20 Drosophila candidate reference 
genes in flies of different ages to be used specifically in RT-qPCR applications. 
Expression stability was seen to vary across sample subsets and no particular genes 
were seen to be stably expressed across all experimental conditions. However, suitable 
experiment-specific reference genes could be selected from the panel of candidate 
genes. Reference genes were selected based on their expression stability in age-related 
experiments. The reference genes cyclophilin 1 (Cyp1) and eukaryotic initiation factor 
1A (eIF-1A) were the most stably expressed genes in samples that contained control, 
middle-aged and old-aged variables, therefore these genes were selected to be used as 
reference genes alongside a target gene of Top2. 
3.4.2 Optimisation of Top2, Cyp1 and eIF-1A primers for RT-qPCR 
Primers were designed for Top2, Cyp1 and eIF-1A to be used in RT-qPCR experiments 
(Materials and Methods Table 2.3). Prior to carrying out analysis of mRNA levels in 
aged Drosophila samples, the amplification efficiency of these primers was required to 
determine their experimental suitability. It is important for primers to work efficiently in 
order to be able to make valid comparisons between genes. A reaction efficiency of 90-
110% is deemed acceptable (Taylor et al., 2010).  
Amplification curves were generated for Top2, Cyp1 and eIF-1A primers, respectively, 
and subsequently used to calculate primer reaction efficiency (Figure 3.10). RNA was 
extracted from tissue of a mixed population of Drosophila and 0.4 µg of total RNA was 
reverse transcribed to cDNA. The stock solution of cDNA was used to create a 1:10 
serial dilution of cDNA samples and 2 µl of each sample was incorporated into a 20 µl 
PCR reaction.  
Primer reaction efficiencies were calculated based on equations described by Rutledge 
and Côté (2003). The equation for calculating reaction efficiencies is shown in 
Appendix Figure A.3. Calculations using the amplification curves shown in Figure 3.10 
demonstrate a reaction efficiency of 103.2% for Top2, 92.1% for Cyp1 and 98.0% for 
eIF-1A. As the reaction efficiencies of these primers fall within the 90-110% range they 
were considered suitable and comparable for further RT-qPCR experiments. 
In addition to analysing primer efficiency, a number of controls were also incorporated 
into the experimental design in order to determine whether there were any genomic 
DNA contaminants or primer dimer formations and to ensure only a single PCR product 
was being amplified. This was achieved through the inclusion of a no reverse 
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transcriptase control and a no template control. Melt curves were analysed in all 
samples to confirm the presence of a single PCR product and to confirm the absence of 














Figure 3.10 Amplification curves for primer efficiency of Top2, Cyp1 and eIF-1A. 
Total RNA was extracted from a mixed population of Drosophila and quantified on a 
NanoDrop ND-1000 spectrophotometer. 0.4 µg of total RNA was reverse transcribed to cDNA 
using PCR Biosystems qPCRBIO cDNA synthesis kit (PB30.11) according to manufacturer 
instructions. The cDNA stock solution was serially diluted 1:10 to create a range of cDNA 
samples. This ensured the standard curve covered the dynamic range of potential template 
concentrations that could be encountered during further studies. cDNA concentrations were 
converted to logarithmic values and plotted against threshold cycle (Ct) values. Amplification 
curves were generated for Top2 (A), Cyp1 (B) and eIF-1A (C) and a line of best fit was added.  
 
Statistical analysis of qPCR data can be carried out using one or numerous reference 
genes using the comparative ΔCt method. In order to select an appropriate method of 





genes under experimental conditions were analysed and evaluated for stability. Figure 
3.11A displays a box and whisker diagram showing the variations in Ct values of the 
two candidate reference genes in male and female samples across all age groups tested. 
Figure 3.11B displays the coefficient of variance of the Ct values to show variability 
between samples. The higher the coefficient of variance, the greater the level of 
















Figure 3.11 Variance of Cyp1 and eIF-1A reference genes across all Drosophila samples 
tested. 
Ct values for the reference genes Cyp1 and eIF-1A from all Drosophila qPCR ageing study 
experiments were collated to observe any variations in expression. (A) Box and whisker plots 
showing the distribution of Ct values for the two candidate reference genes. Yellow dots 
indicate mean value. (B) The coefficient of variance for the data set was calculated to determine 
variability of Ct values for Cyp1 and eIF-1A in male and female Drosophila across all age 





Results from Figure 3.11A show that the range of Ct values differs between males and 
females for both Cyp1 and eIF-1A. However, mean Ct values for each gene are 
comparable between males and females. In addition to this, the coefficient of variance is 
comparable between males and females and is similar for both reference genes. Both 
reference genes have a greater coefficient of variance in female samples than males. As 
the variation between the two candidate reference genes is comparable, subsequent data 
analysis utilising the comparative ΔCt method utilised both reference genes.  
3.4.3 Analysis of Top2 mRNA in male and female Drosophila aged 5, 30 and 50 
days old 
Following the confirmation of primer reaction efficiencies, RT-qPCR was carried out to 
quantify Top2 mRNA levels in the brains of male and female Drosophila aged 5, 30 
and 50 days old. RNA was extracted from 100 brains for each experimental group. 









Figure 3.12 Analysis of RT-qPCR data comparing relative Top2 mRNA expression in 
male and female Drosophila aged 5, 30 and 50 days old.  
Male and female Drosophila were aged up to 5, 30 and 50 days, respectively. 100 brains were 
dissected from each group and RNA was extracted as described in section 2.2.4.1. 0.4 µg of 
total RNA from each sample was converted to cDNA (section 2.2.4.3) and RT-qPCR was 
carried out (section 2.2.5) using both Cyp1 and eIF-1A as reference genes. Results were 
normalised by geometric averaging of both reference genes and presented as expression fold 
change (Vandesompele et al., 2002) (See Appendix Figure A.5). Samples for each individual 
experiment were loaded in triplicate. Results shown are presented as the mean of three 
biological replicates ± standard error. 
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Unlike protein levels of Top2, which have been shown to decrease with age (Figure 
3.9), results from Figure 3.12 show no statistically significant changes in Top2 mRNA 
levels throughout the ageing process. Similarly, there are also no significant changes in 
mRNA levels between male and female Drosophila at each age group tested.  
 
3.5 Immunofluorescent analysis of Top2 in Drosophila brains 
To gain further insight into the expression of Top2 in Drosophila brains, 
immunohistochemical techniques were used to attempt to analyse regional expression 
patterns. Initial experiments aimed to optimise immunofluorescent staining techniques 
and to determine Top2 protein abundance, distribution and localisation in the 










































Figure 3.13 Immunofluorescent staining of Top2 in the Drosophila brain. 
The brains of a mixed population of young Drosophila were dissected and processed as 
described in section 2.2.1.10.  Brains were incubated in a Top2 antibody and a secondary FITC 
antibody was utilised before being mounted in mounting medium containing DAPI. Top2 
staining is seen as green punctate labelling and DAPI is seen as blue staining. Images were 
captured using a Leica DM500 fluorescence microscope. Images A and B show DAPI staining 
at 20 x and 40 x objective, respectively. Images C and D show Top2 staining at 20 x and 40 x 
objective, respectively. Images E and F show an overlay of both DAPI and Top2 staining at 20 
x and 40 x objective, respectively. Structures outlined in yellow identify the optic lobes (OL) 
and the structure outlined in red identifies the central brain (CB), which contains numerous 
structures including the mushroom bodies (not labelled). Image of control brains (staining with 
FITC secondary only and without primary antibody) are shown in G and H. Image G shows 








Pan-wide green punctate labelling of Top2 is expressed in the Drosophila brain (Figure 
3.13). The use of DAPI stains nuclear DNA as a bright blue colour. DAPI staining is 
seen predominantly in peripheral areas of the tissue in Figure 3.13. This may be 
attributed to the relatively short incubation time in the mounting media containing 
DAPI. Brains were viewed using fluorescence microscopy 30-60 minutes after 
mounting, which may not have given the DAPI optimal time to penetrate and stain the 
entire brain. In comparison, brains were incubated in the primary Top2 antibody for 72 
hours. Punctate labelling of Top2 is seen to be similar in size to that of DAPI staining 
when viewing peripheral areas of the brain where staining can be seen to overlap in 
places. As stated previously, DAPI stains nuclear DNA, so this may suggest that Top2 
is predominantly nuclear in location. Results from Figure 3.13 initially provided what 
appeared to be positive staining for Top2. Results shown in Figure 3.13 are from a 
single experiment. Subsequent experiments focussed on optimising 
immunofluorescence techniques using both young and old Drosophila. However, 
further experiments provided no positive staining of Top2, hence further investigation 
would be required to determine whether any age-related/sex-related changes in Top2 
occurs in Drosophila brains.  
 
3.6 Discussion 
Results from this chapter have revealed levels of Top2 protein decrease with age in both 
male and female Drosophila (Figure 3.9). However, no significant changes in Top2 
mRNA were seen during qPCR experiments (Figure 3.12). Although male and female 
Drosophila displayed similar levels of Top2 expression from 5 day old flies to 50 day 
old flies, they demonstrated clear differences in longevity (Figure 3.2) and in AGE 
products (Figure 3.5).  
3.6.1 Sex differences in lifespan 
Analysis from this study revealed a shorter lifespan for male flies relative to female flies 
(Figure 3.2). A study of longevity in 219 inbred Drosophila strains showed that in 70% 
of these strains, virgin females lived longer than virgin males (Arya et al., 2010). Thus, 
it is known that genetic variation can influence sex differences in the longevity of flies 
(Pacifico et al., 2018). A study by Jacobson et al. (2010), which used wildtype 
files similar to this study, also reported that males are seen to be shorter-lived than 
females when housed separately. In the study Jacobson used Dahomey flies, the same 
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strain used in this chapter, and maintained them at 25°C and 65% humidity on a 12 hour 
light/dark cycle and fed them using a standard sugar/yeast medium. Hence, conditions 
were comparable to those used during this chapter.   
Apart from genetic variation, other factors such as diet can affect lifespan and this can 
affect one sex to a higher degree than the other, which may explain the findings in this 
study. For example, Biteau et al. (2010) showed that a major cause of mortality in 
Drosophila was a loss of gut integrity, with the proliferative activity in ageing intestinal 
epithelia correlating with longevity over a range of genotypes. Importantly, Regan et al. 
(2016) uncovered a substantial sex difference in some genotypes of Drosophila in the 
pathology of the ageing gut with males succumbing to intestinal challenges to which 
females are resistant. These findings may partly explain why we see female Drosophila 
outliving males.  
In addition to this, both males and females, individually, were longer lived than a mixed 
population of flies (Figure 3.2). The mating status of Drosophila has been seen to affect 
longevity in both male and female flies (Service, 1989) and mating-induced declines in 
longevity have been reported in both sexes (Service, 1989; Rogina et al., 2007). Mating 
has been seen to induce alterations in female physiology and behaviour and results in 
increased egg production and a shortened life span. Studies have shown that frequent 
mating reduces female lifespan and reproductive success and is mediated by male 
ejaculate accessory gland proteins (Chapman et al., 1995). In male Drosophila it has 
been suggested that mating directly reduces somatic lipid reserves through increased 
energy expenditure on courtship activities (Service, 1989). In addition to this, Gendron 
et al. (2014) reported that the sexual pheromones of one sex can directly reduce 
longevity in the other through interaction with insulin signalling pathways. Decreases in 
insulin signalling have been shown to extend lifespan in adult flies. However, sexual 
attractiveness in Drosophila is mediated by insulin/insulin-like growth factor signalling 
(IIS) as it regulates the transcription of genes associated with the production of cuticular 
hydrocarbons, many of which have been shown to function as pheromones (Kuo et al., 
2012). Also, the perception of female sexual pheromones by males has been seen to 
cause them to rapidly decrease fat stores and reduce resistance to starvation, ultimately 
resulting in a reduced lifespan (Gendron et al., 2014). These studies provide reason for 




3.6.2 Advanced Glycation End-products  
Under normal physiological conditions, cells ensure low intracellular concentrations of 
ROS are maintained. Cells are able to achieve this through a variety of mechanisms, 
which consist of both non-enzymatic and enzymatic processes capable of scavenging 
ROS. The non-enzymatic components include retinal, alpha-tocopherol, ascorbic acid, 
and various other molecules such as glutathione, lipoic acid and thioredoxin, which all 
contain thiol groups, as well as melanin (Holmgren et al., 2005; Covarrubias et al., 
2008; Shay et al., 2008; Zhong et al., 2017). Enzymatic components include superoxide 
dismutase, catalase and glutathione peroxidases, glutathione reductase and 
peroxiredoxins (Snezhkina et al., 2019). A reduction in the ability of the cells to 
scavenge ROS by these mechanisms will result in the accumulation of ROS, which 
leads to oxidative stress (Birben et al., 2012; Schieber & Chandel, 2014).   
Oxidative stress induces lipid peroxidation and glycoxidation reactions, which leads to 
an elevation in the endogenous production of aldehydes and their derivatives such as 
malondialdehyde (Moldogazieva et al., 2019). These are highly reactive and because 
they are electrophilic, they attack free amino groups in proteins and cause covalent 
modifications, resulting in the generation of advanced glycation end products (AGEs) 
and advanced lipoxidation end products (ALEs) (Vistoli et al., 2013). The formation of 
oxidative stress-induced ALEs and AGEs causes the formation of protein cross-links 
and subsequently damages protein structure, which can result in protein oligomerisation 
and aggregation (Fuentealba et al., 2009).     
Oxidative stress-induced ALEs and AGEs along with lipofuscin (a highly oxidised 
aggregate of covalently cross-linked proteins, lipids and carbohydrates) have been 
found to accumulate during ageing and in several age-related diseases (Yamada et al., 
2001). For example, Domínguez-González et al. (2018) measured the levels of the ALE 
protein adducts neuroketal (NKT) and malondialdehyde (MDA) in twelve brain regions 
in middle-aged and old-aged humans with no neurological deficits. Their findings show 
that NKT and MDA increase and decrease in a region-dependent manner. NKT protein 
adducts were seen to significantly increase in the frontal cortex, visual cortex and 
substantia nigra in old-aged individuals compared with middle-aged individuals. 
However, significant decreases of NKT levels were seen in the thalamus. Significant 
increases of MDA protein adduct levels were reported in the frontal cortex, parietal 
cortex, hippocampus, thalamus and putamen in old-aged individuals when compared to 
middle-aged individuals, whereas significant decreases of total MDA levels were found 
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in the temporal cortex and entorhinal cortex in the old-aged group. This suggests that 
particular brain regions may be more susceptible to oxidative stress than others. 
Significant increases in oxidative protein modification levels and lipid peroxidation has 
also been seen in brain homogenate, mitochondria and synaptosomes of Wistar rats 
studied up to 26 months of age (Babusikova et al., 2007).   
Interestingly, Tsakiri et al. (2013) showed that young Drosophila supplied with feed 
enriched in AGEs or in lipofuscin resulted in an increase in the rate of AGE-modified 
proteins and carbonylated proteins that accumulated in their somatic tissues. This was 
accompanied by a reduction in locomotor performance as well as life span. Their study 
showed that these changes were accompanied by reduced proteasome 
peptidase activities suggesting that AGEs or lipofuscin can disrupt proteostasis (a 
complex network of mechanisms, which prevent and eliminate protein misfolding) and 
accelerates the functional decline that occurs with normal ageing. Indeed, natural 
increases in AGEs and AGE-modified proteins during the ageing process may partly 
explain the decreases in locomotor function that are seen in Figure 3.3 in male and 
female Drosophila. Locomotor performance, as demonstrated by climbing assays, was 
seen to significantly decrease over 50 days of ageing in both sexes.  
In addition, the accumulation of AGEs in Drosophila has been shown to strongly 
correlate with mortality rate of flies at different temperatures but was independent of 
dietary restriction (Jacobson et al., 2010). Thus, AGEs are useful biomarkers of ageing-
related damage in flies. AGE products in this current study can clearly be seen to 
increase throughout the ageing process in female Drosophila, as expected (Figure 3.5). 
The same cannot be said for male Drosophila as they do not show any significant 
changes in AGEs from 5 day old flies up to 50 day old flies. However, differences in 
AGEs between males and females are statistically significant. Male Drosophila display 
significantly higher levels of AGEs than females at each age group tested. Previous 
studies in other species have also reported differences in AGEs between sexes. 
Studies carried out in rats have shown that the AGE N-(Carboxyethyl)-lysine (CEL) is 
elevated in males compared to age-matched females (Wang et al., 2006). Evidence 
suggests that higher levels of oxidative stress are generally observed in males compared 
to females (Ide et al., 2002; Kander et al., 2017), which may go some way to explaining 
why fluorescent AGEs are considerably higher in male Drosophila than females. In 
addition to this, Jacobson et al. (2010) measured a number of oxidised protein adducts 
in male and female Drosophila at numerous time points from 7 days up to 45 days old 
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and discovered all protein adducts were higher in males than females at each time point 
tested. Oxidative stress can contribute to ageing and if high levels are present it can 
leave an organism susceptible to DNA damage. If males have a genetic predisposition 
to increased levels of oxidative stress it may explain why the lifespan of male 
Drosophila is lower than that of females.  
3.6.3 Top2 mRNA levels in ageing 
Results from this chapter have revealed no significant changes in Top2 mRNA during 
qPCR experiments (Figure 3.12). This is in contrast to what is shown for Top2B mRNA 
in mammals during ageing where Top2B is seen to decrease (Bhanu et al., 2010; 
Terzioglu-Usak et al., 2017). Bhanu et al. (2010) reported declines in mRNA levels of 
Top2B in cultured rat cerebellar cells that had been aged over 5 weeks in vitro. Top2B 
levels were seen to significantly decrease from 2 weeks onwards and negligible levels 
were reported after 4 weeks of ageing. Furthermore, models based on age-related 
neurodegenerative diseases, such as Alzheimer’s disease, have similarly shown 
decreases in Top2B expression at the mRNA level (Terzioglu-Usak et al., 2017). 
Terzioglu-Usak developed an Alzheimer’s disease model by incubating fibrillar 
amyloid-β 1-42 (Aβ1-42) for 48 hours with cultured cerebellar granule neurons (CGNs) 
isolated from post-natal eight-day rats and found Top2B mRNA levels to be decreased 
compared to control cells.  
As previously stated, the chromosomes of Drosophila are morphologically comparable 
to chromosomes of vertebrates (Mengoli et al., 2014). In this organism Top2 has been 
shown to be expressed in mitotically active cells but has also been found to be stably 
expressed bound to chromatin in non-dividing cells. Based on this expression, 
indications might be made for homologous roles between Drosophila Top2 and 
mammalian Top2A and Top2B (Lee & Berger, 2019). The potential dual role for Top2 
in Drosophila may explain why decreases of mRNA expression are not seen, whilst 
decreases in Top2B mRNA have been reported in some mammalian experiments 
(Bhanu et al., 2010; Terzioglu-Usak et al., 2017).  
Pacifico et al. (2018) investigated age-dependent changes in the Drosophila whole-
brain transcriptome by comparing 5, 20, 30 and 40 day old male and female flies. They 
reported an overall decrease in the expression of genes from the mitochondrial oxidative 
phosphorylation pathway during Drosophila ageing. Davie et al. (2018) also showed 
that genes involved in oxidative phosphorylation decline faster than the average. 
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However, changes in gene expression of Top2 as a function of ageing were not reported. 
Although Pacifico reported an overall downregulation of electron transport chain genes 
with age, increases in stress response genes was also seen in older flies. Interestingly, it 
was also observed that a number of overlapping sets of neuronal function genes, that 
were seen to gradually decline between young and middle-aged flies, became 
upregulated in the oldest group of flies. Pacifico suggested that this reversal pattern of 
gene expression may act as a compensatory response to an overall decline in neuronal 
function. As Top2 plays key roles in neuronal function, the observations by Pacifico et 
al. (2018) may explain why mRNA levels of Top2 are not decreased in 50 day old flies 
in Figure 3.12. 
The reference genes used during this study for qPCR experiments were selected based 
on their expression stability in age-related experiments as described by Ling & 
Salvaterra (2011). The reference genes Cyp1 and eIF-1A were selected with confidence 
and data shown in this chapter were therefore considered valid results. However, data in 
this chapter presents relative levels of Top2, so it may therefore provide useful research 
to determine absolute levels of Top2 mRNA in future experiments to fully elucidate 
age-related changes of Top2 in Drosophila. 
3.6.4 Top2 protein levels in ageing 
3.6.4.1 Age-related changes in protein folding and degradation 
As mentioned previously, cells possess a complex set of mechanisms, referred to as the 
proteostasis network, to prevent and eliminate protein misfolding. The network includes 
protein synthesis, folding, trafficking, disaggregation, and degradation pathways (Balch 
et al., 2008). Often misfolded proteins are caused by inherent errors in protein 
biosynthesis and turnover. Genetic mutations and polymorphisms, genomic instability, 
mistranslation and incorporation of amino-acid analogues are all processes capable of 
causing variations in amino acid sequence and have the potential to affect folding 
pathways and the stability of the native state of a protein (Kikis et al., 2010). 
Nevertheless, older cells contain more proteins with oxidative damage such as ALEs 
and AGEs as shown in this study, as well as oxidised methionine and accumulations of 
cross-linked and aggregated proteins, and less catalytically active enzyme populations 
(Soskic et al., 2008).  
Damaged proteins and those that have reached the end of their lifespan are degraded by 
the proteasomal and autophagic systems (Lilienbaum, 2013). However, these systems 
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have been seen to deteriorate with age. For example, during ageing the assembly of the 
proteasome has been shown to become imbalanced, resulting in alterations in ubiquitin 
ligation machinery and an overall reduction in protein ubiquitination (David, 
2012). Berke & Paulson (2003) suggested that disturbances or impairments of the 
ubiquitin proteasome system can lead to an altered function of this pathway, which can 
positively affect the accumulation of protein aggregates in a cell. These disturbances 
and impairments are thought to be induced by an accumulation of misfolded proteins in 
the endoplasmic reticulum or a loss of function to key enzymes involved in the 
ubiquitin conjugation and deconjugation pathways. The formation of aggregated 
proteins occurs in a cell when a critical concentration of misfolded protein has been 
reached. These aggregated proteins often lead to the formation of amyloid‐like 
structures and can eventually cause numerous types of degenerative disorders leading to 
cell death (Berke & Paulson, 2003). Indeed, large numbers of neurodegenerative 
diseases have been shown to occur as a result of misfolded and aggregated proteins 
(Sweeney et al., 2017). Autophagy, a process that is known to play a housekeeping role 
in removing misfolded or aggregated proteins (Glick et al., 2010), has also been shown 
to be impaired at both the stage of induction and fusion of autophagosomes with 
lysosomes during ageing (Basisty et al., 2018). The comprehensive proteome profiling 
in C. elegans shows an imbalance of these components of proteostasis with age along 
with increased protein aggregation and an overload of chaperone machinery (Walther et 
al., 2015). In addition, the processes by which cells degrade these misfolded proteins 
are, in part, influenced by the energy status of the cell. During ageing, deterioration of 
cellular energetics is seen with alterations in glucose and fatty acid metabolism 
occurring. This reduces the amount of available ATP and alters chaperone activity, 
which results in the accumulation of misfolded protein (Calderwood et al., 2009).  
Age-related changes in the rate of translation may also explain differences in the 
abundance of proteins. However, Toyama et al. (2013) analysed translation levels in 
more than 11,000 genes in 6 month and 24 month old liver and brain tissue in rats and 
showed that 98% of these genes displayed an age-dependent change in translation level 
of less than 2-fold. This illustrated the stability of protein translation levels during 
ageing, which has previously been shown (Walther & Mann, 2011). However, the 
process of translation is only the first step in the production of functional proteins and 
most require assistance to correctly fold, which occurs either co-translationally or post-
translationally and is facilitated by chaperones and other partner proteins, such as 
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disulphide isomerases (McLaughlin & Bulleid, 1998). Decreased chaperone capacity, 
response and activity with age has been shown in several studies (Soti & Csermely, 
2003) and could lead to misfolding and subsequent degradation of Top2, resulting in 
reduced protein levels in the aged Drosophila brain seen in this present study. This may 
also explain why low levels of Top2 protein may be seen despite maintenance of 
mRNA levels. 
3.6.4.2 Modification of Top2 structure by oxidative stress 
It is conceivable that structural modifications to Top2 via oxidative stress may result in 
subsequent changes such as alterations to the active site, blockage of phosphorylation 
sites, or disruption to the binding sites for DNA, magnesium ions or partner proteins. 
This may lead to dysfunction of Top2 and could potentially lead to an increase in 
abortive catalytic cycles of the enzyme (Morimoto et al., 2019). Spontaneously 
occurring stabilised Top2 cleavage complexes have not been considered a serious threat 
to genome stability as they are normally rapidly repaired (Gómez-Herreros et al., 2014; 
Rao et al., 2016; Lee et al., 2018). However, during ageing there is a decrease in the 
efficiency of the DNA damage response (Gorbunova et al., 2007), which may result in 
increased abortive catalytic cycles. 
As the majority of cells in the adult fly brain are non-cycling, the major role of Top2 
will be in supporting transcription. A number of studies have shown that Top2B binding 
is enriched within the promoters and gene bodies of transcribed genes, suggesting that it 
is involved in transcriptional initiation and elongation (Kouzine et al, 2013; Manville et 
al., 2015; Madabhushi et al, 2015). Top2B is known to contribute to neuronal 
development by facilitating the transcriptional elongation of neuronal genes that are 
longer than 200 kb (King et al., 2013). Top2B has also been reported to be involved in 
RNA polymerase II promoter pause release and productive transcription. It is speculated 
that the catalytic activity of Top2B is needed for this process (Bunch, 2018). As stated 
previously, Drosophila possess only a single isoform of Top2. However, its 
involvement in transcriptional activities has previously been reported (Gemkow et al., 
2001; Cugusi et al., 2013), which suggests that correlations between Drosophila and 
mammalian type 2 topoisomerase isoforms can be made. 
A study by Ban et al. (2013) showed that persistent Top2B cleavage complexes arrested 
elongating RNA polymerase II during transcription. In addition, they showed that 
Top2B cleavage complexes are removed from the DNA by the 20S proteasome and 19S 
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ATPases. This process required 19S ATPase ring assembly but was independent of 
ubiquitination of Top2B. Thus, it is plausible that modified Top2 structure induced by 
age-related oxidative stress in Drosophila brains may generate more endogenous 
stabilised Top2 cleavage complexes that are removed by an analogous process in this 
species and could account for the decrease in Top2 protein seen with increasing age 
during this study.  
It is important to consider the possibility that modification of Top2 by oxidative stress 
may have masked epitopes important for antibody recognition. Certainly, the opposite 
has been shown to occur in which modifications of self-proteins have unmasked 
epitopes, resulting in the triggering of an immune response, which may induce 
autoimmune disorders (Abello et al., 2009). Again, future experiments to elucidate the 
binding epitope of the antibody used in this study would rule out this possibility.  
3.6.5 Consequences of declining Top2 levels 
Previous studies have shown dramatic declines in the transcription of long genes when 
Top2 becomes inactivated. As previously stated mammalian Top2B is known to 
contribute to neuronal development by facilitating the transcriptional elongation of long 
neuronal genes (King et al., 2013), with inhibition of Top2B shown to cause reductions 
in expression of these long genes. In organisms that possess just a single isoform of 
Top2, such as yeast, the expression of long genes has also been seen to be impaired 
without the presence of Top2, irrespective of their function (Joshi et al., 2012). This 
reduction in expression was seen to produce a stall in the progression of RNA 
polymerase II during elongation but did not alter transcription initiation of long genes. 
As Drosophila Top2 and each of the human topoisomerase isoforms, Top2A and 
Top2B, can rescue the phenotype of yeast Top2 mutants, it highlights the strong 
functional conservation of type II topoisomerases between species and suggests that 
Top2 in Drosophila also plays important roles in the transcription of long genes 
(Wyckoff & Hsieh, 1988; Jensen et al., 1996). Indeed, increases of positive supercoils 
and subsequent torsional stress can also inhibit RNA polymerase activities and disrupt 
transcription in mammalian cells, with the roles of topoisomerase in relieving torsional 
stress shown to be crucial in maintaining DNA templates in a transcriptionally 
competent state (Gilbert & Allan, 2014). Previous studies have shown that a number of 
genes that are required for proper neuronal function are downregulated with age. Hall et 
al. (2017) reported a downregulation of genes including Sh, Csp, Hdc, Shal and Sap47 
in Drosophila over 40 days of ageing. These genes have been reported to be required for 
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proper neuronal synaptic function. As discussed by Gabel et al. (2015), on average, 
neuronal genes tend to be longer, which implies that elongation during transcription is 
crucial for proper expression of these genes. As Top2 is a key player in the expression 
of long genes it is conceivable that decreases in Top2 may affect the normal function of 
neuronal cells. Not only is the expression of long genes dependent on topoisomerases 
for proper expression but they also rely heavily on DNA repair pathways as long genes 
typically accumulate more DNA damage compared to shorter genes (Vermeij et al., 
2016). Defects to DNA repair pathways have previously been associated with reduced 
lifespan in Drosophila (Garschall et al., 2017). As discussed previously, Top2B has 
been associated with DNA repair pathways in mammals as reported by Gupta et al. 
(2012) and Morotomi-Yano et al. (2018). It is possible that Top2 also plays a role in the 
DNA repair pathways of Drosophila, although further work would need to be carried 
out to elucidate this. Nevertheless, reductions of Top2 with age may have profound 
effects on the ability of cells to repair DNA and may result in increased vulnerability to 
oxidative stress, ultimately having detrimental effects on longevity.  
It is important to remember that Top2 in the Drosophila brain may also be involved in 
DNA replication as Top2 has been shown to be expressed in mitotically active cells 
(Gemkow et al., 2001). A study by Von Trotha et al. (2009) showed that proliferating 
cells can be found in the adult brain of Drosophila, specifically around the antennal 
nerve. It was hypothesised that these may be adult stem cells with the potential to 
generate glial and/or non-glial cell types. In addition, neurogenesis has been shown to 
occur in the medulla cortex of the adult Drosophila optic lobes (Fernandez-hernandez et 
al., 2013). Thus, the consequence of declining levels of Top2 may also lead to 
detrimental effects in this physiological context too.   
A number of questions remain to be answered from this study, including; (1) Is Top2 
structure damaged with ageing? (2) Do higher levels of endogenous Top2 cleavage 
complexes form in aged cells? (3) Is the proteasome system involved in removal and 
degradation of these endogenous Top2 cleavage complexes? 
Experiments aiming to answer these questions may provide useful future research. For 
example, immunoprecipitation experiments may reveal whether structural damage to 
epitopes of Top2 occur during ageing. Furthermore, the use of the trapped in agarose 
DNA immunostaining assay (TARDIS) would allow quantification of topoisomerase–
DNA complexes to be made. Unlike the alkaline comet assay, the TARDIS assay can 
detect these specific modifications rather than the general presence of DNA breaks 
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(Cowell et al., 2010). This may answer whether higher levels of endogenous Top2 
cleavage complexes form in aged cells. Alongside TARDIS assays, the use of 
proteasome inhibitors in future experiments may help to determine whether the 
proteasome system has any involvement in the degradation of Top2 cleavage 
complexes. As stated previously, this system is known to be responsible for the 
degradation and removal of damaged proteins. As protein levels of Top2 have been 
shown to decrease in this study but mRNA levels have been shown to be constant, 
analysis of the rate of transcription may provide insightful research. It may be that 
mRNA levels become upregulated to compensate for a loss of protein. 
It may also be useful to look deeper into the expression of Top2 in Drosophila. In this 
study, relative levels of Top2 were investigated from extracts of whole brain tissue. 
However, brain tissue is made up of numerous cell types and not just neurons. 
Experiments carried out on whole brains alone will result in a loss of cellular 
information and may be hiding cell-specific roles of Top2. Thomas et al. (2010) 
developed and adapted the translating ribosome affinity purification (TRAP) method to 
allow the unique translatome profiles of different cell-types to be determined under 
various physiological, pharmacological and pathological conditions in Drosophila. 
Thomas suggested that translatome profiling using these methods allows questions 
regarding the life-cycle of mRNA molecules in Drosophila to be answered. Future work 
using these methods may help to determine tissue specific expression of Top2. 
In conclusion, Top2 protein levels have been shown to decrease during ageing in male 
and female Drosophila. Alongside decreases in Top2 protein levels, declines in 
locomotor function were also seen in males and females during ageing with significant 









4. Development of a cell line model of ageing using the human 
neuroblastoma cell line SH-SY5Y to investigate changes in Top2B 
expression 
4.1 Introduction 
To explore the expression of Top2B in aged neurons, the development of a suitable cell 
line model was required. The neuroblastoma cell line SH-SY5Y is widely used in the 
field of neuroscience research due to the ability of the cell line to be differentiated into a 
cell with a more mature neuronal-like phenotype. This cell line is derived from the SK-
N-SH cell line, which was cultured from the biopsy of a metastatic tumour in a four 
year old female neuroblastoma patient in 1970 (Kovalevich & Langford, 2013). In an 
undifferentiated state, SH-SY5Y continuously rapidly proliferate (Påhlman et al., 1984) 
and so provide an unlimited supply of material, which is cost effective and also 
bypasses the ethical concerns associated with using human tissue. SH-SY5Y are 
morphologically characterised as neuroblast-like cells possessing only a few short 
neuronal processes with tendencies to grow in clusters (Kovalevich & Langford, 2013) 
and express immature neuronal markers (Påhlman et al., 1984). After induction of 
differentiation SH-SY5Y morphologically become more comparable to mature neurons. 
Cells no longer grow in clusters and they develop long neurite processes forming 
networks with neighbouring cells with reductions in proliferation also seen. In addition, 
mature neuronal markers are expressed such as neuronal nuclei (NeuN), synaptophysin 
(SYN), growth-associated protein (GAP-43), microtubule associated protein (MAP), 
neuron specific enolase (NSE) and synaptic vesicle protein II (SV2) (Shipley et al., 
2016). The SH-SY5Y cell line is known to produce different cellular phenotypes: N-
type cells and S-type cells. N-type cells are neuroblastic and are characterised by neurite 
processes, whereas S-type cells are substrate adherent multipotent precursors to a 
number of non-neuronal cells including glial cells, melanocytes and Schwann cells (Bell 
et al., 2013). The SH-SY5Y cell line is predominantly composed of N-type cells having 
derived from three successive subclone selections of N-type cells. However, a small 
proportion of S-type cells remain in the SH-SY5Y cell line (Forster et al., 2016). SH-
SY5Y have been commonly used to investigate neurodegenerative diseases such as 
Parkinson’s disease and Alzheimer’s disease (Agholme et al., 2010; Xie et al., 2010) 
but its use as a model of ageing has also been reported (Heidari et al., 2018; Rahimi et 
al., 2018). In ageing studies SH-SY5Y cell are most commonly ‘aged’ through 
oxidative stress. Cells are typically stressed until ROS generation occurs to produce a 
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senescence-associated secretory phenotype (SASP), rather than chronologically aged to 
produce the same features of an aged cell (Liu et al., 2013; Heidari et al., 2018). ROS 
generation and subsequent oxidative stress is known to cause mitochondrial 
dysfunction, which is one of the leading triggers of senescence (Chapman et al., 2019). 
Dysfunction of mitochondria alters cell signalling and subsequently SASP is produced 
(section 1.2) (Vizioli et al., 2020). Sub-lethal concentrations of H2O2 can increase 
oxidative stress, cause DNA cleavage and induce a hyperactivation of poly (ADP-
ribose) polymerase (PARP) and subsequent depletion of NAD+. A decrease in SIRT1 
function follows this with an accumulation of acetylated p53 and transcription of p53 
target genes, such as p21, that bind to cyclin E/Cyclin dependent kinase 2 and cyclin 
D/Cyclin dependent kinase 4 complexes to cause G1 arrest in the cell cycle (Chen, 
2016). It is likely that this pathway plays an important role in oxidative stress induced 
cellular senescence (Han et al., 2014). 
As stated previously, SH-SY5Y cells are frequently used because of their ability to be 
differentiated into more neuronal-like cells. The addition of all-trans retinoic acid (RA) 
to the culture medium is one of the most commonly employed methods to induce 
differentiation in the SH-SY5Y cell line. As a vitamin A derivative, RA has been shown 
to induce cellular differentiation and inhibit cell growth (Xicoy et al., 2017). Various 
studies have shown SH-SY5Y can become differentiated into cells with cholinergic 
phenotypes, whereas as others have shown a shift towards a dopaminergic phenotype in 
response to the addition of RA to the culture medium (Xie et al., 2010; Kovalevich & 
Langford, 2013). RA controls a number of aspects associated with cell differentiation, 
proliferation and apoptosis (Gudas & Wagner, 2011). The actions of the two 
transcription factor families, retinoic acid receptors (RAR) and retinoid X receptors 
(RXR) are responsible for the mediation of most RA activities. Once inside a cell, RA 
binds to cellular RA-binding protein II (CRABPII) or FABP5 and is relocated to the 
nucleus (Conserva et al., 2019). In the nucleus, RA binds to RAR, which subsequently 
binds to RXR. This RXR/RAR complex can bind to RA response elements (RAREs) in 
the promoter regions of target genes. Association of the receptor with RA brings about a 
conformational change in its ligand-binding domain such that instead of binding 
transcriptional corepressors, such as nuclear receptor corepressor (NCoR) or silencing 
mediator of retinoic acid and thyroid hormone receptor (SMRT), it can bind to and 
recruit coactivators of expression such as histone acetyl transferases (HATs), including, 
nuclear receptor coactivator 3 (NCoA3). This triggers the transcription of a number of 
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key genes required for neuronal differentiation (Das et al., 2014). Many other co-factors 
are involved in these processes too. For example, interaction of the zinc-finger protein 
Zfp42 with RXR/RAR complexes at some RAREs has been shown to be required for 
RA-induced cell cycle arrest and differentiation of neuroblastoma cells (Huang et al., 
2009).  
It should also be noted that there are exceptions to this model. For example, RXR/RAR 
complexes bound to RA can lead to the recruitment of PRC2 and histone deacetylase 
(HDAC) to repress the expression of genes including homeobox B1 (Hoxb1) and 
fibroblast growth factor 8 (Fgf8) (Cunningham & Duester, 2015).  
In addition to the classical genomic effects briefly described above, RA has a number of 
nongenomic effects, which it elicits by rapidly and transiently activating several kinase 
cascades (Al Tanoury et al., 2013). For example, the addition of RA has been shown to 
activate the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signalling 
pathway as well as extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathways. 
PI3K/Akt has shown to be a regulator of both neuronal differentiation and survival of 
RA-treated neuroblastoma cells with inhibition of PI3K by LY294002 causing 
impairments in RA-induced neuronal differentiation (López-Carballo et al., 2002). The 
PI3K/Akt and ERK1/2 pathways have been seen to regulate RA-induced RXR 
transcriptional activity in neuroblastoma cells (Qiao et al., 2012).   
A number of studies have previously investigated Top2B in the SH-SY5Y cell line. 
However, these studies have predominantly focussed on the regulation of Top2B 
expression during differentiation and development. As stated previously, studies have 
demonstrated increases in Top2B expression at both the mRNA and protein level during 
retinoic acid-induced neuronal differentiation of SH-SY5Y cells, alongside increases in 
the transcription factor Sp1, which also increased at the mRNA and protein level, 
suggesting that Sp1 might regulate Top2B expression by binding to its GC box in the 
promoter region (section 1.5.4) (Guo et al., 2014). In addition to this, the transcription 
factor NURR1 has been implicated in axonal development of dopaminergic neurons 
through interaction with Top2B. Reports have identified two functional NURR1 binding 
sites in the proximal Top2B promoter and propose that NURR1 may influence axon 
genesis in dopaminergic neurons by recruiting Top2B (section 1.5.4) (Heng et al., 
2012). However, to the best of our knowledge no studies have looked into the 
expression of Top2B in an ageing model of the SH-SY5Y cell line.  
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The purpose of this research was to create senescence within the SH-SY5Y cell line to 
provide a model that gives a representation of an aged-like neuron. This chapter 
presents the results found from the development of this model.  
 
4.2 Hydrogen peroxide induced cellular senescence of undifferentiated SH-SY5Y 
cells 
In order to create a cell line model of ageing, a number of approaches were taken to 
induce senescence in SH-SY5Y cells. Methods of cellular senescence induction using 
oxidative stress caused by hydrogen peroxide (H2O2) have been reported in a number of 
studies using various cell types, such as fibroblasts and mesenchymal stem cells 
(Kiyoshima et al., 2012; Choo et al., 2014). In addition, Nopparat et al. (2017) 
demonstrated that senescence can be induced in undifferentiated SH-SY5Y cells 
through exposure to H2O2. Hydroxyl radicals, superoxide anions and H2O2 are all 
examples of reactive oxygen species (ROS) that are generated during redox reactions in 
the human body. Oxidative stress is induced by high levels of these ROS, which can 
cause mitochondria, protein, DNA and lipid membrane dysfunction and can lead to 
losses in cellular function and integrity, ultimately causing cellular senescence 
(Chapman et al., 2019).  
Cell cycle arrest is one of the predominant features of senescence, hence initial 
experiments focussed on creating senescence in undifferentiated SH-SY5Y cells by 
exposing them to a range of H2O2 concentrations and analysing relative proliferation 
using the WST-1 assay. Cells were exposed to a range of concentrations of H2O2 (0.1 to 
2 mM) for 1 hour and then grown over a range of incubation times following exposure 


























Figure 4.1 Proliferation of SH-SY5Y cells treated with a 1 hour pulse of a range of H2O2 
concentrations and grown for 24, 48 or 72 hours. 
Cells were seeded in three 96-well plates in culture media at a density of 1 x 10
5 
cells/ml with 
100 µl added to each well. The cells were then incubated for 48 hours at 37°C to allow cells to 
adhere. SH-SY5Y cells were exposed to H2O2 concentrations of 0.1, 0.5, 1.0 and 2.0 mM for 1 
hour. Supernatant was removed and wells were rinsed in 100 µl culture media. 100 µl fresh 
culture media was added to wells and incubated. WST-1 assays were performed after 24, 48 and 
72 hours (section 2.2.2.11) and an H2O drug vehicle control was analysed alongside treated 
cells. At each time point WST-1 reagent (Roche- 05015944001) was added to a plate and 
incubated for 2 hours. The absorbance of the samples was measured at 450 nm on a plate reader. 
Proliferation data is presented as a measurement of OD at 450 nm (A) and relative cell 
proliferation compared to an untreated control (B). Data is presented as the mean of three 





Results from Figure 4.1 show that 0.1 mM H2O2 reduces proliferation at all post-
exposure times but not significantly (see Appendix table B.1 for p values). However, 1-
hour pulses of 0.5, 1.0 and 2.0 mM reduced relative proliferation to approximately 50% 
with all results significant apart from 0.5 mM after 48 hours (p=0.15) and 2.0 mM after 
24 hours (p=0.0505 Student’s t-test, two-tailed) (see Appendix table B.1 for p values). 
Interestingly, longer post exposure times did not always reduce proliferation further as 
seen in cells treated with 0.1, 0.5 and 1.0 mM H2O2. So although proliferation rates are 
reduced compared to controls they are not inhibited completely as hoped for.   
Previously it has been shown that SH-SY5Y cells treated with 0.1 mM H2O2 for 2 hours 
and then grown for a further 24 hours showed a decrease in ki67 immunoreactivity 
using fluorescence microscopy compared to controls (Nopparat et al., 2017). Ki67 is 
strongly associated with proliferative activity of cells and is expressed in the nuclei in 
all phases of the cell cycle, whereas activity of Ki67 is not seen in quiescent or resting 
differentiated cells in the G0 phase (Juríková et al., 2016). However, in the Nopparat 
study no quantification of Ki67 immunoreactivity was performed, so it is difficult to 
compare with the reduction in proliferation after exposure to 0.1 mM H2O2 for 1 hour in 
this study.   
Alongside WST-1 assays SH-SY5Y cells were exposed to the same range of H2O2 
concentrations and viewed under a light microscope 24, 48 and 72 hours after a 1 hour 
H2O2 exposure. It was found that cells exposed to 0.5, 1.0 and 2.0 mM H2O2 were no 
longer adherent to the culture flask and began to clump together. Trypan blue analysis 
of cells treated with higher concentrations of H2O2 confirmed that a large proportion of 
cells were dead (looked at a flask of leftover cells. No data recorded). Work by 
Nopparat et al. (2017) supports this finding. Following 24 hours post exposure to 2 
hours of H2O2, SH-SY5Y viability decreased significantly at 0.1, 0.2, and 0.4 mM to 
~84%, ~67%, and ~38%, respectively.  
Interestingly, cells exposed to 0.1 mM H2O2 for 1 hour displayed a limited loss of 
adherence and viability compared to the 2 hour exposure in the Nopparat study, 
indicating the length of exposure as well as the dose of H2O2 used can affect the 
viability of the cells.  
Thus, it was decided to treat SH-SY5Y cells with lower doses of H2O2 to determine if 
this could induce senescence in the cells and this was initially assessed by observing 
proliferation. Cells were exposed to a range of concentrations of H2O2 ranging from 0.1 
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µM up to 10 µM for a 1 hour pulse and incubated for 24 hours or 48 hours (Figure 4.2). 
It was decided that WST1 assay would not be used as it does not specifically measure 
the number of viable cells in a culture or their growth but rather an integrated set of 
enzyme activities that are related in a number of ways to cell metabolism (Berridge et 
al., 2005). As such, oxidative stress may significantly affect the results due to 
perturbations in the activity of many mitochondrial and non-mitochondrial enzymes 
involved in reduction of WST1 and may result in under/over estimation of proliferation 
(Stepanenko & Dmitrenko, 2015). Instead, it was decided to quantify the number of 
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Figure 4.2 Proliferation of SH-SY5Y cells over 24 and 48 hours after a 1 hour pulse with a 
range of H2O2 concentrations. 
6-well plates were seeded at 1 x 10
5
 cells/ml (2ml per well) and incubated for 48 hours at 37°C. 
Cells were exposed to working concentrations of H2O2 for 1 hour (2 ml per well). SH-SY5Y 
cells were exposed to a range of H2O2 concentrations (0.1, 0.5, 1.0, 5.0 and 10.0 µM) alongside 
an H2O drug vehicle control.  Supernatant was removed and cells were rinsed in 1 ml DMEM. 2 
ml of fresh DMEM was added to each well and plates were incubated for 24 or 48 hours. Cell 
counts were performed using trypan blue exclusion assay. To detach the cells from the bottom 
of the 6-well plate, a cell scraper was used. Proliferation data is presented as a measurement of 
viable cell counts (A) and relative cell proliferation compared to an untreated control (B). Data 





Results from Figure 4.2B demonstrate no significant reduction in proliferation with 0.1 
µM H2O2 after 24 hours (p=0.31). However, after 48 hours this dose reduced 
proliferation significantly to ~70% of the control (p=1.5x10
-6
). Increasing doses of H2O2 
also show further reductions in relative proliferation compared to the control with all 
remaining results, apart from 0.5 µM H2O2 after 24 hours, demonstrating significant 
reductions in relative proliferation (see Appendix table B.2 for p values). 
From the data above, exposure to a 1 hour pulse of 10 µM H2O2 was most effective, 
reducing relative proliferation to ~30% after 48 hours (p=3.2x10-4). Bearing in mind the 
potential toxicity of H2O2 to SH-SY5Y cells discussed above and shown by Nopparat et 
al. (2017), it was decided to test for senescence using the β-galactosidase (β-gal) assay 
on cells exposed to a 1 hour pulse of 10 µM H2O2 and grown for a further 48 hours. 
Senescence-associated β-gal is a lysosomal enzyme most commonly used as a 
senescence biomarker and can be detected by means of a cytochemical assay (Dimri et 
al., 1995). Reports have shown that senescent cells have large and numerous lysosomes 
and as a result have high levels of β-gal (Kurz et al., 2000). Results for the β-gal assay 







Figure 4.3 β-gal assay of SH-SY5Y cells 48 hours after a 1 hour exposure to 10 µM H2O2.  
SH-SY5Y cells were seeded in a 6-well plate at 1 x 10
5
 cells/ml (2 ml per well) and incubated 
for 48 hours at 37°C. 2 ml working concentrations of H2O2 (B) or a H2O control (A) were added 
to each well and incubated for one hour. Supernatant was removed and plates were rinsed in 1 
ml DMEM. Fresh DMEM was added and then incubated for 24 hours. β-gal assays were carried 
out using Sigma Aldrich Senescence Cells Histochemical Staining Kit (catalogue Number 
CS0030) according to manufacturer instructions. Cells were observed under a light microscope 
and images were obtained. Any cells expressing β-gal should appear bright blue in colour. 




Results from Figure 4.3B show that no blue β-gal staining was observable in H2O2 
treated undifferentiated SH-SY5Y cells treated with 10 µM H2O2. Results seen in the 
control cells (Figure 4.3A) are comparable to those treated with H2O2. This assay was 
carried out in triplicate and staining was not observed in any of the experiments (data 
not shown). In addition to this, attempts were made to induce senescence in 
undifferentiated SH-SY5Y by exposing cells to 10 µM H2O2 for 1 hour on 3 consecutive 
days before carrying out β-gal assays. This also provided negative results (data not 
shown). In contrast, Nopparat et al. (2017) showed that treatment with a 2 hour pulse of 
100 µM H2O2 significantly increased the number of SA- β-gal-positive cells by ~195% 
compared to control cells. 
In conclusion, although proliferation could be significantly reduced to ~30% of control 
cells using 10 µM H2O2 without compromising cellular viability, this treatment did not 
bring about senescence as measured by the β-gal assay. 
 
4.3 Hydrogen peroxide induced cellular senescence of retinoic acid treated SH-
SY5Y cells 
Following unsuccessful attempts to induce senescence in undifferentiated SH-SY5Y 
cells it was decided that further investigations would be made in differentiated-like SH-
SY5Y cells. As stated previously the addition of all-trans retinoic acid (RA) to culture 
medium is one of the most commonly employed methods to induce the differentiation-
like phenotype in the SH-SY5Y cell line. In addition to this, utilising cells that 
phenotypically display mature neuronal-like characteristics may provide a more suitable 
model for further investigations as they are more similar to adult neurons (Shipley et al., 
2016). 
4.3.1 Retinoic acid-induced differentiation-like phenotype in SH-SY5Y cells 
SH-SY5Y are derived from cancerous neuroblastoma cell lines and, as a result of this, 
possess dysregulated cell cycles and display a continued up-regulation of cell 
proliferation. This does not represent a mature neuron, which typically does not divide 
(Fishel et al., 2007). As RA has been shown to induce a differentiated-like phenotype in 
which cell growth is inhibited (Xicoy et al., 2017), SH-SY5Y cells were exposed to 1 
µM and 10 µM RA in culture media. This range of concentrations was chosen but 10 
µM RA has been most commonly used in previous studies to differentiate SH-SY5Y 
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(Kovalevich & Langford, 2013; Shipley et al., 2016). The effect of these concentrations 
of RA on proliferation was monitored and the results are shown in Figure 4.4. Cuende et 
al. (2008) showed that exposure to 10 µM RA causes SH-SY5Y cells to progressively 
develop phenotypic changes compatible with neuronal-like morphology, characterised 
by neurite outgrowth and a reduction in proliferation after 2 days. The expression of 
neuronal markers including Gap43, Map2 and Tau was seen at day 2 and progressively 
increased up to day 5. In addition, a decline in proliferating cell nuclear antigen (PCNA) 
protein was seen, whereas cyclin-dependent kinase inhibitors p27 and p21 were 
increased. This data suggested that treatment of SH-SY5Y cells with RA was suitable to 
differentiate these cells. Similarly, Maruyama et al. (1997) also differentiated SH-SY5Y 






































Figure 4.4 The effects of all-trans retinoic acid on SH-SY5Y proliferation. 
6-well plates were seeded at 1 x 10
5
 cells/ml (2 ml per well) and incubated for 24 hours at 37°C. 
Supernatant was removed and cells were exposed to working concentrations of RA at 1.0 µM or 
10 µM for 24, 48 and 72 hours. A 0.1% DMSO (v/v) control was analysed alongside RA-treated 
cells. Cells were detached from the bottom of the 6-well flask at 24, 48 and 72 hours using a cell 
scraper and viable cells were counted using trypan blue exclusion. Proliferation data is 
presented as a measurement of viable cell counts (A) and relative cell proliferation compared to 







Results from Figure 4.4A shows significant reductions of cell growth in SH-SY5Y cells 
treated with 10 µM RA after 48 and 72 hours compared to the DMSO control with p 
values of 0.027 and 0.005, respectively. However, these cells still continue to 
proliferate, albeit at a much slower rate than the control cells. For example, SH-SY5Y 
cell numbers after 72 hours of 10 µM RA treatment is significantly higher than T0 
(p=0.002), which suggests that some of the cells are not entering cell cycle arrest. 
Differences between the DMSO control and cells treated with 1.0 µM RA are not 
significant, therefore no further experiments were carried out using this concentration of 
RA.  
Alongside proliferation assays, morphological comparisons between undifferentiated 
and 10 µM RA treated cells were made. Cells were monitored for any changes in 








Figure 4.5 Morphological changes of SH-SY5Y after 10 µM RA treatment. 
6-well plates were seeded at 1 x 10
5
 cells/ml (2 ml per well) and incubated for 24 hours at 37°C. 
Supernatant was removed and plates were treated with 10 µM RA or a 0.1% DMSO (v/v) 
control. Cells were observed under a light microscope after 24, 48 and 72 hours and images 
were obtained. Image (A) shows cells treated with DMSO and image (B) shows cells treated 
with 10 µM RA after 72 hours. 
Images seen in Figure 4.5 clearly show morphological changes in SH-SY5Y cells 
treated with 10 µM RA for 72 hours (Figure 4.5B) compared to the DMSO control 
(Figure 4.5A). Untreated cells can be seen to grow in clumps and possess short neurites. 
A neurite is an elongated cylindrical process that extends from the cell body and serves 
as a precursor of axons and dendrites to allow polarisation of the neuron to occur 




develop longer neuronal projections. These morphological changes suggest the 
development of a differentiated-like phenotype in the RA treated cells.  
Although these morphological changes were accompanied by some reduction in 
proliferation, results from figure 4.4 show that proliferation failed to continually 
decrease with time but instead remained stable from 24 to 72 hours. Further molecular 
analysis was needed to determine if differentiated-like cells had developed. 
4.3.2 Quantification of Topoisomerase II protein during SH-SY5Y differentiation 
Previous studies have shown that Top2B is expressed throughout the cell cycle in all 
mammalian cells. However, it is reported to be significantly upregulated when cells 
enter a state of terminal differentiation (Tsutsui et al., 1993; Tiwari et al., 2012; Guo et 
al., 2014; Harkin et al., 2015; Austin et al., 2018). In contrast, Top2A is seen to be 
highly expressed in proliferating cells but not in terminally differentiated tissue. Tsutsui 
et al. (1993) reported that Top2A was present in embryonic rat brains and in the 
cerebellum two days after birth but levels were undetectable after 4 weeks. If a 
differentiation-like phenotype has been achieved in RA-treated SH-SY5Y cells, Top2B 
protein levels should be seen to increase while Top2A levels should be seen to decrease. 
Indeed, Top2A has been used as a marker for proliferation in many other studies 
(Turley et al., 1997; Hong et al., 2012; Şahin et al., 2016). Thus, it was decided to semi-
quantify the levels of Top2A and Top2B in RA treated cells.  
SH-SY5Y cells were treated with 10 µM RA and protein extracts taken at time zero 
(T0) and after 24, 48 and 72 hours. Western blot analysis of Top2A and Top2B was 
carried out on these samples alongside untreated SH-SY5Y cells. Results can be seen in 


























Figure 4.6 Semi-quantification of Top2A over 72 hours of RA-induced differentiation of 
the SH-SY5Y cell line. 
T25 culture flasks were seeded at 1 x 10
5
 cells/ml (5 ml per flask) and incubated for 48 hours at 
37°C. Supernatant was removed and flasks were treated with 10 µM RA or a 0.1% DMSO (v/v) 
control and incubated. Whole cell extraction was carried out at T0 and after 24, 48 and 72 hours 
as described in section 2.2.2.9 and quantified as described in section 2.2.2.10. Equal protein 
loads (56.4 µg) were added to wells of a 7.5% SDS gel. SDS-PAGE was carried out and protein 
was transferred to nitrocellulose paper by wet western transfer. (A) Nitrocellulose blots were 
probed with a Top2A antibody and a GAPDH load control antibody. Analysis of blot 
densitometry was carried out using GeneTools (Syngene). (B) TopA expression is presented as 
a percentage of that seen in T0 cells. The results shown for Top2A are the mean of two 































Figure 4.7 Semi-quantification of Top2B over 72 hours of RA-induced differentiation of 
the SH-SY5Y cell line. 
T25 culture flasks were seeded at 1 x 10
5
 cells/ml (5 ml per flask) and incubated for 48 hours at 
37°C (5% CO2). Supernatant was removed and flasks were treated with 10 µM RA or a 0.1% 
DMSO (v/v) control and incubated. Whole cell extraction was carried out after 24, 48 and 72 
hours as described in section 2.2.2.9 and quantified as described in section 2.2.2.10. Equal 
protein loads (56.4 µg) were added to wells of a 7.5% SDS gel. SDS-PAGE was carried out and 
protein was transferred to nitrocellulose paper by wet western transfer. (A)  Nitrocellulose blots 
were probed with a Top2B antibody and a GAPDH load control antibody. Analysis of blot 
densitometry was carried out using GeneTools (Syngene). (B) Top2B expression is presented as 
a percentage of that seen in T0 cells. Results shown for Top2B are the mean of three 
independent experiments ± standard error. * = p < 0.05 (Student’s t-test, two-tailed). 
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Results shown in Figure 4.6 yielded no significant changes in protein levels of Top2A 
in RA-treated SH-SY5Y cells over 72 hours. In addition, treatment with 10 µM RA at 
all time points investigated did not show any significant differences in Top2B protein 
levels (Figure 4.7), although the high inter-experiment variability should be noted. This 
is unlike previous studies that have shown Top2A decreases during differentiation 
(Thakurela et al., 2013) and Top2B increases in terminally differentiated neurons (Guo 
et al., 2014). 
These findings suggest that a differentiated-like phenotype had not been achieved 
despite some reduction in proliferation and morphological changes characteristic with 
differentiation being noted. 
Interestingly, significant increases were seen in Top2B protein levels between T0-48 
hours and 24-48 hours in the DMSO control with p values of 0.017 and 0.034, 
respectively. Many papers have reported that Top2B protein levels remain stable 
throughout the cell cycle (Woessner et al., 1991; Turley et al., 1997). However, Top2B 
protein levels are shown to increase with increasing proliferation. As equal protein loads 
from extracts were analysed on the gels, it would suggest that Top2B levels increase 
throughout the cell cycle. However, further experiments would be needed to confirm 
this. Nevertheless, this has also been reported in previous studies. For example, Padget 
et al. (2000) demonstrated that both Top2A and Top2B are expressed to higher levels in 
exponentially growing cells than in plateau phase and G0 peripheral blood lymphocyte 
cells, suggesting that there is a positive correlation between type 2 topoisomerase 
protein content and activity. 
Despite these findings it was decided to try to induce senescence using H2O2 in SH-
SY5Y cells pre-exposed to 10 µM RA for 72 hours. 
4.3.3 Hydrogen peroxide-induced cellular senescence of RA treated SH-SY5Y cells 
In order to determine whether it was possible to induce senescence in RA treated cells 
by H2O2 induced oxidative stress, cells were exposed to 100 µM H2O2 for 1 hour post 
incubation with RA. This dose was chosen as previous studies have shown that 
differentiated SH-SY5Y cells are more resistant to the effects of DNA damaging agents 
than undifferentiated cells (Schneider et al., 2011; Tong et al., 2017) with further 
studies showing concentrations of 100 µM H2O2 being used to induce oxidative stress in 
SH-SY5Y cells, whilst maintaining sufficient cell viability (Ramalingam & Kim, 2014). 
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Further proliferation assays were carried out on untreated and RA treated SH-SY5Y 


















Figure 4.8 Proliferation of untreated and RA treated SH-SY5Y cells after treatment with 
H2O2. 
6-well plates were seeded at 1 x 10
5
 cells/ml (2 ml per well) with either DMSO and incubated 
for 48 hours at 37°C or 10 µM RA for 72 hours prior to collection of data. Media was removed 
and replaced with fresh DMSO/RA DMEM (control) or DMSO/RA DMEM containing 100 µM 
H2O2 and incubated for 1 hour at 37°C. Supernatant was removed and fresh DMSO/RA DMEM 
was added to the plates before incubating. Cell counts were taken at 24, 48 and 72 hours after 






Results from Figure 4.8 show a reduction in proliferation in RA treated cells and in cells 
treated with 100 µM H2O2 compared to the DMSO control. Cell numbers in the DMSO 
control were seen to increase during the first 48 hours and then suddenly decrease after 
72 hours. The reason for this decrease was attributed to the 6-well plate becoming over-
confluent and cells detaching from the surface of the plate and dying. Interestingly, 
during this experiment no differences in trends between cells treated with H2O2 can be 
seen. In addition to this, no trends can be seen between H2O2-treated and DMSO-treated 
RA cells and results for RA cells treated with H2O2 are not dissimilar to undifferentiated 
cells treated with H2O2 apart from seeing a slight reduction in relative proliferation. As 
results shown in Figure 4.8 are from one biological replicate, further experiments would 
be required to determine any statistical significance. Alongside this experiment β-gal 
assays were carried out to determine whether senescence had been achieved. Results 





































Figure 4.9 β-gal assay of RA treated SH-SY5Y cells treated with or without 100 µM H2O2. 
6-well plates were seeded at 1 x 10
5
 cells/ml (2 ml per well) in DMEM containing 10 µM RA 
and incubated for 72 hours. Media was removed and replaced with fresh RA DMEM containing 
H2O (control) or RA DMEM containing 100 µM H2O2 and incubated for 1 hour at 37°C. 
Supernatant was removed and fresh RA DMEM was added to the plates before incubating. β-gal 
assays were carried out using Sigma Aldrich Senescence Cells Histochemical Staining Kit 
(catalogue Number CS0030) according to manufacturer instructions after 24, 48 and 72 hours. 
Cells were observed under a light microscope and images were obtained.  
 






Differentiated SH-SY5Y cells treated with 100 µM H2O2 do not appear to have entered 
senescence after analysis of β-gal assay images (Figure 4.9). Senescent cells should 
appear blue in colour after the assay and this cannot be said for these cells. In 
comparison to differentiated SH-SY5Y cells that were treated with DMSO, no colour 
differences between the two groups can be seen. However, H2O2 treated cells do appear 
to have an altered morphology after 48 hours. A large proportion of the cells lost their 
long neurite processes at this time point but interestingly, cells appeared to recover after 
48 hours and began to develop longer neurites again whilst continuing to proliferate.  
In conclusion, pre-treating SH-SY5Y cells with RA prior to exposure to H2O2 did not 
achieve senescence in these cells as determined by the β-gal assay.  
 
4.4 Discussion 
Overall, the data in this chapter suggests that senescence was not achieved in the SH-
SY5Y cell line in both untreated and RA treated cells using adapted protocols published 
by Lopes et al. (2010), Ramalingam et al. (2014) and Xicoy et al. (2017). It has 
previously been reported that senescence can be induced in undifferentiated SH-SY5Y 
cells using a single treatment of 100 µM H2O2 with senescence-associated β-gal staining 
providing positive results (Nopparat et al., 2017). However, this is in contrast to results 
shown in Figure 4.1, 4.2 and 4.3, which demonstrated that the higher doses of H2O2 
were toxic to cells, whereas lower doses were not sufficient to induce cell cycle arrest 
with β-gal assays yielding negative results despite cell culture and treatments being the 
same as Nopparat et al. (2017). SH-SY5Y cells were a gift from Newcastle University 
UK and were at passage two upon receipt. Cells were confirmed to be mycoplasma 
negative and were periodically tested by technical staff throughout the duration of their 
use and confirmed negative using Minerva-biolabs Venor®GeM OneStep kit (Cat. No. 
11-8250) (data not shown). SH-SY5Y cells are derived from the SK-N-SH cell line, 
which was cultured from the biopsy of a metastatic tumour and, as a result, has 
mutations in many genes (Krishna et al., 2014) including the NME1 gene, which is 
implicated in the repair of both SSBs and DSBs in DNA and maintaining genomic 
stability (Kaetzel et al., 2015; Puts et al., 2017). It is possible that a spontaneous 
mutation occurred in a cell within the SH-SY5Y culture and affected the remaining 
population of cells and altered their ability to senesce in response to H2O2 induced 
oxidative stress. It is feasible that DNA damage may be mis-repaired to generate 
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mutation(s) that affect cellular behaviour. Whole-genome sequencing to determine the 
genetic content of the cell line used in this study would be required to answer this 
question.   
The use of a positive control during these experiments may have been able to further 
clarify whether senescence had been achieved or confirmed that the assay was working 
correctly. However, as discussed by Piechota et al. (2016), it appears that the use of β-
gal as a marker of senescence in neurons provides varying results and may not have 
been the correct marker to determine whether H2O2 treated SH-SY5Y cells had entered 
a state of senescence. Other markers of senescence are commonly utilised alongside β-
gal assays such as the tumour suppressor genes p16
 
and p21 to confirm identification of 
senescent cells (Ashapkin et al., 2019; Liu et al., 2019). Indeed, the use of multiple 
markers may have helped to identify the presence of senescent cells during this study. 
Due to the cancerous nature of the SH-SY5Y cell line it was not possible to culture cells 
over time to cause replicative senescence. In addition to this, a sample of 
undifferentiated cells was taken up to a passage number of 40 without seeing any 
morphological changes (images not shown), i.e. they can continuously proliferate as 
reported previously (Pahlman et al., 1984). Undifferentiated SH-SY5Y also express 
immature neuronal markers and lack mature neuronal markers, so they are considered 
similar to immature catecholaminergic neurons and not a good model for dopaminergic 
neurons (Lopes et al., 2010). For this reason and the lack of success using methodology 
described by Nopparat et al. (2017), it was subsequently decided that attempts to induce 
senescence with H2O2 would be made using RA-treated SH-SY5Y cells.  
Proliferation assays seen in Figure 4.4 demonstrate that SH-SY5Y cells treated with 10 
µM RA for 48 hours show a significant reduction in proliferation compared to control 
cells. However, a further reduction in proliferation was not seen after 72 hours of 
incubation, suggesting that the RA was having no further effect on the cells. This is 
unlike findings published by Encinas et al. (2002), Cuende et al. (2009) and Lopes et al. 
(2010). 
As mentioned previously, the SH-SY5Y cell line has been seen to produce different 
cellular phenotypes including N-type cells and S-type cells. S-type cells are substrate 
adherent multipotent precursors to various non-neuronal cells, including glial cells, 
melanocytes and Schwann cells (Bell et al., 2013). Although the SH-SY5Y cell line is 
predominantly composed of N-type cells, it is known that a small proportion of S-type 
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cells remain in the SH-SY5Y cell line (Forster et al., 2016). A study by Encinas et al. 
(2002) reported that N-type cells gain a neuronal-like phenotype more readily than S-
type cells after treatment with 10 µM RA. Furthermore, S-type cells were also seen to 
continue proliferating and created cultures with an overgrown S-type population 10 
days post RA treatment. These results could explain why cells continued to proliferate 
during this study, despite exposure to RA, i.e. there was continued proliferation and 
overgrowth of the S-type cells in culture. However, RA-treated SH-SY5Y cells in this 
chapter were confluent much earlier than day 10 post-treatment, which differs to results 
reported by Encinas et al. (2002). This may suggest that either the culture contained a 
larger proportion of cycling S-type cells or that the N-type cells present were not 
responding to RA in the same manner, despite the same doses of RA being used in this 
study. If one cell type is overgrowing the other it may explain why there were high 
levels of inter-experimental variability when measuring Top2A and Top2B protein after 
72 hours of RA treatment. Interestingly, Encinas supplemented their culture medium 
with 15% FBS compared to 10% in this study, which suggests that serum content may 
affect cellular behaviour. Indeed, it has been shown that serum deprivation alters 
cellular response to DNA damage (Raffaghello et al., 2008). In addition, RA stability 
has been shown to be greatly reduced in serum-free media compared to 15% serum-
supplemented media. Sharow et al. (2012) showed that 69% of RA could be recovered 
from cell-free serum-supplemented media after 24 hours compared to only 27% from 
cell and serum-free media. Thus, it is possible that RA was more stable for longer 
periods of time in media containing 15% FBS compared to 10% FBS, which could 
account for the differences seen.   
Other differentiating protocols have also been published that utilise different serum 
concentrations. For example, Korecka et al. (2013) exposed SH-SY5Y cells to 1 µM 
RA for 8 days in 0.5% serum and showed that the expression profile of transcription 
factors involved in neuronal differentiation significantly changed. Their data showed 
that RAR-A and PAR-B, which control all RA-induced signalling, were significantly 
upregulated following treatment with RA. Some other examples that were shown to be 
upregulated were the neurite outgrowth initiator Rho GTPase RAC1, integrin α1 and ß1, 
which are cell membrane receptors involved in cell adhesion and recognition and Nrf2, 
a transcription factor that regulates neuronal differentiation and antioxidant 
homeostasis. Their data provide strong evidence for a pro-neuronal differentiation 
process in this cell line after treatment with RA. Interestingly, they also showed that the 
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transcription factor Sp1 was also increased (1.45 fold compared to control). As 
discussed previously, Sp1 has been shown to be implicated in the regulation of Top2B 
expression during neuronal differentiation, so it is possible that the increase in Sp1 
expression may have also affected expression of Top2B. However, Top2B expression 
was not investigated during their study.  
A study by Schneider et al. (2011) also supplemented RA differentiating media with a 
reduced amount of FBS using only 1% FBS to differentiate SH-SY5Y cells. Indeed, the 
presence of FBS has been shown to attenuate differentiation induced by RA in murine 
neuroblastoma N2a cells. Without FBS, RA was shown to drive N2a neuronal 
differentiation via protein kinase A (PKA)/phospholipase C (PLC)/protein kinase C 
(PKC) and MEK/ERK pathways. In media supplemented with 10% FBS, RA induced 
neuronal differentiation via PLC/PKC and PKA/PLC/PKC, respectively (Namsi et al., 
2018). Although this is a mouse cell line, it highlights the different signalling pathways 
that can be modulated in the presence or absence of serum. However, as mentioned 
previously, Sharow et al. (2012) reported that RA was significantly more unstable in 
serum-free media compared to media containing 15% FBS, so the results achieved by 
the various differentiating protocols are a complex interplay between maintaining RA 
stability in the media and the effect of serum on the activation of the signalling  
pathways involved in neuronal differentiation.  
In another report by Encinas et al. (2002), the addition of brain-derived neurotrophic 
factor (BDNF) to RA-treated cells in combination with removing serum from the media 
prevented replication of S-type cells in culture and was seen to be stable for up to 3 
weeks. RA has been shown to induce the expression of the neurotrophin tyrosine 
receptor kinase B (TrkB) (Jiao et al., 2014), which is a receptor for BDNF, and is well 
known for its function during nervous system development (Minichiello, 2009). In 
addition, BDNF has been shown to enhance the effects of RA during differentiation 
(Forster et al., 2016).   
Yet another group differentiated SH-SY5Y cells using 10 µM RA but also included the 
mitotic inhibitors cytosine b-D-arabinofuranoside (araC), uridine and 5-fluoro-20 -
deoxyuridine (FdUr) in their long-term culture media to successfully eliminate the 
undifferentiated S-type cells. In this differentiation protocol cells were exposed to 10 
µM RA for 14 days, which was then removed and replaced with mitotic inhibitors for a 
further 16 days. BrdU incorporation showed that proliferation had ceased and several 
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neuronal markers such as Neurogenin, tau, laminin and DRD2 were upregulated 
(Constantinescu et al., 2007). 
Results from Figure 4.4 suggest that neuronal differentiation was not achieved after 
measuring proliferation. This was also confirmed via analysis of Top2A and Top2B. 
Western blot analysis of DMSO-treated SH-SY5Y and RA-treated SH-SY5Y over a 72 
hour period showed no significant differences in Top2A and Top2B protein levels 
between the two treated groups and between the two isoforms (Figure 4.6 and Figure 
4.7). If all cells had become differentiated it would be expected that a significant 
decrease in Top2A levels would be seen as cells stop proliferating and Top2B levels 
would increase as it has been shown to be upregulated during differentiation (Tsutsui et 
al., 1993; Tiwari et al., 2012; Harkin et al., 2015; Austin et al., 2018). If RA-treated 
cells maintain a proportion of proliferating S-type cells it is likely that a significant 
decrease in Top2A would not be seen. Equally, the presence of proliferating cells may 
also explain the insignificant increases in Top2B protein levels over the 72-hour period. 
In addition, this may account for the high inter-experiment variability seen for both 
Top2A and Top2B levels at later time points. Guo et al. (2014) reported significant 
increases in Top2B protein levels in SH-SY5Y cells after 3 days in media containing 10 
µM RA with high levels maintained after 5 days. However, differentiating media used 
by Guo differed to that used in this study. Their study initially cultured SH-SY5Y in 
media supplemented with 10% FBS but RA differentiating media contained only 3% 
FBS. In addition to a reduction in FBS, Guo et al. (2014) also utilised a different whole 
cell extraction technique, incorporating a NaCl concentration of 150 mM in the lysis 
buffer. Previous studies have shown that salt concentration can affect the yield of 
Top2A and Top2B in whole cell extracts of a number of different cell lines (Padget et 
al., 2000). Furthermore, NaCl extraction techniques were also seen to yield more 
Top2B in the CCRF-CEM cell line in comparison to the DNase/RNase method, which 
was the technique used throughout this study. It appears both differentiation protocols 
and extraction techniques can have an effect on the levels of type 2 topoisomerases that 
can be obtained.   
Numerous approaches could have been explored to differentiate the SH-SY5Y cell line 
if more time had been available. Changes to methodology, such as increasing the 
exposure time of RA and incorporating pulses of fresh RA as it degrades could have 
been investigated. Reducing the FBS concentration and incorporating BDNF into the 
122 
 
media or exposing cells to mitotic inhibitors following exposure to RA are also methods 
that could have been explored. 
Unfortunately, further results from proliferation and β-gal assays showed that the 
treatment of cells with 10 µM RA for 72 hours prior to H2O2 exposure did not generate 
a senescent state in the cells. Thus, the generation of senescence in this cell line was 
unsuccessful and more experiments would be needed to achieve this. The results from 
this chapter highlight the difficulties in working with cell lines that are genetically 
damaged (Korecka et al., 2013). Although primary neuronal cells can be readily bought, 
they typically only survive three weeks in culture (Kim et al., 2007), which limits their 
usefulness for the large number of experiments that would be required to induce 
senescence and explore Top2B expression.       
The use of a homogenous human neuronal cell line may have been preferable, such as 
the HCN-2 cell line. Although this cell line is fully clonal compared to SH-SY5Y 
cultures, these cells still must be differentiated into mature neuronal-like cells by the 
addition of nerve growth factor (NGF), isobutylmethylxanthine (IBMX) and the phorbol 
ester12-O-tetradecaoylphorbol-13-acetate (Ronnet et al., 1994). Interestingly, these 
cells have been shown to senesce at approximately passage 21, which may have been 
useful in exploring topoisomerase II expression during this process and over 
chronological ageing. Nevertheless, careful planning of experiments would still have 
been needed to empirically determine the optimal conditions to generate and verify 
senescence.  
Improved methods of measuring proliferation could have been used in this chapter. For 
example, although measuring viable cell numbers using the trypan blue exclusion 
method gives some indication about cell proliferation, utilising assays such as the EdU 
proliferation assay, which directly measures DNA synthesis (Yamakoshi et al., 2011), 
may have yielded more accurate results.  
In conclusion, attempts to induce senescence in both untreated and RA-treated SH-







5. Development of murine models of ageing to investigate changes in 
Top2B expression 
5.1. Introduction 
5.1.1 CAD neuronal cell line model 
Following work carried out on the neuroblastoma cell line SH-SY5Y it was decided that 
an alternative cell line would be utilised to investigate Top2B expression in an aged 
neuronal model. The murine CAD (Cath.a-differentiated) cell line is a variant of the 
Cath.a cell line, which was derived from catecholaminergic central nervous system 
neurons by targeted oncogenesis of transgenic mice carrying the wild-type Simian virus 
SV40 antigen oncogene (Li et al., 2007). The cell line is capable of being differentiated 
through serum starvation and displays many morphological and biochemical 
characteristics of mature neurons after differentiation, including cell cycle arrest and 
development of long neuronal processes (Qi et al., 1997). The CAD cell line has been 
shown to express specific neuronal proteins such as growth-associated protein GAP-43, 
synaptosomal associated protein SNAP-25, class III β-tubulin and synaptotagmin 
(Hashemi et al., 2003). CAD cells also express the rate-limiting enzyme of 
catecholamine biosynthesis, tyrosine hydroxylase, and are therefore considered a 
catecholaminergic cell line (Lazaroff et al., 1998). CAD cells grown in serum-
containing medium possess a flattened morphology with very short neuronal processes 
(Lazaroff et al., 1998) and continuously proliferate with a doubling time of 18-22 hours 
(Qi et al., 1997). In serum-free medium CAD cells become differentiated and undergo 
morphological changes including the development of numerous long neuronal processes 
as well as exhibiting cell cycle arrest (Li et al., 2007).  
Many neuronal cell lines cannot survive in media without serum or exogenous protein, 
including the parental cell line of CAD, Cath.a. The Cath.a cell line, as well as other 
neuronal cell lines such as ND7 and PC12, has been shown to exhibit cell cycle arrest 
and subsequent cell death after serum starvation (Howard et al., 1993; Lindenboim et 
al., 1995). However, Horton et al. (2008) suggests the expression of neurotrophin-3 
(NT3), which is an important neurotropic factor known to play a role in the 
development and maintenance of the vertebrate nervous system (Zhou & Rush, 1996), 
and expression of tropomyosin receptor kinase (Trk) by CAD cells creates an autocrine 
activation loop that is capable of sustaining CAD cell survival in the absence of an 
exogenous protein source. Differentiated CAD cells possess a vesicular and cytoskeletal 
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structure typical of neuronal cells and can be maintained in serum-free medium for at 
least six weeks, after which small mechanical disturbances can cause the cells to detach 
from the surface of the tissue culture vessel (Qi et al., 1997). The cell line is also 
reversibly differentiated when serum is added to the media. Neuronal processes of 
differentiated cells begin to retract and within 12-24 hours 95% of differentiated cells 
re-enter the cell cycle after the addition of serum to the media (Qi et al., 1997).    
In order to create a cell line model of ageing several approaches were taken to induce 
senescence in CAD cells. Differentiated CAD cells were produced and then exposed to 
either sub-cytotoxic levels of oxidative stress caused by hydrogen peroxide (H2O2) or 
chronologically aged in culture. 
After carrying out extensive literature searches, there are no previous studies 
investigating topoisomerases in the CAD cell line to the best of our knowledge. 
5.1.2 Mouse model of ageing 
In addition to using a murine neuronal cell line to investigate expression of Top2B, 
immunohistochemical analysis of mouse hippocampus tissue was also carried out. 
Throughout scientific research inbred mice are the most extensively used strains for the 
study of ageing and age-related diseases (Mitchell et al., 2015). Although the use of 
mice as a model of ageing is expensive and time consuming, with approximately 85% 
of the protein-coding regions of the mouse genome identical to that of the human 
genome, mice are the most commonly used mammalian model in scientific research 
(Batzoglou et al., 2000). Possessing approximately 70 million neurons, the mouse 
brains complexity is less than that of a human. However, the nervous systems of mice 
and humans share many similarities at the cellular level (Vanhooren & Libert, 2013). 
Although mice are much longer lived than Drosophila, with the commonly used male 
C57BL/6 mouse having an average life span of ∼900 days (Kunstyr & Leuenberger, 
1975; Yuan et al., 2009), they are considered short-lived mammals relative to humans 
and therefore a very common model of mammalian ageing. When compared to humans 
and other animal models, mice similarly show phenotypic decreases in cognitive ability 
and memory as they age (Jucker et al., 1994; Matzel et al., 2008). One of the brain 
regions most affected by age is the hippocampus, with similar age-related declines in 
function seen in humans and numerous other mammalian species (Verbitsky et al., 
2004). Mice and humans have evolutionarily conserved brains, which in turn also mean 
they share very similar brain architecture with brain tissues consisting of similar cell 
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types. This makes mice one of the most commonly used animal models to study ageing 
of the brain (Mitchell et al., 2015).  
As mentioned previously (section 1.5.5), the number of studies investigating age-related 
changes in levels of Top2B in murine brains is incredibly limited with Kondapi et al. 
(2004) providing the only study focussing on Top2B levels in rat brains throughout the 
ageing process to the best of our knowledge. The study reported decreases of Top2B 
expression in the cerebellum of rats with expression seen to be high in young rats, 
moderate in adults and low in old rat cerebellar regions. In addition to this, Kondapi et 
al. (2004) suggested that Top2B is only expressed in cerebellar tissue. 
This chapter focussed on developing a differentiated CAD cell line model to investigate 
changes in Top2B protein and mRNA levels during ageing, whilst also investigating 
Top2B expression in mouse hippocampal tissue in young and old samples using 
immunohistochemical techniques. 
5.2 Differentiation of the CAD cell line through serum starvation 
CAD cells are an immortalised cell line and, as a result of this, display a continued up-
regulation of cell proliferation. Similar to the SH-SY5Y cell line, this continued 
proliferation is not a characteristic of mature neurons. Differentiation of CAD cells into 
more mature neuronal-like cells has been reported in previous studies through serum 
starvation (Qi et al., 1997; Li et al., 2007; Horton et al., 2008). In order to create a 
differentiated CAD cell line, cells were seeded in complete media containing serum for 
24 hours before removing and replacing with media without serum. Cell proliferation 
was then monitored and results for serum starvation-induced differentiation of CAD 



















Figure 5.1 The effects of serum starvation on CAD proliferation. 
6-well plates were seeded at 5 x 10
4
 cells/ml (2 ml per well) and incubated for 24 hours at 37°C. 
Supernatant was removed and replaced with fresh complete DMEM/F12 (control) or 
DMEM/F12 without FBS. Viable cells were counted every 24 hours for 120 hours using trypan 
blue exclusion. Data is presented as the mean of three biological replicates ± standard error. 
Results from Figure 5.1 show that cells grown in complete media containing serum 
display an initial lag period but after 24 hours cells proliferate rapidly for the next 24 
hours (p=0.029 Student’s t-test, two-tailed) with a doubling time of 18.39 hours. At 
subsequent time points cell numbers remain similar with no significant increases in 
number between any of the subsequent 24 hour periods. Observations of cells grown in 
complete media under a light microscope indicated that confluency had been reached 
after 96 hours, which may explain why a slight reduction in cell number is seen at 120 
hours. 
In comparison, cells grown in serum-free media display low but significant increases in 
proliferation during the first 24 hours (p=0.007) and although cell numbers generally 
increase between 24 and 48 hours incubation, this is not significant. Cell numbers then 
remain remarkably stable at the remaining time points with no significant increases in 
cell number between any of the subsequent 24 hour periods, indicating that cells have 
entered a state of cell cycle arrest. In addition, numbers of cells grown in serum-free 
media are significantly lower than cells grown in complete media between 72 and 120 
hours with p values of 0.025 (72 hours), 0.0007 (96 hours) and 1.5 x 10
-5
 (120 hours) 
between the two groups. 
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Alongside proliferation assays, morphological comparisons between undifferentiated 
and differentiated cells were made. Cells were monitored for any changes in neurite 















Figure 5.2 The effects of serum starvation on CAD morphology. 
6-well plates were seeded at 5 x 10
4
 cells/ml (2 ml per well) and incubated for 24 hours at 37°C. 
Supernatant was removed and replaced with fresh complete DMEM/F12 (control) or 
DMEM/F12 without FBS. The image of cells in (A) was taken after 1 week in complete 
DMEM/F12 and the image of cells in (B) were taken after 1 week in DMEM/F12 without FBS. 
(C) Neurite length was measured at T0, 3 days and 1 week after the addition of serum-free 
media. Neurite length was measured using ImageJ software and the average neurite length was 
calculated. **= p<0.01 (Student’s t-test, two-tailed). 
 
Images seen in Figure 5.2 show clear morphological changes in CAD cells grown in 
serum-free media (Figure 5.2B) compared to cells grown in complete media (Figure 























shape. After serum starvation, cells became rounder in shape and developed long 
neuronal processes with varicosities. Neurite outgrowth was significant after the 
addition of serum-free media (Figure 5.2C). After 3 days in serum-free media neurites 
were significantly longer (p=0.0048) than T0 cells. Neurites continued to grow between 
day 3 and 1 week (p=0.0094). The development of long neuronal processes in 
conjunction with cell cycle arrest were the two factors used in subsequent experiments 
to determine whether cells had developed a differentiated-like state.  
 
5.3 Semi-quantification of Top2B during CAD differentiation 
As stated in 4.3.2, previous studies have reported that Top2B expression is upregulated 
significantly when cells enter a state of terminal differentiation (Tsutsui et al., 1993; 
Tiwari et al., 2012; Harkin et al., 2015). Therefore, levels of Top2B protein and mRNA 
could also be used to confirm terminal differentiation of CAD cells starved of serum. 
5.3.1 Semi-quantification of Top2B protein during CAD differentiation 
CAD cells were differentiated in serum-free media and protein extracts were taken at 
T0, 24, 48 and 72 hours after the addition of serum-free media. Western blot analysis of 
Top2B was carried out on these samples and results can be seen in Figure 5.3. In 
contrast to previous studies, results shown in Figure 5.3 yielded no significant changes 
in protein levels of Top2B in CAD cells grown in serum-free media over 72 hours with 
protein levels of Top2B appearing to be expressed evenly over the 72 hour period and 
not upregulated. It is possible that CAD cells have not become fully differentiated at 72 
hours and Top2B may become upregulated at later time points, which may explain why 
significant increases in protein levels of Top2B are not seen in Figure 5.3. Interestingly, 
significant growth of neurites can be seen to continue up to 1 week in serum-free media 
(Figure 5.2C). However, cell proliferation was seen to stop after 48 hours in serum-free 
media (Figure 5.1) and was accompanied by the expected changes in morphology 
associated with differentiation of this cell line (Qi et al., 1997). Several other previous 
studies using differentiated CAD cells also used a 72 hour incubation period in serum-
free media to characterise the effect of differentiation (Johnston et al., 2004; Schein et 
al., 2005). For example, Johnston et al. (2004) reported significant alterations in the 
expression and function of the cyclic adenosine monophosphate (cAMP) signalling 
pathway after 72 hours in serum-free media. cAMP has been shown to be critical to the 
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modulation of many cellular activities including differentiation. Thus, the lack of 
















Figure 5.3 Semi-quantification of Top2B over 72 hours of serum starvation-induced 
differentiation in the CAD cell line. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
at 37°C in complete media. Media was removed and replaced with serum-free media and 
incubated. Whole cell extraction was carried out at T0 and after 24, 48 and 72 hours as 
described in section 2.2.2.9 and quantified as described in section 2.2.2.10. Equal protein loads 
(145 μg) were added to wells of a 7.5% SDS gel. SDS-PAGE was carried out and protein was 
transferred to nitrocellulose paper by wet western transfer. (A) Nitrocellulose blots were probed 
with a Top2B antibody and an α-Tubulin load control antibody. Analysis of blot densitometry 
was carried out using GeneTools (Syngene). (B) Top2B expression is presented as percentage 
expression compared to T0 cells. Results shown are the mean of three independent experiments 
± standard error. 
180 kDa Top2B 





5.3.2 Semi-quantification of Top2B mRNA during CAD differentiation 
5.3.2.1 Selection of RT-qPCR reference genes 
The selection of suitable internal reference genes was required for the normalisation of 
RT-qPCR data. Reference genes had to be suitable for neuronal tissue but also stably 
expressed throughout the ageing process. Bibliographic surveys carried out by Boda et 
al. (2009) reported that glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and β-
actin are the most frequently used reference genes in mouse brain studies. The 
bibliographic survey encompassed a range of articles and studies that experimented on 
various tissues from mouse brains, including the cerebellum, brain stem, neocortex, 
septum, hippocampus and the olfactory bulb. In addition to this, work by Tanic et al. 
(2007) reported that GAPDH and β-actin were the most stably expressed reference 
genes in tissues from rat hippocampus and cortex during ageing when comparing the 
five most commonly used endogenous controls (GAPDH, β-actin, 18S rRNA, 
hypoxanthine phosphoribosyltransferase and cyclophilin B). However, they also 
reported that variation in all reference genes tested was seen under different 
experimental conditions. Due to potential variability in expression both GAPDH and β-
actin were selected to be used as reference genes in this study and were tested for 
variability before carrying out statistical analysis in each experiment. Both reference 
genes were used alongside a target gene of Top2B. 
5.3.2.2 Optimisation of Top2B, GAPDH and β-actin primers for RT-qPCR 
Primers were designed for Top2B, GAPDH and β-actin to be used in RT-qPCR 
experiments (Materials and Methods Table 2.3). Prior to carrying out analysis of mRNA 
levels in CAD cells, the amplification efficiency of these primers was required to 
determine their experimental suitability.  
Amplification curves were generated for Top2B, GAPDH and β-actin primers, 
respectively, and subsequently used to calculate primer reaction efficiency (Figure 5.4). 
RNA was extracted from differentiated CAD cells and 0.4 µg of total RNA was reverse 
transcribed to cDNA. Serial dilutions of stock cDNA were made as previously 
described (section 3.4.2). 
Primer reaction efficiencies were calculated and demonstrated an efficiency of 99.6% 
for Top2B, 94.5% for GAPDH and 95.2% for β-actin. A reaction efficiency of 90-110% 
is deemed acceptable (Taylor et al., 2010). As the efficiencies of these primers fall 
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within the 90-110% range they were considered suitable and comparable for further RT-
qPCR experiments. 
In addition to analysing primer efficiency, a number of controls were also incorporated 
into the experimental design as previously described in section 3.4.2. Melt curves were 
also analysed in all samples to confirm the presence of a single PCR product and to 
confirm the absence of contaminating genomic DNA (representative melt curves are 













Figure 5.4 Amplification curves for primer efficiency of Top2B, GAPDH and β-actin. 
Total RNA was extracted from serum-free treated CAD cells (section 2.2.4) and quantified on a 
NanoDrop ND-1000 spectrophotometer. 0.4 µg of total RNA was reverse transcribed to cDNA 
using PCR Biosystems qPCRBIO cDNA synthesis kit (PB30.11) according to manufacturer 
instructions. The cDNA stock solution was serially diluted 1:10 to create a range of cDNA 
samples. This ensured the standard curve covered the dynamic range of potential template 
concentrations that could be encountered during further studies. cDNA concentrations were 
converted to logarithmic values and plotted against threshold cycle (Ct) values. Amplification 






As stated in section 3.4.2, statistical analysis of qPCR data can be carried out using one 
or numerous reference genes using the comparative ΔCt method. In order to select an 
appropriate method of statistical analysis, the threshold cycle (Ct) values of β-actin and 
GAPDH were analysed under experimental conditions and evaluated for stability. 
Figure 5.5A displays a box and whisker diagram showing the variations in Ct values of 
β-actin and GAPDH in differentiated CAD cell samples during the first 72 hours in 
serum-free media. Figure 5.5B displays the coefficient of variance of the Ct values to 
















Figure 5.5 Variance of β-actin and GAPDH reference genes from all CAD 72 hour 
differentiation experiments. 
Ct values for the reference genes β-actin and GAPDH were collated from all CAD 
differentiation qPCR studies to observe any variations in expression. (A) Box and whisker plots 
showing the distribution of Ct values for the two candidate reference genes. Yellow dots 
indicate mean value. (B) The coefficient of variance for the data set was calculated to determine 





Results from Figure 5.5A show that the range of Ct values is comparable between β-
actin and GAPDH. The mean Ct values for each gene are also comparable, hence 
subsequent data analysis of the following experiment (section 5.3.2.3) utilised both 
reference genes for normalisation.  
5.3.2.3 Analysis of Top2B mRNA during CAD differentiation 
Following the confirmation of primer reaction efficiencies, RT-qPCR was carried out to 
quantify Top2B mRNA levels in CAD cells during the first 72 hours of differentiation 
in serum-free media. RNA was extracted from CAD cells at T0, 24, 48 and 72 hours 
after the introduction of serum-free media. Ct values for Top2B were normalised 
against the β-actin and GAPDH reference genes. Results are shown in Figure 5.6. 
Similar to protein levels of Top2B, relative levels of Top2B mRNA also do not 








Figure 5.6 Analysis of RT-qPCR data comparing relative Top2B expression in CAD cells 
during the first 72 hours of differentiation in serum-free media. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
in complete media. Media was removed and replaced with serum-free media and incubated. 
Cells were harvested at T0 and then every 24 hours for 72 hours and RNA was extracted as 
described in section 2.2.4.1 and quantified on a NanoDrop ND-1000 spectrophotometer. 0.4 µg 
of total RNA from each sample was converted to cDNA (section 2.2.4.3) and RT-qPCR was 
carried out (section 2.2.5) using β-actin and GAPDH as reference genes. Results were 
normalised by geometric averaging of both reference genes and presented as expression fold 
change (Vandesompele et al., 2002) (calculation described in Appendix Figure A.5). Samples 
for each individual experiment were loaded in triplicate. Results shown are presented as the 
mean of three biological replicates ± standard error. 
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Despite CAD cells displaying a significant reduction in proliferation and changes in 
morphology associated with differentiation when starved of serum, levels of Top2B 
mRNA and protein do not change over a period of 72 hours. Nevertheless, as cell cycle 
arrest had been successfully induced and a mature neuronal-like morphology achieved, 
it was decided to use these conditions for further experiments to create a CAD cell line 
model of senescence using hydrogen peroxide. 
 
5.4 Hydrogen peroxide-induced cellular senescence of serum-free treated CAD 
cells 
After successfully inducing cell cycle arrest and developing a more mature neuronal-
like phenotype in CAD cells, experiments were carried out attempting to induce 
senescence in serum-free treated cells using H2O2-induced oxidative stress. Serum-free 
treated CAD cells were exposed to 50 µM, 100 µM and 150 µM H2O2, respectively, and 






























Figure 5.7 β-gal assays of serum-free treated CAD cells treated with a range of H2O2 
concentrations. 
6-well plates were seeded at 5 x 10
4
 cells/ml (2 ml per well) and incubated for 24 hours. Cells 
were differentiated in serum-free media for 72 hours as described in section 2.2.2.7. Media was 
removed and replaced with fresh serum-free DMEM/F12 containing H2O (control) (A) or 
serum-free DMEM/F12 containing 50 (B), 100 (C) or 150 µM (D) H2O2 and incubated for 24 
hours. β-gal assays were carried out using Sigma Aldrich Senescence Cells Histochemical 
Staining Kit according to manufacturer instructions. Cells were observed using brightfield 
microscopy and images were obtained. 
 
Results in Figure 5.7 show that differentiated CAD cells treated with a range of H2O2 
concentrations did not appear to have entered a state of senescence after analysis of β-
gal assay images. Cells appeared to maintain morphology with the exception of a few 
cells that had shorter neuronal projections. Furthermore, cells did not express the 
characteristic blue β-gal stain, suggesting cells had not become senescent. Further 
experiments were carried out utilising lab-made reagents (section 2.2.13 method 2) to 
determine whether the kit being used was functioning correctly. However, these 






experiments were carried out involving the treatment of CAD cells with H2O2 every day 
for 3 days in an attempt to induce senescence but these experiments also ended with the 
same results (data not shown).  
To further confirm that oxidative stress-induced senescence had not been achieved, p21 
levels in cells exposed to H2O2 were explored. Previous studies in other cell lines have 
shown that sub-lethal ROS concentrations can induce senescence by inducing p21 
leading to G1 arrest (Macip et al., 2002; Chakraborty et al., 2016). Indeed, p21 is often 
referred to as a senescence marker (Ashapkin et al., 2019). Protein levels of p21 were 
investigated by western blotting in CAD cells that had been grown in serum-free media 










Figure 5.8 Semi-quantification of p21 in CAD cells grown in serum-free (-) or complete (+) 
media treated with or without a 24 hour pulse of H2O2. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
at 37°C in complete media. Media was removed and replaced with serum-free media and 
maintained as described in section 2.2.2.7.2. Cells were harvested at T0 and then 24 hours after 
being exposed to 50 or 100 µM H2O2 alongside a 24 hour control. Cells were also harvested 
from cycling cells grown in complete media for 72 hours. Whole cell extractions were carried 
out as described in section 2.2.2.9 and quantified as described in section 2.2.2.10. Equal protein 
loads (195 μg) were added to wells of a 12.5% SDS gel. SDS-PAGE was carried out and protein 
was transferred to nitrocellulose paper by wet western transfer. Nitrocellulose blots were probed 







From the results seen in Figure 5.8 protein levels of p21 do not appear to appreciably 
change in serum-free treated CAD cells exposed to H2O2 suggesting that senescence had 
not been achieved in these cells. Interestingly, p21 expression in CAD cells grown in 
complete media for 72 hours is at a similar level to that seen in serum-free treated cells 
exposed to H2O2. Low basal levels of p21 have been seen to control population 
heterogeneity in cell cycle activity (Overton et al., 2014). However, as previously stated 
sub-lethal ROS concentrations can induce senescence by inducing p21, so it is 
interesting that p21 is not expressed more in cells exposed to H2O2.  
As it was not possible to induce senescence in differentiated CAD cells by oxidative 
stress, it was decided to age the cells chronologically over a period of six weeks. It has 
previously been reported that CAD cells can be maintained in serum-free media for six 
weeks, hence subsequent experiments utilised a range of aged CAD cells, from newly 
differentiated up to six weeks old, to elucidate any age-related changes in Top2B levels.  
 
5.5 Semi-quantification of Top2B in serum-free treated CAD cells over six weeks of 
ageing 
5.5.1 Semi-quantification of Top2B protein in serum-free treated CAD cells over 
six weeks of ageing 
Western blotting experiments were utilised to generate semi-quantitative data of protein 
levels of Top2B in serum-free treated CAD cells during ageing. CAD cells were 
chronologically aged between T0 and six weeks and cells were harvested at weekly time 
points. The seeding of flasks was staggered over a six week period to ensure that cells at 
each time point could be harvested and stored on the same day. This was done to 
prevent protein degradation of some of the samples, which would have been frozen 
down for long periods of time without staggering. Western blot analysis of Top2B in 






















Figure 5.9 Semi-quantification of Top2B protein levels in CAD cells during six weeks of 
ageing in serum-free media. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
at 37°C in complete media. Media was removed and replaced with serum-free media and 
maintained as described in section 2.2.2.7.2. Cells were harvested at T0 and then at weekly 
intervals up to six weeks. Whole cell extractions were carried out as described in section 2.2.2.9 
and quantified as described in section 2.2.2.10. Equal protein loads (89 μg) were added to wells 
of a 7.5% SDS gel. SDS-PAGE was carried out and protein was transferred to nitrocellulose 
paper by wet western transfer. (A) Nitrocellulose blots were probed with a Top2B antibody and 
an α-Tubulin load control antibody. Analysis of blot densitometry was carried out using 
GeneTools (Syngene). (B) Top2B expression is presented as percentage expression compared to 











Results show that Top2B protein levels decline in serum-free treated CAD cells over six 
weeks of ageing (Figure 5.9). After one week of ageing, levels of Top2B can be seen to 
decrease by ~20% (p=0.0003 Student’s t-test, two-tailed). Levels then plateau between 
weeks 1 and 3 before decreasing again after week 4 with levels of Top2B significantly 
lower in weeks 5 and 6 compared to levels seen in week 3 with p values of 0.029 and 
0.040, respectively. After six weeks of ageing protein levels of Top2B are 45% lower 
than at T0 (p=0.001). These findings are novel in a neuronal cell line to the best of our 
knowledge.  
Alongside measurements of protein levels of Top2B in serum-free treated CAD cells 
during ageing, the tumour suppressor gene p21 was also analysed. A study by Jurk et al. 
(2012) demonstrated that post-mitotic neurons develop a p21-dependent senescence-like 
phenotype driven by a DNA damage response. As increases in oxidative stress and 
subsequent increases in DNA damage have been reported in ageing and 
neurodegenerative diseases (Mattson & Magnus, 2006), the analysis of p21 in ageing 
CAD cells might indicate whether a senescence-like state has developed in these cells 

































Figure 5.10 Semi-quantification of p21 in serum-free treated CAD cells during six weeks 
of ageing. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
at 37°C in complete media. Media was removed and replaced with serum-free media and 
maintained as described in section 2.2.2.7.2. Cells were harvested at T0 and then at weekly 
intervals up to six weeks. Whole cell extractions were carried out as described in section 2.2.2.9 
and quantified as described in section 2.2.2.10. Equal protein loads (89 μg) were added to wells 
of a 7.5% SDS gel. SDS-PAGE was carried out and protein was transferred to nitrocellulose 
paper by wet western transfer. (A) Nitrocellulose blots were probed with a p21 antibody and an 
α-Tubulin load control antibody. Analysis of blot densitometry was carried out using GeneTools 
(Syngene). (B) p21 expression is presented as percentage expression compared to T0 cells. 
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In Figure 5.10A protein levels of p21 can be seen to increase over six weeks of ageing 
in serum-free treated CAD cells. However, results were obtained from only two 
biological replicates and statistical analysis of densitometry does not provide statistical 
significance. Further experiments would need to be carried out to confirm whether 
protein levels of p21 significantly increase in aged CAD cells. If p21 levels were shown 
to significantly increase it may support previous studies suggesting that post-mitotic 
neurons develop a p21-dependent senescence-like phenotype (Jurk et al., 2012; 
Riessland et al., 2019). 
To confirm the non-proliferative state and differentiated-like morphology of the serum-
free treated CAD cell line over the time course, cell counts were taken throughout the 
six week experiment and images of cells were acquired to monitor and measure any 
changes in neurite length. The culture flasks containing CAD cells to be used for 
measuring cell counts became infected ~4 weeks into the six week experiment, so 
proliferation results are shown up to day 30. Neurite measurements were taken for the 
































Figure 5.11 Proliferation of CAD cells over 30 days in serum-free media and neurite 
length over 6 weeks in serum-free media. 
T25 culture flasks were seeded at 5 x 10
4
 cells/ml (5 ml per flask) and incubated for 24 hours at 
37°C in complete media. Media was removed and replaced with serum-free media and 
maintained as described in section 2.2.2.7.2. (A) Viable cell counts were obtained at T0 and 
then at weekly intervals up to 30 days using trypan blue exclusion. (B) Images of cells were 
taken at weekly intervals, neurite length was measured using ImageJ software and the average 
neurite length was calculated. **= p<0.01 (Student’s t-test, two-tailed). 
 
From the data above, proliferation of CAD cells grown in serum-free media can be seen 
to significantly increase up to day 7 (p=0.0006), after which no further increases in 
proliferation are seen (Figure 5.11A). These results differ slightly to the proliferation 
assay carried out in Figure 5.1, which displayed cell cycle arrest after 48 hours. 







vessel used. Slight differences in seeding densities may be the cause for the variations 
seen between experiments. Between 7 and 24 days no significant changes in viable 
number of cells were observed. At day 27 the number of viable cells decreased 
significantly (p=0.046) but no significant changes were observed at day 30. These 
results demonstrate that CAD cells can be maintained in serum-free media for 
prolonged periods of time without seeing any further increases in proliferation after the 
development of a differentiated-like phenotype, which supports the use of this cell line 
in these ageing studies. Neurite outgrowth was also measured alongside proliferation to 
determine if any morphological changes occurred during ageing. Neurite outgrowth of 
CAD cells can be seen to increase significantly during the first week in serum-free 
media (Figure 5.11B), after which neurite length does not change. These results 
demonstrate that the neurite morphology of CAD cells can be maintained over 
prolonged periods of time in serum-free media. 
5.5.2 Semi-quantification of Top2B mRNA in serum-free treated CAD cells over 
six weeks of ageing 
RT-qPCR experiments were carried out alongside western blot analysis to semi-
quantify levels of Top2B mRNA in serum-free treated cells that had been aged over six 
weeks. CAD cells were chronologically aged between T0 and six weeks and cells were 
harvested at weekly time points as previously described in section 5.5.1 to allow the 
collection of all cells to occur on the same day. RNA was extracted and converted to 
cDNA before carrying out RT-qPCR experiments utilising previously optimised Top2B, 
GAPDH and β-actin primers (section 5.3.2.2). As discussed by Ling & Salvaterra 
(2011), the selection of suitable references genes is specific to each experiment and 
need to be validated at the post-experimental data analysis stage. In order to select an 
appropriate method of statistical analysis, the threshold cycle (Ct) values of β-actin and 
GAPDH were analysed under experimental conditions and evaluated for stability. Box 
and whisker diagrams showing the variations in Ct values of β-actin and GAPDH in 
differentiated CAD cell samples during six weeks of ageing were created and the 





















Figure 5.12 Variance of β-actin and GAPDH reference genes from all 6 week CAD 
experiments. 
Ct values for the reference genes β-actin and GAPDH were collated from all CAD 6 week 
qPCR studies to observe any variations in expression. (A) Box and whisker plots showing the 
distribution of Ct values for the two candidate reference genes. Yellow dots indicate mean 
value. (B) The coefficient of variance for the data set was calculated to determine variability of 
Ct values for β-actin and GAPDH over 6 weeks of ageing in CAD cells. 
 
During the previous experiment looking at Top2B expression during 72 hours of 
differentiation (section 5.3.2.2), both GAPDH and β-actin were stably expressed and 
comparable, so therefore could be used for data analysis. However, over six weeks of 
ageing β-actin was no longer as stably expressed and variability had increased in 
comparison to results seen after 72 hours of differentiation. The coefficient of variance 
for β-actin increased from 3.2 during the previous experiment to 8.5 after 6 weeks of 





two sets of experiments. In comparison, the coefficient of variance only increased by 
1.7 in GAPDH and the interquartile range of GAPDH was 1.42 in the first set of 
experiments and 1.36 over 6 weeks of ageing, indicating that GAPDH is more stably 
expressed than β-actin. Thus, subsequent analysis utilised only GAPDH for data 
normalisation. Results for Top2B mRNA expression over six weeks of ageing can be 








   
Figure 5.13 Semi-quantification of Top2B mRNA in serum-free treated CAD cells during 
six weeks of ageing. 
T75 culture flasks were seeded at 5 x 10
4
 cells/ml (12 ml per flask) and incubated for 24 hours 
at 37°C in complete media. Media was removed and replaced with serum-free media and 
maintained as described in section 2.2.2.7.2. Cells were harvested at T0 and then at weekly 
intervals up to six weeks and RNA was extracted as described in section 2.2.4.1 and quantified 
on a NanoDrop ND-1000 spectrophotometer. 0.4 µg of total RNA from each sample was 
converted to cDNA (section 2.2.4.3) and RT-qPCR was carried out (section 2.2.5) using 
GAPDH as a reference gene. Results were normalised against GAPDH and presented as 
expression fold change (Vandesompele et al., 2002) (calculation described in Appendix Figure 
C.2). Samples for each individual experiment were loaded in triplicate. Results shown are 
presented as the mean of three biological replicates ± standard error. 
 
Results from Figure 5.13 demonstrate decreases of Top2B mRNA levels in serum-free 
treated CAD cells over six weeks of ageing. During the first four weeks of ageing no 
significant changes in Top2B expression were observed. However, levels of Top2B are 
significantly lower at five and six weeks of ageing compared to T0 with p values of 
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0.033 and 0.014, respectively. Although changes in expression at week 4 are not 
significant, it does appear to be an anomalous result as it is the only week that displays 
an increase in Top2B expression. All other weeks display a decrease in Top2B 
expression, which is in line with decreases in Top2B protein levels seen in Figure 5.9. 
In conclusion, semi-quantitative analysis of Top2B has shown that both protein and 
mRNA levels decrease with age in serum-free treated CAD cells. These results are 
novel in a neuronal cell line to the best of our knowledge. 
 
5.6 Immunohistochemical analysis of Top2B in mouse hippocampal tissue 
Following the analysis of Top2B protein and mRNA levels in the CAD cell line, further 
experiments focussed on the analysis of Top2B in mouse brain tissue using 
immunohistochemical techniques. As previously stated, one of the brain regions most 
affected by age is the hippocampus, with similar age-related declines in function seen in 
humans and numerous other mammalian species (Verbitsky et al., 2004). The 
hippocampus is heavily involved with memory formation and age-related deterioration 
of the hippocampus is associated with numerous dementia-related diseases such as 
Alzheimer’s disease (Lindberg et al., 2012). Hence, Top2B was analysed in mouse 
brain tissue from the hippocampus.  
Preliminary experiments utilised immunofluorescent techniques to determine whether it 
was possible to identify Top2B expression in mouse hippocampal tissue. Tissue 
samples from a 29.5 month old C57BL/6 male mouse were sectioned using a cryostat 
(Bright Instrument OTF/AS Cryostat). 12 µm sections were cut sequentially and 
























Figure 5.14 Immunofluorescent analysis of Top2B in hippocampal tissue of a 29.5 month 
old C57BL/6 male mouse. 
The brain of a 29.5 month old C57BL/6 male mouse was sectioned using a cryostat. 12 µm 
sections were cut and placed sequentially on Histobond+ slides (Marienfeld Superior: 0810721). 
Sections were viewed under a light microscope to ensure sections of the hippocampus were 
being collected. Tissue was processed as described in section 2.2.6.3 and sections were 
incubated in a Top2B antibody or an isotype control. Sections were incubated in a secondary 
FITC antibody before being mounted in mounting medium containing DAPI. (A) Sections 
treated with Top2B antibody. (B) An overlay of Top2B and DAPI. (C) Sections treated with the 
isotype control. (D) An overlay of the isotype control and DAPI. Top2B staining is seen as 
green punctate labelling as indicated by the white arrows and DAPI is seen as blue staining in 








Preliminary immunofluorescent analysis of Top2B in hippocampal tissue provided 
some encouraging results. Green punctate labelling could be seen only in sections 
incubated with the Top2B antibody (Figure 5.14A), although staining was not very 
strong, whereas punctate labelling could not be seen at all in the isotype control (Figure 
5.14C). Due to poor DAPI staining it was not possible to confirm whether the punctate 
labelling seen in the sections incubated with the Top2B antibody was nuclear or not. To 
further investigate Top2B expression in mouse hippocampal tissue the highly sensitive 





































































Figure 5.15 DAB immunoperoxidase staining of Top2B in the hippocampus of 4 and 31 
month old C57BL/6 male mice. 
30 µm sections of brain tissue from 4 and 31 month old mice were cut using a Leica VT1000S 
vibratome and were viewed under a light microscope to ensure sections of the hippocampus 
were being collected. Sections were processed as described in section 2.2.6.4.2 using Top2B 
antibody NBP1-89527. (A) Control section of the 4 month old mouse with secondary antibody 
only (no primary antibody). (B) Control section of the 31 month old mouse with secondary 
antibody only (no primary antibody). (C) Control section of the 4 month old mouse with 
secondary antibody and neutral red counterstaining (no primary antibody). (D) Control section 
of the 31 month old mouse with secondary antibody and neutral red counterstaining (no primary 
antibody). (E & G) Low magnification of Top2B labelling in the 4 month old mouse. (F & H) 
Low magnification of Top2B labelling in the 31 month old mouse. (I) Top2B labelling in the 4 
month old mouse with a black rectangle indicating the area observed in (K) under higher 
magnification where punctate labelling represents Top2B. (J) Top2B labelling in a 
counterstained section of the 31 month old mouse with a black rectangle indicating the area 
observed in (L) under higher magnification. (L) Higher power magnification of a 31 month 
counterstained section shows nuclear labelling of Top2B as indicated by arrows. 





Images from Figure 5.15 show that immunoreactivity of Top2B, in the form of punctate 
labelling, is much stronger in the hippocampus of the younger 4 month old mouse 
compared to labelling seen in the older 31 month old mouse. Analysis of a 
counterstained section from the 31 month old mouse (Figure 5.15F) appears to show 
that Top2B staining is nuclear. This is in agreement with the literature that suggests that 
Top2B protein is predominantly nuclear (Mirski et al., 1999; Onoda et al., 2014; Austin 
et al., 2018). Age-related declines in levels of Top2B have been reported in cerebellar 
tissue of rats (Kondapi et al., 2004). However, in that study it was reported that Top2B 
was not present in hippocampal tissue. Maeda et al. (2000) contradicted findings by 
Kondapi et al. (2004) and indicated that Top2B is present in rat hippocampal tissue. 
Observations of mouse hippocampal tissue in Figure 5.15 are in agreement with this. 
However, studies by Maeda et al. (2000) do not look at Top2B levels throughout the 
ageing process. The observations seen in mouse hippocampal tissue in Figure 5.15 are 
novel to the best of our knowledge. However, these preliminary observations were 
made from hippocampal sections of one young and one aged mouse. Further 
experiments utilising tissue from a number of young and old animals would be required 
to confirm any statistical significance. 
 
5.7 Discussion  
This chapter provides evidence that Top2B levels decrease with age as both protein and 
mRNA levels are seen to decrease over time in serum-free treated CAD cells with 
immunohistochemical sections of mouse hippocampus similarly showing decreases in 
expression during ageing in young versus aged animals.  
As differentiated CAD cells could be maintained in culture over prolonged periods of 
time, this allowed age-related changes in protein and mRNA levels of Top2B to be 
observed. The age-related decreases in Top2B protein and mRNA seen in neuronal cells 
in this study are in agreement with a very limited number of studies, which have 
previously shown similar results in mouse cerebellum tissue and cerebellar granule 
neurons (Kondapi et al., 2004; Bhanu et al., 2010). This raises the important question; 





5.7.1 Reductions of Top2B mRNA 
The activities of the transcription factor Sp1 have been observed in many cellular 
processes including cell differentiation, cell growth, chromatin remodelling, immune 
responses, responses to DNA damage and apoptosis by binding to the GC and GT box 
sequences of gene promoters (Gory et al., 1997). As discussed in section 1.5.4, Sp1 has 
been reported to be a regulator of Top2B expression with interference of Sp1 binding to 
GC-rich DNA sequences causing a decrease in Top2B expression at both the mRNA 
and protein level (Guo et al., 2014). Activity of Sp1 has been shown to decrease in aged 
rat brains (Ammendola et al., 1992) with Kim et al. (2012) also reporting lower levels 
of Sp1 in various tissues including liver, kidney and spleen from aged mice compared to 
young mice as well as in senescent human diploid fibroblasts. Interestingly, experiments 
on human diploid fibroblast cells have demonstrated that a majority of cells with 
depleted Sp1 also had a senescence-like phenotype and displayed increased ROS levels 
compared to control cells (Kim et al., 2012). In addition to decreases seen in Sp1 with 
increasing age, the transcription factor NURR1 also exhibits age-dependent decreases in 
neuronal tissues. Previous studies have shown that NURR1 influences the development 
and differentiation of mesencephalic dopaminergic neurons through axon genesis 
regulation (Heng et al., 2012). Furthermore, it has also been associated with the 
maintenance of function in dopaminergic neurons and provides neuroprotection (Eells et 
al., 2002). NURR1 has been shown to directly bind to a region on the Top2B promoter 
with NURR1 knockout models displaying significant reductions of Top2B expression in 
mouse brain sections. As discussed in section 1.5.4, this suggests a role for NURR1 in 
the regulation of Top2B expression (Terzioglu-Usak et al., 2017). Numerous studies 
have reported changes in expression of NURR1 in dopaminergic neurons with 
significant decreases shown in the substantia nigra of aged humans and rats (Chu et al., 
2002; Parkinson et al., 2015). Further studies by Ahn et al. (2018) have shown NURR1 
immunoreactivity to gradually decrease during normal ageing in the hippocampus of 
gerbils and suggest it may be associated with a decline in hippocampus-dependent 
cognitive function. As Top2B has been reported to be regulated by both Sp1 and 
NURR1, the decrease of these transcription factors throughout the ageing process will 
likely affect the activities of Top2B. This may prevent a number of essential processes 
such as neuronal maintenance from functioning correctly. Indeed, a decrease in these 




Chromatin architecture has been shown to be altered by age-related epigenetic changes 
such as DNA methylation (Armstrong et al., 2019). DNA methylation is a key player in 
the modulation of gene expression with the activity of DNA methyltransferase enzymes 
typically responsible for gene silencing through the addition of a methyl group to the 
carbon 5 position of cytosine to produce 5-methylcytosine (Johnson et al., 2012). It is 
suggested that the methylation of cytosine prevents gene transcription by interfering 
with the transcriptional machinery or through interference of the recognition sequence 
of transcription factors. Typically, during development, DNA methylation patterns in 
the genome change as a result of de novo DNA methylation and demethylation. As a 
result, DNA methylation patterns that regulate tissue-specific gene transcription are 
stable and unique in differentiated cells. Interestingly, post-mitotic neurons are still seen 
to express DNA methyltransferases and some components associated with 
demethylation, with neuronal activity reported to modulate DNA methylation patterns 
in response to both physiological and environmental stimuli (Moore et al., 2013). This 
may also cause a reduction in Top2B mRNA. 
Reductions in mRNA may be responsible for the declines in protein levels of Top2B 
that are seen in this study. However, as discussed in chapter 3 (3.6.4.1), misfolding and 
degradation of Top2B may also lead to a reduction in protein levels during ageing as a 
result of proteostasis dysfunction.   
5.7.2 Implications of reductions of Top2B 
Indeed, normal cognitive function relies heavily on the accurate regulation of DNA 
methylation with age-related changes in DNA methylation seen to alter the chromatin 
architecture of DNA, which has been associated with the progression of 
neurodegenerative diseases (Berson et al., 2018). The presence of DSBs in DNA is not 
just a deleterious event caused by exposure to DNA damaging agents but is 
physiologically crucial for mediating transcription of key genes. Previous work by 
Bunch et al. (2015) has shown that type II topoisomerases are crucial for RNA 
polymerase II (Pol II) pause release and transcriptional elongation. Pol II activities are 
known to initiate RNA synthesis but studies have shown that pausing of Pol II during 
early elongation acts as a regulatory mechanism (Adelman & Lis, 2012). The pause 
release of Pol II is necessary for productive RNA synthesis and topoisomerases are 
known to be involved in this process (Bunch et al., 2015). Furthermore, the action of 
Pol II during transcription elongation has been shown to cause axial rotation in DNA, 
which introduces positively supercoiled DNA in front of the enzyme (Björkegren & 
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Baranello, 2018). The actions of topoisomerase in relieving torsional stress in DNA are 
essential to maintaining DNA templates in a transcriptionally competent state (Gilbert 
& Allan, 2014). As Top2B is known to have key roles in the regulation of transcription 
and gene expression, age-related decreases in levels of Top2B may have detrimental 
effects on gene expression, particularly in areas with altered chromatin architecture 
caused by changes in DNA methylation. 
The transcription factor CCCTC-binding factor (CTCF), which also acts as a 
transcriptional activator, has key roles in the regulation of chromatin structure and gene 
regulation. Top2B associates with chromatin and has also been shown to be crucial for 
the maintenance of chromatin architecture (Uusküla-Reimand et al., 2016). Chromatin 
architecture and organisation are considered to have a major impact on DNA topology 
and could be a source of topological stress. Top2B has been seen to facilitate 
transcription initiation through the formation of a favourable chromatin environment, 
with topological stress caused by chromatin looping thought to be relieved by the 
actions of Top2B. Therefore, Top2B is considered a key component in the maintenance 
of chromatin architecture (Uusküla-Reimand et al., 2016; Canela et al., 2017). CTCF 
has been reported to be enriched at Top2B binding sites with over half of the Top2B 
binding sites overlapping with CTCF suggesting an overlap of roles (Barutcu et al., 
2017). Age-related decreases of CTCF have previously been reported (Sun et al., 2018). 
If CTCF decreases, Top2B may be relied upon more heavily to maintain chromatin 
architecture and vice versa. If both Top2B and CTCF decrease equally with age, this 
may ultimately compromise chromatin architecture and lead to age-related dysfunction 
of gene regulation. It is likely that age-related decreases in Top2B affect chromatin 
architecture and maintenance. Hence, subsequent disruptions in transcriptional 
regulation are possible.  
Indeed, Top2B is known to be crucial in facilitating the expression of long genes with 
inhibition of Top2B shown to cause reductions in expression of these genes (King et al., 
2013). Long genes such as ubiquitin protein ligase E3A (Ube3a) play an important role 
in maintaining normal neuronal function, including synaptic plasticity, and its 
expression is tightly regulated with increases of the gene linked to autism spectrum 
disorders and depletion of the gene known to cause Angelman syndrome during 
development (Lam et al., 2017). Substantial age-related decreases in Ube3a expression 
have been reported in human, monkey and cat cortex, which highlights a vulnerability 
during brain ageing that may be responsible for a change in cortical function and 
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plasticity (Williams et al., 2010). Top2B has been implicated in the expression of 
Ube3a and it is possible that the age-related decreases seen in Top2B may have 
subsequent implications in the expression of long genes such as Ube3a and have 
detrimental effects to the maintenance of neuronal function (King et al., 2013). Top2B 
has also been shown to actively repress genes through its role in chromatin architecture 
maintenance. It is suggested that the repression of these genes is dependent on the 
maintenance of DNA template integrity (Tiwari et al., 2012). One such repressed gene 
is Ngfr p75, which is widely expressed during development and is a key regulator of 
cell death but becomes downregulated and repressed after development (Nykjaer et al., 
2005). Expression of Ngfr p75 is typically only seen in adults in response to injury and 
DNA damage, with reports showing it is responsible for cell death accompanying 
neurodegeneration (Miller & Kaplan, 2001). Upregulation of Ngfr p75 has been 
observed in the absence of Top2B in mouse embryonic stem cells that had been 
differentiated into postmitotic glutamatergic neurons and resulted in phenotypic 
premature cell death (Tiwari et al., 2012). In addition to this, Kraemer et al. (2014) 
suggested a mechanism linking oxidative stress to an upregulation of Ngfr p75 through 
ligand-independent cleavage. During the study 4-hydroxynoneal (HNE), a product of 
lipid peroxidation caused by oxidative stress, was seen to activate Ngfr p75 signalling in 
cells cultured from the superior cervical ganglia of mice, subsequently linking Ngfr p75 
activation to oxidative stress. As oxidative stress is known to increase with age and 
subsequently cause increases in DNA damage, decreases in Top2B mRNA and protein 
levels with age may cause an upregulation of Ngfr p75 in serum-free treated CAD cells 
over six weeks of ageing. Indeed, the significant reduction of viable CAD cell numbers 
shown in Figure 5.11 after 27 days in serum-free media may indicate an increase in the 
activation of tumour necrosis factor receptors such as Ngfr p75. 
Increases in neuronal activity have been shown to cause expression of early-response 
genes that are crucial for experience-driven changes to synapses, learning and memory. 
This neuronal activity can stimulate the formation of DSBs in the promotors of 
numerous early-response genes and is seen to induce their expression (Madabhushi et 
al., 2015). DSBs stimulated by neuronal activity are thought to be mediated by Top2B. 
Indeed, Top2B has been shown to be bound to the promotors of some of these genes. In 
particular, Top2B binding was seen to be significantly enriched within the promoter of 
the early-response gene Neuronal PAS domain protein 4 (Npas4) and Top2B 
knockdown models in cortical neurons from E16 Swiss-Webster mice have 
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demonstrated a reduction in DSBs and subsequently a reduction in the expression of 
early-response genes (Madabhushi et al., 2015). Npas4 is a rapidly induced early-
response gene that is only expressed in neurons and is selectively induced by neuronal 
activity. Expression of Npas4 leads to the modification of synaptic connections and has 
been associated with the regulation of learning and memory formation in the 
hippocampus and amygdala (Sun & Lin, 2016). Npas4 has been implicated in 
development, maintenance and survival of neurons and synapses, as well as regulating 
synaptic plasticity via downstream target genes, such as brain‐derived neurotrophic 
factor (BDNF) (Qiu et al., 2016). Deletion of Npas4 from the CA3 region of the 
hippocampus in Npas4 conditional knockout mice models has been shown to result in 
memory formation impairments, suggesting experience-dependent changes in neural 
circuitry associated with memory formation are likely to occur in neurons in which 
Npas4 has been induced (Ramamoorthi et al., 2011). As binding of Top2B to the 
promotor of Npas4 has been reported, it is likely that age-related declines in Top2B may 
affect expression of Npas4 and consequently lead to learning and memory impairments. 
Indeed, declines in Npas4 have been observed in the ventral hippocampus of aged rats 
(Calabrese et al., 2013).  
In addition to its roles in the development and maintenance of neuronal function, Top2B 
has also been shown to have roles in DNA repair. As discussed in section 1.5.6, the 
capacity of base excision repair (BER) in neurons is thought to be regulated by Top2B-
mediated DNA breaks (Gupta et al., 2012). Gupta suggested that Top2B activity at 
abasic sites indicated an overlap of Top2B in BER processing regions, thus implicating 
it in the regulation of BER pathway intermediates. Top2B dynamically responds to 
DNA damage and is rapidly recruited to DSBs (Emmons et al., 2006). Furthermore, 
Top2B knockout cells display increased sensitivity to DNA damaging agents with 
decreases in homologous recombination (HR)-mediated DSB repair also observed, 
suggesting roles for Top2B in DSB repair pathways (Morotomi-Yano et al., 2018). The 
age-related declines of Top2B seen in this study may have consequences for DNA 
repair pathways, including HR and BER, and could result in an increase and subsequent 
accumulation of DNA damage in neuronal cells, which may cause dysfunction and cell 
death.  
5.7.3 The use of the CAD cell line as a differentiated neuronal model of ageing 
The ability to chronologically age CAD cells was particularly useful as H2O2 induced 
oxidative stress did not bring about senescence in serum-free treated cells with β-gal 
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assays providing negative results similar to the previous experiments using the 
neuroblastoma SH-SY5Y cell line. As discussed in the previous chapter, the use of a 
positive control during these experiments may have been able to further clarify whether 
senescence had been achieved and confirmed that the assay was working correctly or 
not. As previous studies have shown that other differentiated neuronal cell lines are 
more resistant to the effects of DNA damaging agents than undifferentiated cells 
(Schneider et al., 2011; Tong et al., 2017), this may have also been the case with serum-
free treated CAD cells. The concentrations of H2O2 used in this chapter may have been 
too low to induce senescence in the serum-free treated CAD cells and it may have 
provided useful research to further investigate a greater range of H2O2 concentrations 
and exposure times to fully elucidate whether senescence could be achieved using this 
method. In addition to this, the β-gal assay may not be suitable to determine senescence 
in these experiments with studies by Piechota et al. (2016) suggesting that β-gal should 
be used with caution when identifying senescence in neurons as β-gal activity cannot be 
solely attributed to senescence either in vitro or in vivo. Piechota reported relatively 
high levels of β-gal in young 3 month old mice and suggested that this marker may be 
linked to non-senescent activities. In addition to this, primary cultures of cortical 
neurons also exhibited noticeable β-gal activity early in culture. Interestingly, treatment 
of these cells with low doses of doxorubicin did not increase the numbers of β-gal 
positive cells (Piechota et al., 2016). It appears that the use of β-gal as a marker of 
senescence in neurons provides varying results and may not have been the correct 
marker to determine whether H2O2 treated CAD cells had entered a state of senescence. 
Piechota et al. (2016) goes on to suggest the use of repressor element 1-silencing 
transcription factor (REST) as a marker of neuronal senescence in vitro. In contrast to β-
gal, REST was seen to display a pattern of expression that correlated with neuronal age, 
thus the use of REST as a neuronal marker of senescence may have been more suitable 
for the set of experiments in this chapter. 
Although serum-free treated CAD cells can be maintained in culture for six weeks, this 
is still much shorter than the length of time a mature neuronal cell survives in vivo, 
which raises the question as to how reliable serum-free treated CAD cells are as a model 
of ageing. p21 is used as a marker of senescence and post-mitotic neurons have been 
shown to develop a p21-dependent senescence-like phenotype (Jurk et al., 2012; 
Riessland et al., 2019). The results from Figure 5.10 shows increases in p21 over six 
weeks of ageing in serum-free treated CAD cells but further experiments would be 
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required to confirm any statistical significance as results shown are from only two 
biological replicates. If further experiments demonstrated that p21 does increase 
significantly then it may provide evidence that CAD cells are displaying a phenotypic 
characteristic of aged cells and are therefore suitable as a model of ageing. 
Nevertheless, levels of Top2B mRNA and protein were seen to decrease over six weeks 
of ageing (Figure 5.9 and Figure 5.13), which is also seen when comparing sections of 
hippocampus tissue from young and aged mice (Figure 5.15). However, as stated above, 
the use of more suitable markers of senescence in future experiments, such as REST, 
may also support the use of serum-free treated CAD cells as a model of ageing. In 
addition to these markers of senescence, aged cells are known to develop an 
accumulation of DNA damage whilst experiencing increased levels of oxidative stress, 
with numerous neurodegenerative diseases linked to increases in ROS (Castelli et al., 
2019). Measuring DNA damage in serum-free treated CAD cells over a prolonged 
period of time would provide information on the accumulation of DNA damage with 
age but also may provide information on the ability of DNA repair pathways to cope 
with oxidative stress throughout the ageing process. This is an area of research that was 
investigated further in the following chapter.  
Results shown in Figure 5.3 and Figure 5.6 showed that protein and mRNA levels of 
Top2B did not increase during the first 72 hours in serum-free media. Numerous studies 
have shown that Top2B becomes upregulated during differentiation, so it would be 
expected that Top2B mRNA and protein would increase during these experiments. 
These experiments were carried out based on previous proliferation experiments that 
showed that cells ceased proliferating at 48 hours (Figure 5.1). As cells were seen to 
exit the cell cycle at this point it was assumed that differentiation had taken place. 
However, later proliferation experiments that were carried out up to 30 days (Figure 
5.11A) demonstrated that cells continued to grow during the first week in serum-free 
media before proliferation stopped. Furthermore, neurites were also seen to continue 
growing significantly during the first week in serum-free media. This indicates that 
terminal differentiation of CAD cells had not been reached after 72 hours in serum-free 
media and may explain why significant increases in Top2B mRNA and protein levels 
were not seen. Interestingly, chronological ageing in CAD cells did not show an 
increase in Top2B mRNA or protein levels after one week of ageing (Figure 5.9 and 
Figure 5.13). Instead, both Top2B mRNA and protein were seen to decrease after one 
week of ageing and continued to do so over six weeks. It is possible that Top2B mRNA 
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and protein levels increased between 72 hours and six days of ageing during the 
differentiation process before decreasing again at one week. However, that cannot be 
determined from this set of experiments. Further experiments using extracts from CAD 
cells over the first week of ageing in serum-free media may determine whether Top2B 
levels increase during differentiation in this cell line. Although Top2B mRNA and 
protein levels are typically seen to increase during differentiation, it may be possible 
that cell line specific changes in Top2B levels are being observed in the CAD cell line. 
Indeed, work by Kenig et al. (2016) showed that glioblastoma stem cells treated with 
all-trans retinoic acid to induce differentiation towards an astrocyte phenotype resulted 
in a decrease in Top2B expression over 120 hours, whilst results shown by Guo et al. 
(2014) report an increase in Top2B expression at both the mRNA and protein level 
during retinoic acid-induced neuronal differentiation of the neuroblastoma cell line SH-
SY5Y over 120 hours. 
Results seen in Figure 5.8 showed that protein levels of p21 were evenly expressed in 
serum-free treated CAD cells and in cells exposed to H2O2, which suggested that 
senescence had not been achieved in these cells. As a tumour suppressor gene it would 
be expected that p21 levels would increase after exposing cells to H2O2. However, this 
was not the case in CAD cells. Work by Ho et al. (2013) demonstrated that p21 
expression and proliferative decline are not due to elevated H2O2 levels and are not 
mediated by p53 as their results suggested that the accumulation of H2O2 in long term 
cultured placenta-derived multipotent cells only made minor contributions towards p21 
expression levels. They suggested that p21 increases were mediated by protein kinase C 
(PKC) α and β through p53- and H2O2-independent pathways. This may explain why 
p21 protein levels were not seen to significantly increase in CAD cells treated with 
H2O2. It may have also been expected that protein levels of p21 would be higher in 
serum-free treated cells compared those grown in complete media as these cells are 
entering cell cycle arrest and p21 expression is known to inhibit the cell cycle. 
However, a study by Morris-Hanon et al. (2017) reported no significant changes in 
levels of p21 in glioma cell lines exposed to nutrient restriction. There may be 
conditions that are specific to certain cell lines and this may explain why p21 protein 






5.7.4 Declines of Top2B in hippocampal tissue 
Although results in Figure 5.15 show Top2B immunoreactivity in the hippocampus 
from one young and one aged mouse, it does provide promising initial results and a 
proof of methodology that demonstrates Top2B can be identified in mouse brain tissue 
using these techniques. Results from Figure 5.15 show clear differences in Top2B 
expression with punctate labelling seen to be much stronger in tissue from the young 
animal compared to the aged animal. These results are also in support of previous work 
by Maeda et al. (2000), which demonstrated that Top2B expression can be seen in 
murine tissue of the hippocampus. This also contradicts work by Kondapi et al. (2004), 
which suggested that Top2B was predominantly expressed in cerebellar tissue and was 
not seen at all in hippocampal tissue. As stated previously, the hippocampus is one of 
the brain regions most affected by age (Verbitsky et al., 2004) with age-related 
deterioration of the hippocampus associated with numerous dementia-related diseases, 
such as Alzheimer’s disease (Lindberg et al., 2012). Additional experiments would need 
to be carried out to determine whether levels of Top2B decrease significantly in the 
hippocampus of aged mice. As Top2B is a key player in neuronal development, 
neuronal maintenance, the transcription of long genes and has roles in DNA repair 
pathways, decreases in Top2B in an area such as the hippocampus may lead to 
numerous neurodegenerative conditions.  
In conclusion, Top2B mRNA and protein were seen to decrease during ageing in serum-
free treated CAD cells in vitro and a concomitant increase in p21 was also observed, 
whilst punctate labelling of Top2B was seen to be higher in young mouse hippocampal 
tissue compared to aged tissue. The CAD cell line would be a useful model to further 
examine the consequences of reductions in Top2B and the mouse model may provide 









6. The DNA damage response of differentiated CAD cells during 
ageing 
6.1 Introduction 
Previous studies have demonstrated that during normal ageing brain function declines 
and leads to learning, memory and motor coordination impairments (Alexander et al., 
2012; Castelli et al., 2019). Ageing is multifactorial in nature but it is thought that a 
combination of an increase in exposure to toxins such as ROS and a decline in cellular 
damage repair mechanisms could be at the heart of the process (Mattson & Magnus, 
2006). DNA is a major target for age-related damage and is considered by some as a 
cause of ageing itself (Gorbunova & Seluanov, 2007). 
DNA double strand breaks (DSBs) are thought to be one of the most toxic lesions that 
must be repaired to preserve chromosomal integrity in a cell (Mehta & Haber, 2014). 
DSBs can be induced spontaneously by ROS but also by exposure to ionising radiation, 
chemotherapeutic agents and other substances such as bioflavonoids (Negritto, 2010; 
Jekimovs et al., 2014; Goodenow et al., 2020). When DSBs occur, a mammalian 
histone variant H2AX becomes phosphorylated at serine 139, which is located in its 
carboxy terminal tail and is a unique site among the H2A histone family. This specific 
phosphorylation is denoted γH2AX (Rogakou et al., 1998; Podhorecka et al., 2010). 
Ataxia telangiectasia mutated (ATM) is the major kinase that controls γ-
phosphorylation in human cells. However, ATR (ATM and Rad3 related) can also 
phosphorylate H2AX during hypoxia and replication fork collapse (Paull et al., 2000; 
McKinnon, 2004). When a DSB is generated, rapid phosphorylation of H2AX begins 
and spans both sites of damage on the chromatin and can range from several kilobases 
to a megabase in length (Rogakou et al., 1999; O’Hagan et al., 2011; Seo et al., 2012). 
γH2AX then recruits mediator of DNA damage checkpoint 1 (MDC1), which facilitates 
further phosphorylation of H2AX. Together, these recruit additional factors, such as 
p53-binding protein 1 (53BP1), C-terminal binding protein-interacting protein (CtIP) 
and Mre11-Rad50-Nbs1 (MRN) to the site of damage, which will carry out repair (Yuan 
et al., 2010).  
In order to repair DSBs in post-mitotic neurons the error-prone NHEJ pathway is the 
predominant DSB repair pathway (Vyjayanti & Rao, 2006). NHEJ is a repair 
mechanism in which two DSB ends are directly joined by ligation (Chiruvella et al., 
2013) and can be broken down into individual steps, which include; (1) DNA end 
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recognition and assembly, including NHEJ complex stabilisation at the DNA double 
strand break; (2) DNA end bridging and promotion of end stability; (3) Processing of 
the DNA end; (4) Ligation of the broken ends and subsequent termination of the NHEJ 
complex (Davis & Chen, 2013). The joining of the two DSB ends are characterised by 
having little or no homology between the two ends. Thus, NHEJ is recognised as having 
a high potential for making errors. The NHEJ repair pathway was considered the only 
pathway to be utilised in post-mitotic neurons to repair DSBs associated with oxidative 
damage, as HR is known to require a sister chromatid template, which is not present in 
non-replicating neuronal cells, in order to repair DSBs. However, recent studies have 
reported RNA-templated HR repair mechanisms of DSBs at active transcription sites in 
terminally differentiated post-mitotic neurons. It has been shown that the HR repair 
protein RAD52 is recruited to DSB sites and has demonstrated an HR repair mechanism 
in post-mitotic neurons (Welty et al., 2018). 
After the successful repair of a DSB, γH2AX dephosphorylation occurs to restore the 
cell to its pre-stressed state. The phosphatases PP2A, PP4, and the p53-induced 
phosphatase 1 (WIP1) dephosphorylates γH2AX at serine 139 (Chowdhury et al., 2005; 
Nakada et al., 2008; Moon et al., 2010). Several reports have shown that γH2AX foci 
form spontaneously (Costes et al., 2006 & 2010; Pustovalova et al., 2016). In addition, 
further studies have reported the presence of large persistent γH2AX foci in ageing 
tissues, including the liver, brain and also in ageing cells, such as hematopoietic stem 
cells (HSCs), dermal fibroblasts and ovarian primordial follicles. It was subsequently 
interpreted that these foci were due to unrepairable DSBs (Rube et al., 2011; Hewitt et 
al., 2012; Titus et al., 2013). However, Mamouni et al. (2014) suggested that these 
persistent foci may reflect inadequate H2AX dephosphorylation, which may reduce 
with age. Nevertheless, the observed increase in persistent γH2AX foci with age 
correlates with evidence that shows an increase in macromolecular damage with ageing 
(López-Otín et al., 2013). 
The functionality of neuronal stem cells has been shown to be directly affected by the 
persistent presence of DSBs. As a result, these cells either undergo premature 
senescence or terminally differentiate into astroglial cells, which leads to a reduction in 
proliferative potential and may lead to a loss of neuronal cells over time, subsequently 
causing neurodegeneration and cognitive impairment that is often seen in ageing. 
(Schneider et al., 2013). Thus, it is clear that unrepaired DSBs accumulate with age and 
are associated with major age-related cellular phenotypes, such as cellular senescence. 
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6.2 Do DSBs accumulate in serum-free treated CAD cells when chronologically 
aged in vitro? 
This chapter explores the levels of DSBs in serum-free treated CAD cells over a 6 week 
period to determine whether this type of damage increases with age in this cell line. 
This may allow conclusions to be made about the suitability of serum-free treated CAD 
cells as a model of ageing and allow exploration of the DNA damage response in ageing 
in future experiments.  
The γH2AX assay was used to measure DSBs and the alkaline Comet assay was used to 
measure both SSBs and DSBs in serum-free treated CAD cells that were 
chronologically aged. As previously stated, the quantification of γH2AX foci through 
immunofluorescence techniques is associated with the amount of DSBs present in a cell. 
Hence, the more foci that are seen in a nucleus, the more DSB damage is present 
(Kinner et al., 2008). The Comet assay, also known as single-cell gel electrophoresis, is 
a simple technique and is considered to be one of the gold standard techniques for 
measuring DNA strand breaks, which includes both SSBs and DSBs 
(Figueroa-González & Pérez-Plasencia, 2017). The alkaline Comet assay is sensitive to 
alkali labile sites and is associated with being sensitive to both SSBs and DSBs, 
whereas the neutral Comet assay is associated with being sensitive to only DSBs 
(Afanasieva & Sivolob, 2018). In the Comet assay, cells are embedded in agarose and 
then electrophoresed. If DNA contains breaks, chromatin supercoils become relaxed and 
broken ends are able to migrate to the anode due to DNA being negatively charged. 
Cells are described as ‘comets’ with the head of the comet containing a mass of 
undamaged DNA while the tail of the comet contains damaged DNA. The relative 
amount of DNA that migrates to the anode can be viewed using fluorescence 
microscopy and gives some indication of the relative number of DNA breaks in a cell. 
Undamaged DNA contains fewer broken ends, which results in larger fragments of 
DNA that do not migrate during electrophoresis, resulting in a comet without a tail. 
Comet assay results can be analysed manually or using automated software. Cells can 
be analysed manually and sorted into one of five classes ranging from 0-4 depending on 
tail intensity as described by Collins et al. (1995). Cells with no DNA damage are given 
a score of 0 and cells that are highly damaged are given a score of 4. Hence, the more 
damage that is seen in a population of cells, the higher the score. Automated analysis 
can also be carried out using software such as ImageJ with the OpenComet plugin. This 
software recognises cells, outlines the head and tail of the comet and measures the 
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percentage of DNA that is seen in the tail of the comet compared to the head. Hence, the 
more damage that is seen in the cell, the higher the percentage of DNA will be 
measured in the tail. 
6.2.1 Quantification of DNA damage in serum-free treated CAD cells  
6.2.1.1 γH2AX foci analysis of DNA damage 
In order to quantify DNA damage during chronological ageing in vitro, serum-free 
treated CAD cells were maintained in culture for a total of 6 weeks. Samples of cells 
were processed each week, γH2AX assays were carried out and γH2AX foci were 





































Figure 6.1 γH2AX foci analysis over 6 weeks in serum-free treated CAD cells. 
T25 culture flasks were seeded at 5 x 10
4
 cells/ml (5 ml per flask) and incubated for 24 hours at 
37°C (5% CO2) in complete media. Media was removed and replaced with serum-free media 
and maintained as described in section 2.2.2.7.2 and aged to specific time points prior to 
carrying out γH2AX assays. Sterilised 24 x 24 mm coverslips were placed in each well of a 6-
well plate. Once CAD cells had been aged to the correct time point they were seeded into the 6-
well plate at a density of 5 x 10
4
 cells/ml (2 ml per well) and incubated for 24 hours. γH2AX 
assays were carried out as described in section 2.2.2.15 at weekly intervals for 6 weeks. (A) 
CAD cells at week 1. (B) CAD cells at week 6. (C) Mean number of γH2AX foci per nucleus 
over 6 weeks (100 cells were analysed per week). Results shown are the mean of three 








Results from Figure 6.1 show that the mean number of γH2AX foci per cell increases 
significantly over 6 weeks of ageing in serum-free treated CAD cells. During the first 2 
weeks of ageing the mean number of γH2AX foci did not increase significantly in cells. 
However, all remaining weeks displayed a significantly increased mean number of 
γH2AX foci when compared to week one (see Appendix table C.1 for p values). 
Significant weekly increases in mean γH2AX foci are seen between weeks 2-3 
(p=0.042) and between weeks 5-6 (p=0.015). Further analysis of the data shows that the 
number of cells displaying 25< foci per cell is significantly higher in week 6 cells 
compared to week one cells with a p value of 0.001.  
In conclusion, DNA damage significantly increases in serum-free treated CAD cells 
over 6 weeks, as demonstrated by the γH2AX assay. As the γH2AX assay only shows 
the presence of DNA DSBs it was decided that further DNA damage assays would be 
carried out to explore damage throughout ageing. The alkaline Comet assay, which 
measures DNA damage caused by both SSBs and DSBs, was used in subsequent 
experiments. 
6.2.1.2 Comet assay analysis of DNA damage 
In order to further quantify DNA damage during the ageing process, serum-free treated 
CAD cells were maintained in culture for a total of 6 weeks. Samples of cells were 
processed at T0, week 1, week 4 and at week 6. Comet assays were carried out and cells 
were analysed. Cells were analysed manually and sorted into one of five classes ranging 
from 0-4, depending on tail intensity, as described by Collins et al. (1995) (section 
2.2.2.15). Automated analysis using the OpenComet plugin on ImageJ was also used. 
However, the software was not sensitive enough to accurately identify cells on many of 
the images that were analysed (Figure 6.3). In addition, issues were encountered during 
week 4 of the experiment, which resulted in an insufficient number of cells available for 
processing. Hence, analysis of week 4 cells has been removed from the results. Results 
























Figure 6.2 Manual scoring analysis of Comet assay over 6 weeks in serum-free treated 
CAD cells. 
T25 culture flasks were seeded at 5 x 10
4
 cells/ml (5 ml per flask) and incubated for 24 hours at 
37°C (5% CO2) in complete media. Media was removed and replaced with serum-free media 
and maintained as described in section 2.2.2.7.2 and aged to specific time points prior to 
carrying out Comet assays. Comet assays were carried out as described in section 2.2.2.16. (A) 
CAD cells at T0. (B) CAD cells at week 6. (C) Cells were analysed manually and were sorted 
into one of five classes ranging from 0-4 depending tail intensity as described by Collins et al. 
(1995). Cells with no DNA damage were given a score of 0 and cells that were highly damaged 
were given a score of 4. 50 cells were analysed per group. Results shown are the mean of three 






















Figure 6.3 Variability of OpenComet image analysis of serum-free treated CAD cells.  
OpenComet analysis of images obtained from the Comet assay described in Figure 6.2 shows 
variability and errors in comet head/tail identification. (A & B) Week 1 CAD cells. (C & D)  
Week 6 cells.  
 
Results from Figure 6.2 show that DNA damage significantly increases in serum-free 
treated CAD cells over six weeks of ageing. DNA damage is significantly higher at 
week 1 and week 6 compared to T0 cells with p values of 0.029 and 0.031, respectively. 
Results from the Comet assay therefore validated results seen during the γH2AX assay 
in Figure 6.1. 
Images from Figure 6.3 demonstrate the issues in obtaining reliable data using the 
OpenComet plugin on ImageJ. The software showed variability between images and 
was unable to successfully identify the heads and tails of each comet. Further analysis 
by the software, which calculated the percentage of DNA in the tail compared to the 







In conclusion, DNA damage, in the form of SSBs and DSBs, significantly increases in 




The results show that levels of DSBs significantly increase when serum-free treated 
CAD cells are chronologically aged in vitro, as shown by γH2AX assays in Figure 6.1. 
This is in line with previous studies such as Sedelnikova et al. (2004), who 
demonstrated that DSBs are shown to accumulate in a number of organs in ageing mice. 
Tissues obtained from brain, liver, testes, kidney and lung all demonstrated age-related 
increases in γH2AX foci between 2 to 20 month old tissue samples. In addition, 
Sedelnikova also reported an accumulation of DSBs in senescing human cell cultures. 
Normal human fibroblasts, WI38 fibroblasts and PrEC prostate epithelial cells all 
showed increases in γH2AX foci with increasing passage number, as well as 
senescence-associated β-gal staining, which suggested that during senescence and 
normal ageing, mammalian cells are seen to accumulate persistent DNA damage that 
leads to unrepairable DSBs. Increases in DSB accumulation have not only been reported 
in cell culture and mouse tissue during normal ageing but have also been reported in the 
brain tissues from patients with mild age-related cognitive impairment and Alzheimer’s 
disease. Shandhag et al. (2019) showed that immunostaining for γH2AX revealed 
significant increases of foci in neurons and astrocytes in the frontal cortex and 
hippocampus of patients with mild cognitive impairment and Alzheimer’s disease 
compared to cognitively unimpaired controls. DSBs can cause severe adverse effects on 
DNA, which can subsequently have detrimental effects on gene expression, chromatin 
stability and cellular functions (Shandhag et al., 2019). As DSBs are seen to increase in 
ageing per se and are exacerbated in certain disease states, this suggests that DSBs 
could be an important driver of neurodegeneration and cognitive decline. However, this 







6.3.1 Why do DSBs accumulate during ageing? 
6.3.1.1 Decreases in DNA repair capacity  
Numerous studies have demonstrated that defective DNA repair pathways, alongside an 
accumulation of DNA lesions and a decrease in genomic stability, underlies ageing and 
a number of neurodegenerative disorders (Baltanás et al., 2011; Borgesius et al., 2011; 
Mata-Garrido et al., 2016). Although the expression of repair factors is widespread in a 
number of different cell types, the organs of the central nervous system appear to be 
particularly affected by impaired DNA repair (Alt & Schwer, 2018). Several studies 
have looked at the ability of repair pathways to repair DSBs during ageing. As stated 
previously, the error-prone NHEJ pathway is the predominant DSB repair pathway in 
post-mitotic neurons (Vyjayanti & Rao, 2006). A study by Seluanov et al. (2004) 
showed that NHEJ efficiency decreased in aged senescent normal human fibroblasts by 
measuring the number of NHEJ events using a GFP reporter plasmid, which was co-
transfected with a restriction enzyme (I-SceI) to induce DSBs within the construct 
(Seluanov et al., 2004). In addition, levels of ATM phosphorylation have been seen to 
decrease in aged mice after ionizing radiation (Feng et al., 2007) and reduced the 
expression level of genes involved in DSB processing and repair. Genes including 
ATM, MRE11, RAD51 and BRCA1 have been reported to decline in ageing ovarian 
mouse and human primordial follicles (Oktay et al., 2015; Titus et al., 2013). This 
suggests that the reductions in DSB processing genes with age may have detrimental 
outcomes for cells containing DSBs. Work by Vyjayanti & Rao (2006) demonstrated 
that NHEJ activity is present in isolated neurons of the rat cerebral cortex and showed 
that cohesive end-joining activity decreases in an age-dependent manner. Neuronal 
extracts from young (0-4 days), adult (6 months) and old (28 months) rats were 
analysed and NHEJ activity assays were carried out. NHEJ activity was seen to 
significantly decrease with age as adult and old extracts displayed average percentage 
decreases in activity of 28% and 40%, respectively, compared to young extracts. It is 
therefore likely that decreases in NHEJ capacity with age will cause neuronal 
vulnerability to ROS and lead to increases in DNA damage, particularly as it has been 
reported that an accumulation of DNA damage can produce dysregulation of the DNA 
damage response and can lead to a senescence-like phenotype in neurons (Sedelnikova 
et al., 2004). In conclusion, a reduction in DNA repair capacity may be partly 
responsible for the increases in DSBs seen in Figure 6.1. 
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6.3.1.2 Increased levels of endogenous toxins in aged cells and the response of 
Top2B 
Concomitant with a decrease in repair capacity, there may also be an increase in the 
levels of endogenous toxins such as ROS, which could account for the increase of SSBs 
and DSBs seen in this chapter. As stated previously, excess levels of ROS have been 
seen to contribute to adverse modifications in cells and can amplify the development of 
damage to DNA, which can induce apoptosis and necrosis (Lundgren et al., 2018). One 
of the main causes of increasing ROS levels is believed to be inefficient electron 
transfer in the mitochondrial respiratory chain. The mitochondrial respiratory chain 
consists of five protein complexes. A proton gradient is created through the exchange of 
electrons down the respiratory chain at increasing reduction potentials from complex 
one through to four. This electron transfer mediated by the respiratory chain is 
connected to the final protein complex, ATP synthase, which drives ATP synthesis. 
However, premature leaking of some electrons occurs at the respiratory chain, which 
results in the generation of ROS (Payne & Chinnery, 2015). Modifications to 
mitochondria have been reported to occur during ageing and are due to changes in 
mitochondria-nucleus interactions and homeostatic alterations to mitochondria. 
Ineffective control of ROS in mitochondria can lead to ROS signalling alterations and 
ultimately result in a shift towards a pro-oxidant state in cells (Davalli et al., 2016). 
ROS can damage DNA via oxidation of bases. This oxidation can lead to the formation 
of a DNA base lesion, which is one of the most deleterious consequences of oxidative 
stress. For example, guanine possesses a low redox potential and is particularly 
susceptible to oxidative stress with 7,8-dihydro-8-oxoguanine (8-oxoG) commonly 
formed under conditions of oxidative stress, which can lead to G:C to T:A transversion 
mutations if left unrepaired (Nakabeppu, 2014). BER is known to play a pivotal role in 
repairing these damaged bases. BER takes place in a number of steps, including: 
excision of the base, incision, end processing, repair synthesis and ligation (Krokan & 
Bjørås, 2013). DNA glycosylases are responsible for initiating BER by recognising and 
removing the damaged DNA base. The removal of a base leaves an abasic site (AP site), 
which is then processed by short-patch or long-patch repair to complete BER (Jacobs & 
Schär, 2012). Although oxidised bases are recognised and repaired by the BER 
pathway, when oxidised bases occur simultaneously on opposing strands of DNA, 
attempted BER can lead to the generation of DSBs (Cannan et al., 2014). As previously 
discussed, Top2B has been implicated in having an indirect but significant role in 
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regulating BER capacity in neurons (Gupta et al., 2012). The presence of abasic sites 
within the vicinity of Top2B cleavage sites have been seen to act as endogenous 
topoisomerase II poisons and cause subsequent Top2B-mediated cleavage. The 
activities of Top2B at abasic sites suggested a possible overlap of Top2B in BER 
processing regions, thus implicating Top2B activity in the regulation of BER pathway 
intermediates (Gupta et al., 2012). Indeed, it is possible that declines in Top2B mRNA 
and protein levels in serum-free treated CAD cells, shown in chapter 5, are a 
contributing factor towards increased unrepaired oxidised bases present on opposing 
DNA strands, which could lead to an increase in DSBs as shown in this chapter 
(Cannan et al., 2014).  
In a study by Kenig et al. (2016), it was suggested that glioblastoma stem cells are more 
resistant to chemotherapeutic agents because of their increased efficiency of DNA 
repair. Kenig investigated whether increased expression of Top2B was one of the 
underlying reasons for the phenomenon. In vitro work reported that glioblastoma cells 
with endogenously low levels of Top2B (U251 cell line) display increased sensitivity to 
DNA damage-inducing drugs compared to cells with endogenously high levels of 
Top2B (NCH421k cell line). In addition, the down-regulation of Top2B in NCH421k 
cells increased their sensitivity to DNA damage-inducing drugs to the same level as 
detected in U251 cells. Thus, highlighting the potential role of Top2B in DNA repair 
mechanisms as previously discussed. Although this in vitro study is not a representation 
of biological ageing, it does provide information about a key element of cellular ageing, 
namely increased oxidative stress. Kenig used a range of drugs to induce stress on 
glioblastoma cells, including the topoisomerase II poison etoposide (VP-16). Top2A is 
the primary target of VP-16 with drug-stabilised Top2A complexes being detected with 
as little as 1 µM VP-16 in mouse and human cells. Nevertheless, Top2B is also targeted 
by the drug, with VP-16 stabilised Top2B complexes being induced from 10 µM in 
mouse and human cells (Willmore et al., 1998; Cowell et al., 2011; Atwal et al., 2017). 
These drug stabilised complexes are processed in the cell to give rise to DSBs, which 
then elicit the phosphorylation of histone H2AX in a dose response similar to that 
observed for TOP2-DNA complexes (Atwal et al., 2019). In addition to VP-16, the 
cross-linking agent cisplatin (CisPt), the alkylating agent methyl-methanesulfonate 
(MMS) that forms DNA adducts, as well as hydrogen peroxide (H2O2) that induces both 
single and double strand breaks, were also used. Cells treated with either MMS or CisPt 
were found to have increased levels of DNA damage as measured by the γH2AX assay. 
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In addition, checkpoint kinase 1 (CHK1) was seen to increase after downregulation of 
Top2B, with CHK1 known to be a key coordinator of the DNA damage response (Patil 
et al., 2013). Kenig suggested that the increased sensitivity to oxidative stress displayed 
by Top2B depleted NCH421k cells could be a consequence of an increased DNA 
damage load and less efficient repair of DNA lesions after genotoxic stress induction. 
As oxidative stress is known to increase with age, the results shown in this chapter may 
be comparable, in part, to those discussed by Kenig et al. (2016). The decreases in 
Top2B during ageing, shown in chapter 5, and the increases of DSBs shown in this 
chapter may point towards both an increase in oxidative stress and less efficient repair 
of DNA lesions with age and highlight the crucial role of Top2B in the maintenance of 
DNA integrity.  
DSBs in neurons are repaired through pathways that are promoted by either the DNA 
repair subunit protein Ku70 or Poly (ADP-ribose) polymerase 1 (PARP-1). Mandraju et 
al. (2011) reported that Top2B associates with both Ku70 and PARP-1, suggesting that 
Top2B is associated with DSB repair in primary neurons. Results from the study 
showed that levels of Top2B increased during recovery in cerebellar granule neurons 
from rats that had been exposed to H2O2 alongside enhanced levels of Ku70 and PARP-
1. Analysis of co-immunoprecipitation experiments revealed that Top2B strongly 
interacted with Ku70 and PARP-1 in neuronal extracts that had been exposed to H2O2, 
thus implicating Top2B in DSB repair in neurons. Although increases in Top2B has 
been associated with DNA repair, it is also important to note that the generation of 
Top2B-DNA cleavage complex intermediates is required to activate early response 
genes in neurons (Madabhushi et al., 2015). Early response genes have been shown to 
be activated in response to neuronal activity and neuronal insults. Therefore, the 
presence of Top2B in this context may also be due to its transcriptional activities in 
early response gene expression (Duclot & Kabbaj, 2017). 
Recent work by Morotomi-Yano et al. (2018) showed that Top2B was rapidly recruited 
to laser-induced DSB sites. This was independent of ATM or DNA-PKcs activity but 
inhibitors of PARP-1 and HDAC could partially prevent this recruitment. The study 
also showed that catalytic inhibitors of Top2B prevented its recruitment to DSBs by 
reducing the enzyme’s mobility. Using Top2B-knockout Nalm-6 cells they also showed 
an increased sensitivity to bleomycin and decreased HR-mediated repair. However, 
further studies are required to assess the role of Top2B on NHEJ. Nevertheless, this 
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raises the intriguing possibility that the decrease in Top2B shown in chapter 5 could 
also impact on the cells ability to carry out NHEJ.  
6.3.1.3 Decreases of antioxidant system capacity in aged cells 
Antioxidant systems are also known to decrease with ageing, which may also account 
for the increases in ROS. For example, as levels of ROS increase, nuclear factor 
erythroid 2-related factor (Nrf2) translocates from the cytoplasm into the nucleus and 
activates expression of genes including glutathione, NAD(P)H/quinone oxidoreductase 
1 (NQO1) and heme oxygenase 1 (HO1), which produce antioxidant activity to 
counteract ROS (Zhang & Gordon, 2004). The activation of this transcription factor has 
been shown to decline in an age-related manner, as reported by Duan et al. (2009). 
Duan reported that expression of Nrf2 dramatically declined in aged astrocytes and in 
the spinal cord of mice and suggested that the reduced antioxidant effects induced by 
Nrf2 contributed to the increased vulnerability of the cells to oxidative stress and 
resulted in reduced neuroprotection. Furthermore, age-related declines in Nrf2 targets, 
such as glutathione, have been demonstrated in murine brain models (Sasaki et al., 
2001; Wang et al., 2003). Indeed, the restoration of Nrf2 transcriptional activity through 
the addition of epigallocatechin gallate was seen to provide protection in aged astrocytes 
(Duan et al., 2009). Alzheimer’s disease, which is associated with high levels of 
oxidative stress and an accumulation of oxidative damage, also exhibits dysfunction of 
Nrf2 (Ramsey et al., 2007). Ramsey reported a significant decrease in nuclear Nrf2 
levels in Alzheimer’s diseases cases and suggested that Nrf2-mediated transcription is 
not induced in the neurons of Alzheimer’s disease patients, despite the abundant 
presence of oxidative stress. The importance of Nrf2 in the homeostatic regulation of 
ROS suggests that the age-related increases of DNA damage seen in serum-free treated 
CAD cells in Figure 6.1 and Figure 6.2 may be due, in part, to a reduction in Nrf2 
activation. However, further investigation would be required to determine this.  
In conclusion, there may be decreased repair, increased ROS levels and decreased 
antioxidants, which would account for the increase of DSBs over time, as demonstrated 
by the γH2AX assay in Figure 6.1. 
6.3.2 DNA damage as measured by the alkaline Comet assay  
As a method of validating results seen in the γH2AX assays, the alkaline Comet assay, 
which measures both SSBs and DSBs, was used. As shown in Figure 6.2, DNA damage 
can be seen to increase in serum-free treated CAD cells over six weeks of ageing using 
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the manual method of DNA damage quantification, detailed by Collins et al. (1995). 
This is in line with other studies such as Swain & Subba Rao (2011), who demonstrated 
that DNA damage increased with age using the Comet assay. They showed that isolated 
neurons and astrocytes from the cerebral cortex of young (7 days), adult (6 months) and 
old (2 years) rats display marked increases in DNA damage in terms of SSBs and DSBs 
between young and adult samples, with further increases seen in old samples. Swain and 
Subba Rao analysed Comet images using the automated Tritek CometScore
TM
 Freeware 
v1.5 image analysis software rather than using manual methods, as shown in Figure 6.2. 
Unfortunately, issues arose when trying to quantify DNA damage using the automated 
OpenComet plugin on ImageJ during this chapter. As previously stated, the software 
was unable to successfully identify the heads and tails of every comet in each image. In 
images where cells were considerably damaged, such as week 6 images, the head of the 
comet would sometimes be separated from the tail, thus giving false measurements. 
Future experiments may have benefitted from electrophoresing cells for a shorter length 
of time to avoid this problem. In addition, adjusting the image intensity threshold of the 
software may have allowed cells with overall weaker staining intensity to be identified. 
As suggested by Gyori et al. (2014), selecting an adaptive threshold allows the software 
to take into account the illumination of each Comet assay image, which can vary 
significantly.   
In conclusion, the CAD cell line can be used as a model for ageing studies and would be 
a useful model for further work. Although it is an in vitro model of ageing and is not the 
same as organismal ageing, it may still provide a useful model of ageing. Results shown 
in serum-free treated CAD cells displaying increases in DNA damage with age are 
similar to those seen in studies of neurons isolated from rats throughout the ageing 
process (Swain & Subba Rao, 2011) and during in vivo experiments using mouse tissues 
(Sedelnikova et al., 2004). As DSBs have been shown to increase and Top2B has been 
shown to decrease during six weeks of ageing in serum-free treated CAD cells, it raises 
the interesting question as to whether Top2B can have an impact on DNA repair. Future 
work using the CAD cell line to investigate whether the epigenetic upregulation of 
Top2B can modulate DNA repair mechanisms may provide useful research as it may be 
possible to determine whether Top2B upregulation could be used as a potential strategy 





7. Final discussion and future work 
7.1 Top2 during Drosophila ageing 
The aim of chapter 3 was to establish a model of ageing in Drosophila and to carry out 
subsequent experiments to determine levels of mRNA and protein of the single 
Drosophila type 2 topoisomerase isoform, Top2, during ageing in brain tissue. 
The analysis of longevity, locomotor function and AGEs in male and female flies 
allowed appropriate age ranges to be selected to establish a robust model of ageing so 
that further experiments could observe changes in Top2 throughout the ageing process.   
Results showed that levels of Top2 protein decreased with age in both male and female 
Drosophila brain tissue (Figure 3.9). However, no significant changes in Top2 mRNA 
were seen during qPCR experiments (Figure 3.12). This is in contrast to previous 
reports in mammals that have shown decreases of mRNA in the mammalian Top2B 
isoform (Bhanu et al., 2010). There are a number of possible reasons that could explain 
the differences of mRNA and protein levels during ageing. For example, species-
specific changes may be the cause of these differences, particularly as Drosophila only 
possess a single isoform of Top2, which has been suggested to carry out the roles of 
both Top2A and Top2B in this organism (Lee & Berger, 2019). Another possible reason 
for the maintenance of Top2 mRNA in Drosophila could be partially explained by a 
study by Pacifico et al. (2018). The study demonstrated that a number of overlapping 
sets of neuronal function genes, which are seen to decline between young and middle-
aged Drosophila, become upregulated in the oldest group of flies. It was suggested that 
this reversal pattern of gene expression may be a compensatory response to an overall 
decline in neuronal function. Although Top2 was not discussed in the study, it has been 
shown to play key roles in neuronal function. Therefore, the observations by Pacifico et 
al. (2018) may explain why mRNA levels of Top2 were not decreased in 50 day old 
flies in Figure 3.12.  
As Top2 mRNA is seen to be expressed during ageing with no significant changes, why 
then were protein levels seen to decrease? The process of translation is only the first 
step in the production of functional proteins and most require assistance to correctly 
fold, which occurs either co-translationally or post-translationally. This process is 
facilitated by chaperone proteins and other partner proteins such as disulphide 
isomerases (McLaughlin & Bulleid, 1998). Studies have previously shown that 
chaperone capacity, response and activity declines with age (Soti & Csermely, 2003) 
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and can lead to misfolding of proteins and subsequent degradation. It is conceivable that 
this could occur to Top2 during ageing and result in reduced protein levels in the 
Drosophila brain. This may be one of the reasons to suggest why low levels of Top2 
protein may be seen, despite continued mRNA expression.  
A lack of Top2 protein may present a number of issues for ageing Drosophila. In 
mammals, decreases in Top2B have been shown to cause reductions in the expression 
of long genes (King et al., 2016). Similarly, Joshi et al. (2012) reported that the 
inactivation of the single Top2 isoform in yeast produced a sudden decrease of RNA 
polymerase II transcripts greater than ∼3 kb in length. Hence, it is likely that Top2 in 
Drosophila also plays important roles in the transcription of long genes. An inability to 
transcribe these long genes may lead to dysfunction of many key processes. As 
previously discussed, numerous genes that are required for proper neuronal function, 
including Sh, Csp, Hdc, Shal and Sap47, are downregulated in Drosophila during 40 
days of ageing (Hall et al., 2017). It is possible that Top2 is responsible for the 
expression of genes like these. Reductions of Top2 could therefore lead to neuronal 
dysfunction and ultimately cause neurodegeneration.  
The increase of oxidative stress-induced AGEs in female flies, shown in Figure 3.5, 
suggests that oxidative stress increases during ageing in female Drosophila. 
Interestingly, males do not display significant increases in AGEs during ageing but they 
do display significantly higher levels of AGEs than females at each age point, 
suggesting that males may have a predisposition to increased levels of oxidative stress. 
It is plausible that structural modifications to Top2 occurs via oxidative stress and this 
may result in subsequent changes, such as alterations to the active site, blockage of 
phosphorylation sites, or disruption to the binding sites for DNA, magnesium ions or 
partner proteins. These changes may lead to Top2 dysfunction and could potentially 
lead to an increase in abortive catalytic cycles of the enzyme (Morimoto et al., 2019). 
As males display significantly higher levels of AGEs throughout the life span compared 
to females, it is conceivable that modifications to proteins via oxidative stress may 
occur more frequently compared to females and at earlier stages in life. This could 
partly explain why male longevity in this study is seen to be significantly lower than 
females.  
Drosophila have provided a useful in vivo model to explore Top2 levels in brain tissue 
during ageing and may provide useful results in future research. As discussed 
previously, experiments aiming to answer whether Top2 structure is damaged with 
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ageing or whether higher levels of endogenous cleavage complexes are formed in aged 
cells can be investigated using this model. It may also be interesting to carry out further 
experiments on males and females to fully elucidate any differences in Top2 between 
the sexes during ageing. Experiments focussing on determining absolute levels of Top2 
mRNA, rather than relative levels, may allow such questions to be answered. 
 
7.2 Developing senescence in the SH-SY5Y cell line 
Developing a cell line model of ageing using the human neuroblastoma cell line SH-
SY5Y to investigate changes in Top2B expression was the focus of chapter 4. 
Numerous studies have used oxidative stress-inducing agents to prematurely induce 
cellular senescence in cell lines to use them as in vitro models of ageing (Zhang et al., 
2020). Previous studies have reported that senescence can be induced in undifferentiated 
SH-SY5Y cells using a single treatment of 100 µM H2O2 (Nopparat et al., 2017). 
Nopparat demonstrated positive senescence-associated β-gal staining in cells treated 
with H2O2. However, results shown in chapter 4 are in contrast to this. The results 
demonstrate that the higher doses of H2O2 were toxic to cells, whereas lower doses were 
not sufficient to induce cell cycle arrest. In addition, β-gal assays yielded negative 
results despite cell culture and treatments being the same as the Nopparat study. 
Piechota et al. (2016) suggested that the β-gal assay may not be suitable to determine 
senescence in neuronal cells and should be used with caution as β-gal activity cannot be 
solely attributed to senescence, either in vitro or in vivo. Piechota reported relatively 
high levels of β-gal activity in young (3 month old) mice and suggested that this marker 
may be linked to activities outside of senescence. Indeed, primary cultures of cortical 
neurons also exhibited noticeable β-gal activity early in culture during this study. If 
further work was to be carried out using this cell line it may be worth investigating 
alternative markers of senescence, such as repressor element 1-silencing transcription 
factor (REST), as it has been shown to display a pattern of expression that is correlated 
with neuronal age (Piechota et al., 2016).  
The cancerous nature of the SH-SY5Y cell line meant it was not possible to culture cells 
over a prolonged period of time to cause replicative senescence. However, 
undifferentiated SH-SY5Y also express immature neuronal markers and lack mature 
neuronal markers, thus, they are considered to be similar to immature catecholaminergic 
neurons (Lopes et al., 2010). Subsequent attempts were made to differentiate SH-SY5Y 
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cells into more neuronal-like cells (i.e. non-proliferating cells with complex dendritic 
processes that more closely resemble mature neurons) using 10 µM RA. Further 
experiments were then attempted to induce senescence in RA-treated SH-SY5Y cells 
using H2O2 to create a cell line model of neuronal ageing. Results in chapter 4 
demonstrated continued proliferation of RA-treated SH-SY5Y cells, albeit at a reduced 
rate. The SH-SY5Y cell line has been seen to produce different cellular phenotypes, 
which includes N-type cells and S-type cells. These cells demonstrate clear differences, 
with S-type cells being substrate adherent multipotent precursors to various non-
neuronal cells including glial cells, melanocytes and Schwann cells, and N-type cells 
being neuroblastic, characterised by neurite processes. The SH-SY5Y cell line is 
predominantly composed of N-type cells with only a small proportion of S-type cells 
remaining (Forster et al., 2016). However, studies have reported that S-type cells do not 
readily develop neuronal-like phenotypes when treated with RA and continue 
proliferating, unlike N-type cells (Encinas et al., 2002). This suggested that continually 
proliferating S-type cells could have been one of the reasons for the continued 
proliferation seen in this study.  
Levels of Top2A and Top2B were semi-quantified by western blot analysis in SH-
SY5Y cells over 72 hours post RA treatment. Previous studies have shown that during 
cell differentiation Top2A is typically seen to decline and Top2B is seen to be 
upregulated (Tsutsui et al., 1993; Tiwari et al., 2012; Harkin et al., 2015; Austin et al., 
2018). However, changes in protein levels of Top2A and Top2B were not significant 
over this time period and a high level of inter-experiment variability was seen (Figure 
4.6 and Figure 4.7). As S-type cells have previously been shown to continue 
proliferating during RA treatment, it was postulated that the high levels of inter-
experimental variability seen during western blotting may be due to varying levels of S-
type cell overgrowth.  
Ultimately, experiments aiming to develop a human neuronal cell line model of ageing 
were unsuccessful in chapter 4. If more time was available, changes to the methodology 
utilised on the SH-SY5Y cell line, such as increasing the exposure time of RA and 
incorporating pulses of fresh RA as it degrades could have been investigated in an 
attempt to fully differentiate cells. Reducing the FBS concentration and incorporating 
BDNF into the media or exposing cells to mitotic inhibitors following exposure to RA 
are also methods that could have been explored. However, problems with ageing 
differentiated SH-SY5Y cells may have still persisted. Work by Shipley et al. (2016) 
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demonstrated a method of inducing terminal differentiation in SH-SY5Y cells using RA 
and BDNF, as previously described. However, Shipley reported that SH-SY5Y cells are 
only stable for up to 14 days after terminal differentiation. It is conceivable that this 
may not be long enough for SH-SY5Y cells to develop an aged phenotype and to 
observe age-related changes in Top2B expression, particularly when serum-free treated 
CAD cells were capable of being aged up to six weeks in culture during this study. As 
this is the case, it may be useful to carry out further research on an alternative human 
cell line, such as HCN-2, or source primary neuronal cells. However, further ethical 
considerations would need to be addressed prior to acquiring and utilising primary 
human neuronal cells.   
 
7.3 Top2B in the CAD cell line and mouse hippocampal tissue during ageing 
In chapter 5, the murine CAD cell line was utilised to create a cell line model of ageing 
in order to semi-quantify levels of Top2B during ageing. Results from this chapter 
demonstrated that mRNA and protein levels of Top2B decline during ageing in vitro, 
whilst concomitant increases in the tumour suppressor gene p21 were also seen during 
six weeks of ageing. Results seen for Top2B are similar with those described by Bhanu 
et al. (2010), who reported a decrease in both mRNA and protein in cerebellar granule 
neurons isolated from rat pups and aged over five weeks in culture. However, it is worth 
noting that the results seen in this chapter are the first demonstration, to the best of our 
knowledge, that this decrease of Top2B has been seen in a neuronal cell line that has 
been chronologically aged.  
In contrast to results shown in Drosophila Top2, mRNA levels of Top2B were seen to 
decrease in serum-free treated CAD cells with significant reductions seen at weeks 5 
and 6 (Figure 5.9 and Figure 5.13). As previously discussed, a number of transcription 
factors that have been reported to be regulators of Top2B expression have been shown 
to decline in an age-dependent manner. The transcription factor Sp1 is involved in 
numerous cellular processes, which includes cell differentiation, cell growth, chromatin 
remodelling, immune responses, responses to DNA damage and apoptosis by binding to 
the GC and GT box sequences of gene promoters (Gory et al., 1997). This particular 
transcription factor has been shown to decrease in aged rat brains (Ammendola et al., 
1992). In addition, the transcription factor NURR1, which is known to influence the 
development, differentiation and maintenance of mesencephalic dopaminergic neurons 
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through axon genesis regulation, has also been shown to decrease in an age-dependent 
manner (Eells et al., 2002; Heng et al., 2012; Parkinson et al., 2015). Both Sp1 and 
NURR1 have been associated with the regulation of Top2B expression and as such, it is 
plausible that age-related decreases in these transcription factors may, in part, be 
responsible for the decreases of Top2B mRNA seen during ageing in chapter 5. In 
addition to reductions of transcription factors, epigenetic changes such as DNA 
methylation, which is known to be a key player in the modulation of gene expression, 
have been seen to occur during ageing (Armstrong et al., 2019). Methylation of cytosine 
is suggested to prevent gene transcription by interfering with the transcriptional 
machinery or through interference of the recognition sequence of transcription factors 
(Johnson et al., 2012). Although DNA methylation patterns that regulate tissue-specific 
gene transcription are typically shown to be stable in differentiated cells, post-mitotic 
neurons have been seen to maintain DNA methyltransferase expression and activity of 
neurons has been shown to modulate the methylation expression patterns in response to 
physiological and environmental stimuli. It is therefore plausible that changes in 
methylation patterns in neurons that occur during ageing could be another potential 
cause for the decreases of Top2B mRNA reported in this study.  
As previously discussed, it is a logical assumption that decreases in Top2B mRNA may 
also cause the age-related reductions in Top2B protein that have been demonstrated in 
this study (Figure 5.9). However, other explanations for the decrease in protein levels 
that were seen should not be discounted. As previously discussed, the misfolding and 
subsequent degradation of proteins may provide a potential cause for the decline in 
Top2B protein shown in serum-free treated CAD cells during ageing. The proteostasis 
network is a complex network of mechanisms that prevent and eliminate protein 
misfolding (Balch et al., 2008). Age-related declines to elements of the proteostasis 
network are known to take place and can result in an increase of misfolded proteins and 
subsequent aggregation, resulting in a loss of function (Kikis et al., 2010). A decline in 
the mechanisms that prevent protein misfolding may be a cause for the declines in 
Top2B protein levels in aged CAD cells. However, it is very likely that concomitant 
changes in methylation patterns, transcription factor decreases, changes to mechanisms 
of protein homeostasis and many other processes will be responsible for the decreases 
of Top2B mRNA and protein levels seen in this study.     
Alongside analysis of Top2B, protein levels of the tumour suppressor gene p21 were 
also investigated through western blot analysis (Figure 5.10). As previously stated, p21 
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is commonly used as a marker of senescence with post-mitotic neurons shown to 
develop a p21-dependent senescence-like phenotype (Jurk et al., 2012; Riessland et al., 
2019). Although further experiments would need to be carried out to determine 
statistical significance, the results from Figure 5.10 showed increases in p21 protein 
levels over six weeks of ageing, particularly at weeks 5 and 6, displaying opposite 
trends in levels compared to Top2B at these time points. Further experiments may 
demonstrate that p21 protein levels do increase significantly and provide evidence that 
CAD cells are displaying a phenotypic characteristic of aged cells, therefore 
highlighting its suitability as a model of ageing. 
In addition to experiments carried out in the murine CAD cell line, the preliminary 
study investigating Top2B levels in sections of mouse hippocampus tissue also 
displayed reductions in Top2B punctate labelling in a 31 month old animal compared to 
a 4 month old animal (Figure 5.15). Further biological replicates would need to be 
carried out to determine the statistical significance of this result. Nevertheless, if 
decreases in Top2B punctate labelling during ageing can be shown to be statistically 
significant, this would be the first time that this has been shown in mouse hippocampus 
tissue, to the best of our knowledge, and would represent an important finding using a 
mammalian in vivo model.  
Declines in Top2B expression during ageing may pose numerous problems for an 
organism. As previously discussed, normal cognitive function relies heavily on the 
accurate regulation of DNA methylation, with changes in methylation patterns known to 
affect the chromatin architecture of DNA. The progression of neurodegenerative 
diseases has been associated with these changes in methylation patterns (Berson et al., 
2018). It has been suggested that Top2B is required for the maintenance of chromatin 
structure (Tiwari et al., 2012), as well as being crucial for the development and 
maintenance of neurons, whilst also being involved in transcriptional roles such as RNA 
polymerase II pause release and elongation, which is vital for the transcription of long 
genes. It is likely that age-related decreases in levels of Top2B will have detrimental 
effects on gene expression and neuronal function, particularly in areas with altered 
chromatin architecture caused by changes in DNA methylation, which may 
subsequently lead to neurodegeneration. Top2B has also been shown to have roles in 
DNA repair, as discussed by Gupta et al. (2012), who suggested that the capacity of 
BER in neurons is regulated by Top2B-mediated DNA breaks. Work by Morotomi-
Yano et al. (2018) also suggested roles for Top2B in DSB repair pathways. Indeed, 
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reductions of Top2B may cause neuronal dysfunction and present transcriptional issues, 
resulting in an accumulation of DNA damage, but it may also impair crucial pathways 
that are responsible for repairing this damage and ultimately lead to cell death. 
 
7.4 Increases of DNA damage during ageing 
In chapter 6, the CAD cell line was utilised to investigate levels of DNA damage during 
ageing in vitro. DNA damage, in the form of DSBs, was seen to progressively increase 
over six weeks of ageing in serum-free treated CAD cells, as demonstrated by the 
γH2AX assay (Figure 6.1). This was supported by the alkaline Comet assay, which also 
demonstrated increases in DNA damage (SSBs and DSBs) over the same time period 
(Figure 6.2). Results from this study are in line with previous studies that have also 
demonstrated an accumulation of DSBs in ageing mice (Sedelnikova et al., 2004). 
Sedelnikova reported age-related increases in γH2AX foci in mouse tissue obtained 
from brain, liver, testes, kidney and lung from 2 to 20 month old tissue samples. As 
CAD cells are an in vitro model, the fact that results are similar to in vivo models is an 
encouraging sign for the use of this cell line as a model of ageing. Higher levels of 
γH2AX foci in the brain tissues from patients with mild age-related cognitive 
impairment and Alzheimer’s disease have been shown compared to unimpaired controls 
(Shandhag et al., 2019). This suggests that DNA damage increases during ageing, per 
se, and is exacerbated in certain disease states. Indeed, accumulations of DNA damage 
have been shown to be a predominant feature of numerous age-related 
neurodegenerative diseases, with DSBs causing severe adverse effects on DNA, which 
can subsequently effect gene expression, chromatin stability and cellular functions 
(Stein & Toiber, 2017). 
Alongside increases in DNA damage during ageing, concomitant decreases in DNA 
repair pathway efficiency has also been reported, with organs of the central nervous 
system seen to be particularly affected by impaired repair (Baltanás et al., 2011; 
Borgesius et al., 2011; Alt & Schwer, 2018). The increases of DNA damage shown in 
chapter 6 may be the result of a decrease in efficiency of the NHEJ repair pathway. 
NHEJ is the predominant repair pathway used to repair DSBs in post-mitotic neurons 
and previous studies have demonstrated decreases in its efficiency during ageing 
(Seluanov et al., 2004; Vyjayanti & Rao, 2006). In addition, increases in DNA damage 
may also be attributed to increased levels of endogenous ROS, as they are known to 
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amplify the development of damage to DNA, via oxidation of bases, which can induce 
base lesions and lead to senescence, apoptosis and necrosis (Lundgren et al., 2018). The 
BER pathway is typically responsible for the repair of damaged bases. However, when 
oxidised bases occur simultaneously on opposing strands of DNA, attempted BER can 
lead to the generation of DSBs (Cannan et al., 2014). The suggested roles of Top2B in 
regulating BER, via BER pathway intermediates, may influence the progression of 
DNA damage during ageing (Gupta et al., 2012). Studies have shown that glioblastoma 
cells displaying increased levels of Top2B are more resistant to chemotherapeutic and 
oxidative stress-inducing agents compared to cells displaying low levels of Top2B, 
which highlights its potential roles in DNA repair mechanisms (Kenig et al., 2016). 
Indeed, Top2B has also been reported to associate in neuronal extracts with DNA repair 
protein Ku70 and PARP-1, both of which are promotors of DNA repair pathways 
(Mandraju et al., 2011). It is therefore plausible that the declines of Top2B mRNA and 
protein levels shown in chapter 5 contribute towards an increase of unrepaired oxidised 
bases on opposing DNA strands, leading to an increase in DSBs during ageing. As 
discussed previously, the expression of early response genes has been seen to be 
activated in response to neuronal activity and neuronal insults. Top2B is required for 
early response gene expression, so its decline during ageing may also have implications 
on the transcription of these genes (Madabhushi et al., 2015). Decreases in repair 
pathway efficiency, increases in ROS levels and decreases in antioxidants may all 
account for the increases of DSBs over time in the CAD cell line, as demonstrated by 
the γH2AX assay in Figure 6.1. 
The CAD cell line has provided a useful model of ageing during this study and may be a 
suitable model for future investigations. It may be interesting to fully elucidate the roles 
of Top2B in DNA repair mechanisms by upregulating its expression in chronologically 
aged cells. By doing this it will be possible to find out whether DNA damage decreases 
in aged cells with increased Top2B expression and may provide future research to find a 
potential therapeutic use in neurodegenerative conditions.    
 
7.5 Conclusion 
To conclude, the focus of this project was to determine the expression of Top2B in aged 
neurons through the development of suitable models. Top2B has previously been shown 
to be a crucial component of neuronal differentiation and development, illustrated by 
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the genetic deletion of Top2B in mice, which has been seen to cause neuronal defects 
during development (Lyu & Wang, 2003). However, studies investigating age-related 
changes in Top2B expression in neuronal tissue are limited. 
The body of work presented in this thesis provides evidence that during ageing Top2 
decreases in the brain tissue of Drosophila, with decreases of Top2B in the CAD mouse 
neuronal cell line also seen. Decreases of Top2B in CAD cells are accompanied by an 
increase in DNA damage. Interestingly, preliminary experiments on mouse 
hippocampal tissue also revealed a decrease in Top2B during ageing. To further our 
understanding of Top2B, it is imperative to investigate whether these changes are 
observed in human brain tissues during normal ageing. It would also be extremely 
interesting to see if there is a difference in expression of Top2B in normally aged 
individuals versus those with neurodegenerative conditions. Highlighting any 
differences between normal and disease states may provide further scope for research 
into potential therapeutic targets. 
Top2B has been shown to display a wide range of roles in the development and 
maintenance of neuronal cells in previous studies, including roles in RNA Polymerase II 
pause release and elongation, transcription of long genes and early response genes and 
roles in DNA repair pathways. It is therefore highly likely that a decrease of Top2B 
during ageing will have detrimental effects on a number of biological processes and 
potentially lead to neurodegenerative conditions. Elucidating the exact functional 
consequences of reductions in Top2B on transcription and repair pathways will improve 
our understanding of its roles in these processes. Furthermore, the cause of declining 
levels of Top2B also needs to be investigated. It is likely that reductions in Top2B will 
be caused by several mechanisms and research aiming to understand why Top2B 
reduces during ageing may be of great importance.  
Numerous neurodegenerative diseases are linked to increases in oxidative stress and 
subsequent DNA damage, which includes Parkinson’s disease, Alzheimer’s disease, 
multiple sclerosis, motor neurone disease, Huntington’s disease, mild cognitive 
impairment and cerebral ischemia (Venkataraman et al., 2013). As DNA damage has 
been shown to increase during ageing, with accompanying decreases in Top2B, as 
shown by our studies in the CAD cell line, future research may benefit from 
investigating whether an upregulation of Top2B is able to reduce the amount of DNA 
damage that occurs during ageing. If DNA damage is shown to decrease with Top2B 
upregulation it will provide further opportunities for investigation. Preliminary studies 
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showed that Top2B decreased during ageing in mouse hippocampal tissue. As the 
hippocampus is crucial for learning and memory formation and is a brain region 
prominently affected in Alzheimer’s disease, exploring Top2B modulation in ageing 
may ultimately provide a potential target for future therapeutics in neurodegenerative 
diseases.  
This work has shown that Top2 decreases in Drosophila during ageing and Top2B is 
decreased in aged mouse neuronal cells, with a concomitant increase in DNA damage. 
This provides solid evidence that future work is imperative to understand the impact of 
this in humans during the ageing process and could provide insights into mechanisms 
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=             (Sum of No. deaths group 1 – expected No. deaths group 1)
2 
             
                                 Expected No. deaths group 1 
                                                                                                              + 
                    (Sum of No. deaths group 2 – expected No. deaths group 2)
2 
             
                                 Expected No. deaths group 2 
Figure A.1 Calculating statistical significance using the log-rank test. 
(A) Equation used to perform a log-rank test as shown in Figure 3.2 to determine statistical 
significance of Drosophila longevity. ΣOjt represents the sum of the observed number of 
events in the j
th
 group over time and ΣEjt represents the sum of the expected number of events in 
the jth group over time. (B) Practical example of how log-rank tests were calculated in this 
study. The value given after the final calculation is approximately distributed as chi-square with 
1 degree of freedom. Thus, the critical value for the test can be found in the table of critical 
values of the X
2 
distribution. 






























0 300 300 600 0 0 0 0 0 
3 296 296 592 4 4 8 2 2 
6 296 296 592 0 0 0 0 0 
9 289 296 585 7 0 7 3.4581 0.506003 












Figure A.2 Optimisation of Drosophila brain protein extraction and western blot analysis 
of Top2. 
Drosophila were selected (Mixed ages), processed and protein was extracted as described in 
2.2.1.9 from 30 (27.85 µg total protein load), 40 (34.47 µg total protein load) and 50 (41.63 µg 
total protein load) brains, respectively. Protein samples were loaded onto a 7.5% SDS gel and 
western blotting was performed.  
 
 
Primer efficiency = (10
(-1/slope)
-1) x 100 
Example: Top2 primer efficiency from Figure 3.10 
= (10
(-1/-3.2473)
-1) x 100 
Efficiency = 103.2% 
 
Figure A.3 Calculating the efficiency of primers. 
































Figure A.4 Representative melt curves from RT-qPCR of primers used in Drosophila 
experiments. 
Melt curves of primer optimisation experiments. (A) Melt curve for Top2. (B) Melt curve for 

















Figure A.5 Analysing qPCR results with two reference genes. 
Relative gene expression using two reference genes was calculated using these equations. (A) 
Converted primer efficiencies were calculated by using the equation with previously calculated 
primer efficiencies as described in Figure A. ΔCt was calculated by subtracting the sample Ct 
from the control average Ct. (B) RQ was calculated. E in the equation is the base of exponential 
amplification (the converted primer efficiency of the reaction). (C) Relative gene expression 
was calculated where GOI is the gene of interest, REFs are the reference genes and GEOMEAN 























Coefficient of variance =                                     x 100 
 
Figure A.6 Example calculation of the coefficient of variance of qPCR primers using Ct 
data. 
The coefficient of variance (CV) is calculated using the mean Ct value of the primer and the 
standard deviation (SD) of the Ct values. The higher the CV value, the greater the level of 
















































p value (Test vs Control) 
0.1 24 0.222 
0.1 48 0.206 
0.1 72 0.073 
0.5 24 0.014* 
0.5 48 0.154 
0.5 72 0.0002** 
1.0 24 0.018* 
1.0 48 0.008** 
1.0 72 0.0002** 
2.0 24 0.0505 
2.0 48 <0.0001*** 





p value (Test vs Control) 
0.1 24 0.314 
0.1 48 <0.0001*** 
0.5 24 0.054 
0.5 48 <0.0001*** 
1.0 24 0.033* 
1.0 48 0.005** 
5.0 24 <0.0001*** 
5.0 48 0.003** 
10.0 24 0.0014** 























Figure C.1 Representative melt curves from RT-qPCR of primers used in CAD 
experiments. 
Melt curves of primer optimisation experiments. (A) Melt curve for Top2B. (B) Melt 





ΔCte (experimental) = Average Ct (gene of interest) – Average Ct (reference gene) 
ΔCtc (control) = Average Ct (gene of interest) – Average Ct (reference gene) 
ΔΔCt = ΔCte – ΔCtc 
Relative fold change = 2 
–ΔΔCt 
 
Figure C.2 Analysing qPCR results with one reference gene 
Calculations used to determine relative changes in gene expression using the ΔCt method as 
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